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Dopamine, an important modulatory neurotransmitter, influences a 
wide range of brain functions through its action on different brain 
regions. Particularly, its role as a modulator of the plasticity processes 
underlying learning and memory, reward and goal-directed behaviors is 
well recognized. Hippocampal dopamine acting through D1/D5 
receptors is proposed to mediate informational saliency and thus 
promote the persistence of hippocampus-dependent long-term 
memories. Altered dopaminergic signaling is implicated in the 
pathophysiology of many neuropsychiatric and addictive disorders and 
in the age-associated memory deficits.  
 
In this study, using cellular models of memory such as long-term 
potentiation (LTP) and synaptic tagging and capture (STC) in acute 
hippocampal slices of rats, we have investigated how the dopaminergic 
mechanisms differentially influence the information processing and 
affect the encoding and maintenance of memories. We present 
evidence for an interesting aspect of dopaminergic modulation that in 
CA1 pyramidal neurons, dopamine D1/D5 receptor activation leads to 
dose-dependent, differential intracellular mechanisms which 
significantly influence the ongoing associative information processing. 
We reveal a critical dose-sensor and integrator role for mitogen-
activated kinases in these mechanisms. These results provide hints at 
  ix 
how concomitant activation of homosynaptic and heterosynaptic 
modulatory mechanisms help to tune the specificity of the plasticity 
events and the duration of the plastic change. As it is known that many 
addictive drugs and drugs used to treat certain neuropsychiatric 
conditions also result in altered extracellular dopamine concentrations, 
our results present an important aspect to consider in understanding 
and treating these conditions.   
 
In the second part of the study, we have investigated the impairments 
in the synaptic plasticity processes in aging and provide evidence for 
altered plasticity and dopaminergic mechanisms, and the consequent 
deficits in associative information processing. We also report a possible 
strategy for restoration of the observed deficits using a cell-permeable 
Zn2+ chelator. These results have implications in understanding the 
adverse consequences of Zn2+ accumulation on synaptic plasticity 
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CHAPTER 1 – INTRODUCTION 
 
1.1 Brain, plasticity and memory 
 
One of the longstanding quests in science is to understand how the 
brain coordinates and carries out an array of functions attributed to it. 
Brain is one of the most complex organs with an estimated hundred 
billion neurons, about 10 to 50 times more glial cells and trillions of 
connections between them. A significant leap in the understanding of 
brain function has been the appreciation of the ‘plastic’ nature of the 
brain i.e., connections in the brain are not hardwired but they change 
and reorganize with one’s experiences. 
  
Of the many functions attributed to the brain, learning and memory are 
among the most fundamental. All organisms, vertebrates and 
invertebrates alike, constantly need to adapt to the changes in their 
environments for survival. Learning and memory are highly crucial for 
this adaptability. To learn and to remember which is a predator, which 
is a prey, where to find food, how to head back to the shelter, what is 
safe and what is not, are all critical for survival. For higher order 
animals, learning and memory serve not just the survival functions but 
also support their complex behaviors; for instance, enabling language 
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and communication, finding and courting a sexual partner, guarding a 
group or protecting the progeny, social behaviors etc., 
  
For humans, learning and memory’s role becomes even more crucial 
with the array of complex behaviors getting large, with the multitude of 
skills we have acquired and continue to acquire. With a minute to 
ponder, one would appreciate that it is almost impossible to imagine a 
life without memory! Our personality arises out of our memories. Our 
everyday lives would be in a mess if not for memories. 
 
“You have to begin to lose your memory, if only in bits and pieces, to 
realize that memory is what makes our lives. Life without memory is no 
life at all. Our memory is our coherence, our reason, our feeling, even 
our action. Without it we are nothing.”  
                                                                                       ― Luis Buñuel  
 
1.2 Memory and the role of hippocampus 
 
1.2.1 In search of memory: Role of hippocampus 
 
The hippocampus had caught the attention of the anatomists since 
earlier times because of its striking appearance resembling a ram’s 
horn (Latin: Cornu Ammonis) or a seahorse (‘Hippocampus’ as coined 
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by the 16th century anatomist Giulio Arantius). Its unique 
cytoarchitecture with neuronal cell bodies organized into single layers 
and their dendritic trees projecting in definite orientation was quite 
impressive to the researchers.  
 
Over the course of research, many functions have been associated 
with the hippocampus. However, it was Sanger Brown and Hans 
Schäfer (1888) who together first hinted at the hippocampus’ role in 
memory by their observations in rhesus monkeys with bilateral 
temporal lobe lesions. This initial observation was followed-up by a 
report from Vladimir Bekhterev (1900) who associated memory 
impairments in two of his patients to lesions in the hippocampus and 
neighboring cortical areas. Later, German psychologist Richard Semon 
(1908) coined the term ‘engram’ referring to the physical change in the 
neurons that constituted a memory trace. 
 
Even though there had been hints about a role for the hippocampus in 
memory, more direct evidence of this came from the observations of 
William Scoville and Brenda Milner (1957), particularly in a patient 
named Henry Gustav Molaison (known famously as H.M). H.M suffered 
from intractable epileptic seizures from his childhood and as an attempt 
to remove the source of seizures, neurosurgeon Scoville removed 
large parts of his temporal lobe. Though successful in reducing his 
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seizures, this surgery left H.M with severe global amnesia, both 
anterograde and retrograde, that persisted until he passed away in 
2008.  He was then “locked” forever in the present as his memory for 
events from the day of operation was very short-lived (anterograde) 
and he was unable to recall information experienced for many years 
prior to the operation (retrograde). As he himself described, it was as if 
he was ‘constantly waking up from a dream’ every moment. Following 
the operation, H.M’s cognitive abilities were studied extensively by 
Milner and others, and in true sense, he dedicated himself to the 
advancement of our understanding. As Dr. Suzanne Corkin, who 
worked with H.M for a long time, noted in one of her articles (Corkin, 
2002): 
“He (H.M) has taught us a great deal about the cognitive and neural 
organization of memory. We are in his debt.” 
 
1.2.2 Types of memory and memory systems 
 
In the 1970s through 80s, various propositions suggested that there 
could be more than one type of memory. Of importance were Endel 
Tulving’s suggestion of classifying memories into episodic 
(spatiotemporal context-dependent) and semantic (context-
independent) (Tulving and Donaldson, 1972), Gaffan’s proposal of 
recognition and association memory forms (Gaffan, 1974) and 
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suggestion from Hirsh (1974) of context-bound and context free 
memories. Based on the discovery of hippocampal place cells in rats 
(O'Keefe and Dostrovsky, 1971), Nadel and O’Keefe (1974) suggested 
that only place learning and episodic memories critically depended on 
hippocampus whereas other brain circuits were involved in other forms 
of memory. Cohen and Squire extended these ideas and proposed that 
memories could be distinguished as declarative and procedural 
memories (Cohen and Squire, 1980; Squire and Zola-Morgan, 1988).  
Some psychologists also used different terms such as explicit and 
implicit memories to appreciate different types of memory.  
 
Declarative (explicit) forms of the memory are the ones which can be 
consciously retrieved and involve the memory for facts (semantic) and 
events (episodic). Non-declarative (implicit) forms, on the other hand, 
do not need conscious effort in retrieving and involve the various forms 
of procedural, skill and non-associative memories (Nadel, 2008). A 
general classification of memory systems is shown in Figure 1.1. 
     
Hippocampus, along with other medial temporal lobe structures, 
supports formation, consolidation and retrieval of many forms of spatial 
and nonspatial declarative forms of memory. The sensory information 
from the sensory and association cortices enters the hippocampus 
through entorhinal cortex (EC). EC can relay both nonspatial and 
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spatial sensory information, from lateral entorhinal cortex (LEC) and 
medial entorhinal cortex (MEC) respectively. The global amnesia in 
H.M seems to have been resulted from the bilateral removal of the 
hippocampus, amygdala, entorhinal cortex and other para-hippocampal 





Figure 1.1: Types of memory. A scheme representing the different 
types of memory and the main brain structures involved.  
(Adapted and modified from Neurobiology of Learning and Memory, 82(3), Squire L, Memory 
systems of the brain: A brief history and current perspective, 171-177, Copyright (2004), with 
permission from Elsevier; (Squire, 2004)). 
 
A parallel line of thought suggests that there exist multiple knowledge 
systems each capable of processing and storing knowledge; the 
difference between the systems is reflected only in the nature of 
knowledge they process and on the time scale of storage (Nadel, 
2008). Here, hippocampus is a crucial part of the ‘knowing where’ 
system, which provides specific information concerning the animal’s 
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location in space and the context of events. Such cognitive mapping 
system makes hippocampus a critical structure involved in episodic 
memory. 
 
1.2.3 Memory consolidation 
 
Memory formation involves three distinct phases of acquisition, 
consolidation and retrieval (Abel and Lattal, 2001; McGaugh, 2000). 
Acquisition is the process where the sensory information is acquired 
and when the sensory information is significantly strong, relevant or 
attended to, it becomes encoded as a short-term memory (STM). 
STMs are labile and last for a short duration (from seconds to hours). 
However, some memories with high emotional content, however, can 
be immediately encoded as long-term memories and those are called 
‘flashbulb memories.’ For the STM to last longer, it has to undergo a 
process of ‘consolidation’ wherein it is stabilized by a host of 
mechanisms. Thus, memory consolidation is a process of gradually 
converting STMs into long-term memories (LTMs).  
 
Consolidation mechanisms operate at different levels and timescales. 
Cellular consolidation involves both synaptic and cell-wide mechanisms 
whereas systems consolidation involves dynamic interaction between 
the initial traces and their representations in the cortex. Hippocampus 
plays a crucial role in the consolidation of declarative and spatial forms 
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of memories. Retrieval is the process of recalling the memories from 
storage. It is now clear that memories are again labile and vulnerable 
to modifications upon retrieval (Nader et al., 2000; Sara, 2000a; Sara, 
2000b) and are stored back in a process termed ‘reconsolidation’. 
Reconsolidation can also serve as a means to ‘update’ memories. 
Recently, a further distinction has been made with the introduction of 
‘working memory’, which is the memory actively held at any instance 
for on-line manipulation. Although similar to STM, working memory also 
involves brain regions other than hippocampus. A general scheme of 





Figure 1.2: Memory consolidation. A scheme representing the 
processes of memory consolidation, retrieval and reconsolidation. 




1.2.4 Hippocampal anatomy and circuitry 
 
Pioneering works of Santiago Ramon y Cajal (1857-1934) and Lorente 
de Ńo (1934) laid foundations for the hippocampal neuroanatomical 
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studies. Cajal particularly noted the laminar arrangement of the afferent 
systems and the direction of signal flow, while De Ńo described 
hippocampal cell types, dendritic arbor and connections and divided 
the hippocampal formation into defined sub-regions terming them CA1, 
CA2, CA3 and CA4.  
 
The term hippocampal formation sometimes refers to the hippocampus 
proper, dentate gyrus (DG), subicular complex, entorhinal cortex (EC) 
together. One of the distinguishing features of the information flow 
along major synaptic connections of hippocampal is that it is mostly 
unidirectional and the regions do not project back to the region from 
where they receive the direct afferents (Amaral and Witter, 1995). 
 
Major components of the hippocampal synaptic network are shown in 
Figure 1.3. The hippocampus receives major multimodal sensory 
inputs from the sensory and association cortices, which mainly enter 
hippocampal circuit through projections from the medial and lateral EC 
(Amaral and Witter, 1995). One major input is the perforant pathway 
(PP) which is the projection from the EC layer II, through angular 
bundle, synapsing to the DG. The dentate granule cells, in turn, send 
projections to the CA3 neurons via the mossy fiber (MF) pathway. CA3 
pyramidal neurons then project to the CA2 and CA1 fields. Axons of 
CA3 neurons that synapse onto CA1/CA2 dendrites have been named 
  10 
as Schaffer collaterals (SC) (after the Hungarian anatomist, Karl 
Schaffer, 1892). 
 
Figure 1.3: The Hippocampal circuitry: A schematic of a rodent brain 
showing the hippocampus and a transverse section. The enlarged view 
shows the major components of hippocampal network. For description 
see text below (Reprinted by permission from Macmillan Publishers Ltd: Nature 
Reviews Neuroscience. Neves et al. copyright 2008; (Neves et al., 2008)). 
 
 
CA3 neurons also send associational axon branches to other CA3 cells 
in the region that constitutes the associational or recurrent fibers. 
Pyramidal neurons of the CA1 field then project both to subiculum as 
well as to deep layers of entorhinal cortex. Subicular neurons finally 
send their projections back to EC and to the pre- and parasubiculum. 
 
All the subfields of the hippocampus proper (i.e., CA3, CA2 and CA1) 
have a similar laminar organization. The principal cells in these fields 
are called pyramidal cells (See Figure 1.4 for a typical CA1 pyramidal 
neuron). The pyramidal cells are packed into a layer termed ‘stratum 
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pyramidale (s.p)’ (Pyramidal cell layer). The basal dendrites of these 
cells extend into a layer called ‘stratum oriens (s.o)’ which also has 
many types of interneurons (Lavenex et al., 2007) 
 
Some CA3-CA3 association fibers and CA3 to CA1/CA2 Schaffer 
collateral fibers are located in the stratum oriens. On top of the stratum 
oriens is a fiber-containing layer called alveus. Only in CA3 field, there 
is also a layer called ‘stratum lucidum (s.l)’ beneath the pyramidal layer 
which is occupied by mossy fibers. The apical dendrites of the 
pyramidal cells extend to ‘stratum radiatum (s.r)’ which is located 
immediately below the 
pyramidal layer in CA1 and 
CA2 but below stratum 
lucidum in CA3. This is the 
major layer with CA3 to CA3 
association fiber synapses 
and the CA3 to CA1/CA2 
Schaffer collateral synapses. 
The apical dendrites also 
extend to a more distal region 
called ‘stratum lacunosum 
moleculare (s.l.m)’ where the 
fibers from the entorhinal 
cortex terminate (temporoammonic-alvear pathway or a branch of 
 
 
Figure 1.4: CA1 pyramidal neuron 
and layer-specific inputs. Line 
drawing of a CA1 pyramidal neuron 
showing the dendritic tree and the 
layer-specific inputs that it receives (for 
description see text). 
(Line drawing reprinted by permission from Journal 
of Comparative Neurology. Bannister and Larkman, 
1995. Copyright © 1999-2016, John Wiley & Sons, 
Inc. All Rights Reserved; (Bannister and Larkman, 
1995)). 
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perforant path). However, the entorhinal cortex inputs received at 
different locations along the transverse axis of CA1 differ and are from 
layer III neurons as opposed to layer II neurons that project to CA3 and 
CA2 (Amaral and Lavenex, 2007).  
 
CA3 and CA2 are heavily innervated by associational connections (i.e., 
collaterals of their own axons) and from commisural fibers (i.e., axons 
of the contralateral CA3 and CA2). Both radiatum and lacunosum 
moleculare contain different classes of interneurons. CA1 is one of the 
major output regions of the hippocampus. CA2 and CA3 have almost 
no known direct projections to the neocortex. Along with the major CA3 
Schaffer collateral input (and probably inputs from CA2), CA1 neurons 
receive inputs from LEC and MEC depending on their location along 
the transverse axis and they project back to the same region of EC 
(Amaral et al., 2007). 
 
In the human brain, hippocampus appears as a fold or bulge occupying 
the floor of the lateral ventricle. The rat hippocampal formation is an 
elongated structure with its C-shaped long axis extending from the 
midline near septal nuclei arching over and behind the thalamus into 
the temporal lobe.  Because of its unique orientation, it has a septal 
pole and a temporal pole (the long axis being septotemporal axis) as 
well as a dorsal and a ventral portion. Hence the orthogonal axis is also 
referred to as its transverse axis (Amaral et al., 2007).   
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1.2.5 Neuromodulators in hippocampus 
 
 
Hippocampal functions are subject to a wide variety of modulatory 
influences by the neurotransmitters such as dopamine, noradrenaline, 
acetylcholine, endocannabinoids and by other hormones. Many of the 
subcortical, brain stem and hypothalamic nuclei send their projections 
to different regions of the hippocampal formation. Studies that used 
anterograde and retrograde tracing of projections in rodents showed 
that the CA1 region received (i) large cholinergic inputs from the septal 
nuclei (Swanson,1987); (ii) serotonergic inputs from the raphe nuclei; 
(iii) noradrenergic inputs from the pontine nuclei locus coeruleus (LC); 
and (iv) dopaminergic inputs from the ventral tegmental area (VTA) and 
substantia nigra pars compacta (SNPc) (Bischoff et al., 1979; Gasbarri 
et al., 1997; Gasbarri et al., 1994; Scatton et al., 1980; Storm-
Mathisen, 1977a; Storm-Mathisen, 1977b). Though the CA1 pyramidal 
neurons express various classes of receptors for each of these 
neuromodulators, the distribution of receptors can be 
compartmentalized in various subcellular domains. The various classes 
of interneurons in the region might also differ in the receptors they 
express. This means that the same modulatory neurotransmitter might 
have different actions on different neuronal compartments. 
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1.3 Hippocampal synaptic plasticity and memory 
 
1.3.1 Synaptic plasticity and memory 
 
Cajal, with his ‘Neuron Doctrine’, had suggested that neurons were not 
syncytial but individual entities. Later, Charles Sherrington showed that 
neurons communicate at a junction called ‘Synapse’ (Sherrington, 
1897) and that it forms the basis of neuronal function (Sherrington, 
1906). Polish psychologist Jerzy Konorski (1948) coined the term 
“Synaptic plasticity” to refer to the changes in synaptic efficacy. Donald 
Hebb, a Canadian psychologist, first proposed the concept that 
synaptic connections could be strengthened via activity-dependent 
mechanisms. In his book ‘The Organization of Behavior: A 
Neuropsychological Theory’ (1949), he proposed, 
 
“When an axon of cell A is near enough to excite cell B and repeatedly 
and persistently takes part in firing it, some growth process or 
metabolic change takes place in one or both the cells such that A’s 
efficiency as one of the cells firing B, is increased.” 
 
Hebb’s postulate can essentially be stated as ‘cells that fire together, 
wire together’. Though the Hebb’s postulate was unattended for quite 
some time, it gained renewed interest after the discovery of the 
phenomenon of long-term potentiation (LTP) by Timothy Bliss and 
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Terje Lomo in 1973 (Bliss and Lomo, 1973). Bliss and Lomo, while 
working with anaesthetized rabbits observed that a brief, strong tetanic 
stimulation of the perforant path inputs to the DG resulted in a long-
lasting enhancement in the strength of excitatory synaptic transmission 
at these synapses. Shortly before these findings, Kandel and Spencer, 
with their seminal paper in 1968, “‘Cellular neurophysiological 
approaches in the study of learning,’’ had stressed on the novel cellular 
approaches to address the psychological concepts of learning (Kandel 
and Spencer, 1968). Eric Kandel used the invertebrate sea slug 
Aplysia to elegantly demonstrate many of the invertebrate models of 
learning and spearheaded an era of investigation into the 
neurobiological basis of learning and memory. The capacity for 
alterations of synaptic connection between neurons was later proposed 
as a correlate of memory formation (“Synaptic Plasticity and Memory 
Hypothesis”; (Martin et al., 2000). 
 
Forms of plasticity that could be the basis of persistent behavioral 
outcome necessarily need to be long lasting. LTP and LTD constitute 
such long-lasting forms of plasticity, and they are respectively the 
persistent increase or decrease in synaptic strength resulting from 
specific patterns of synaptic activity (Malenka and Bear, 2004). Since 
their discovery, LTP, LTD and other related activity-dependent 
phenomena have been demonstrated in a wide range of synapses in 
different regions of the nervous system, in various organisms ranging 
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from sea slugs to flies to mammals and are currently regarded as the 
leading candidate cellular models for learning and memory formation. 
Additional forms of synaptic plasticity such as homeostatic plasticity 
(Turrigiano and Nelson, 2004) and metaplasticity (Abraham and Bear, 
1996) have also been reported. 
 
1.3.2 Long-term potentiation (LTP) and Long-term depression 
(LTD) 
 
LTP is the persistent increase in the strength of the synaptic 
connections following a brief period of activity (Figure 1.5) (Bliss and 
Gardner-Medwin, 1973; Bliss and Lomo, 1973; Bliss and Collingridge, 
1993). LTP, in itself, is a broad term that denotes the long-lasting 
increase in synaptic strength resulting from a wide variety of stimulation 
or patterns of activity and thus the underlying mechanisms that give 
rise to LTP in each case may not be the same. Following its first report, 
many different forms of LTP have been demonstrated in the excitatory 
synapses of many brain regions. The most studied among all and 
probably the best characterized is NMDA receptor-dependent LTP at 
the Schaffer collateral synapses of the hippocampal CA1 region. 
 
If synaptic connections are only strengthened by LTP, however, the 
network would readily approach saturation and prevent the acquisition 
of new information. LTD, a persistent decrease in the synaptic efficacy 
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(Figure 1.5), and related mechanisms prevent such saturation by 
selectively decreasing synaptic weights (Bear, 1995; Malenka and 








Figure 1.5: LTP and LTD. High frequency stimulation (HFS) induced 
LTP and Low-frequency stimulation (LFS) induced LTD of field EPSP 
slopes. Representative traces are shown on the right. (Reprinted by 
permission from Macmillan Publishers Ltd: Nature Chemical Biology. Fleming and England. 
copyright 2010; (Fleming and England, 2010)). 
 
 
1.3.3 Types of LTP 
 
The type of LTP elicited depends on many factors. As mentioned 
above, different types of LTP, differing in the underlying mechanisms, 
can be elicited with particular patterns of stimulation paradigm. LTP 
also depends on the age of the animals being studied, specific brain 
region and synapses under consideration and the timing of pre- and 
post-synaptic stimulation. Two broad types are NMDAR-dependent and 
NMDAR-independent forms. The classic form of LTP induced by 
tetanic stimulation at CA1-SC synapses is NMDAR-dependent 
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(Collingridge et al., 1983). NMDAR-independent forms include the 200-
Hz LTP in CA1 region induced with four 0.5-s, 200-Hz stimuli 
separated by 5 s (Grover and Teyler, 1990), TEA LTP (induced using 
tetraethylammonium (TEA+) ion application in CA1; (Aniksztejn and 
Ben-Ari, 1991; Powell et al., 1994) and the predominantly presynaptic 
mechanism-mediated mossy fiber LTP in CA3 (MF-LTP); (Harris and 
Cotman, 1986; Zalutsky and Nicoll, 1990). 
 
1.3.3.1 Slow-onset potentiation (SOP) 
 
Most forms of LTP are accompanied by a rapid change in the 
Excitatory post-synaptic potential (EPSP) or current (EPSC) 
magnitude, immediately following the LTP inducing stimuli. However, 
this is not the case with the potentiation induced by direct application of 
certain chemicals. Such potentiation where there is no change in EPSP 
magnitude at the time of induction but the increase in synaptic strength 
develops gradually over time, is termed ‘slow-onset potentiation (SOP)’ 
or sometimes as ‘chemical LTP’. SOP has been observed in the CA1 
region following application of either dopamine or the dopamine D1/D5 
receptor agonist SKF-38393 (Huang and Kandel, 1995; Navakkode et 
al., 2007; Navakkode et al., 2012; Sajikumar et al., 2005), cAMP 
analogs (Frey et al., 1993), BDNF (Messaoudi et al., 2002), the 
adenylyl cyclase activator forskolin (Huang, 1997; Lu et al., 1999), 
carbachol (Auerbach and Segal, 1994), group I mGluR agonists 
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(Manahan-Vaughan and Reymann, 1997) to acute hippocampal slices. 
Interestingly, these forms of SOP lack the early phase of LTP.  
 
1.3.4 NMDAR-dependent LTP: Properties  
 
NMDA receptor-dependent LTP of synaptic transmission represents an 
example of a Hebbian learning rule in that a strong stimulus to the 
presynaptic cells drives the spike firing in the postsynaptic cells when 





Four properties of NMDAR-dependent LTP make it an attractive 
candidate model for memory.  
1)   Persistence: LTP, unlike short-term forms of plasticity, can persist 
for long periods and thus offers a basis for explaining memory 
formation and maintenance (Bliss and Gardner-Medwin, 1973; Bliss 
and Lomo, 1973). 
2)   Input-specificity (Andersen et al., 1977; Bliss and Lomo, 1973): Out 
of the numerous synaptic inputs onto a neuron, LTP is only elicited 
in the inputs that received a LTP-inducing stimulus but not in those 
that did not. This, in a way, increases the computational power of 
the neuronal circuits. 
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3)   Cooperativity (McNaughton et al., 1978): LTP induction exhibits 
intensity threshold i.e., only stimuli that cross certain intensity 
threshold lead to the induction of LTP whereas weaker stimuli do 
not. However, LTP can be induced by weaker stimuli if given 
simultaneously to a crucial number of presynaptic fibers. This 
property is called ‘cooperativity’ as the collective weak responses 
help to cross the threshold barrier. This helps to keep the excitatory 
drive in check to maintain network stability and filters out signals 
without significant information from entering long-term storage.  
4)   Associativity (Levy and Steward, 1979; McNaughton et al., 1978): A 
weak input, that by itself does not lead to LTP, can be potentiated if 
its activation coincides (or happens within a short time-window) with 
a LTP-inducing stimulation in another input to the same neuron. 
This property of associativity makes LTP an attractive mechanism 
for associating two pieces of information conveyed by different 
inputs that synapse on the same postsynaptic neuron. 
  
1.3.4.2 Temporal characteristics: E-LTP and L-LTP 
 
Synaptic plasticity mechanisms occur on time scales ranging from 
milliseconds to days, weeks, or longer. Examples of short-term forms 
of plasticity (Short-term potentiation; STP) are synaptic facilitation (or 
Paired-pulse facilitation; PPF) and post-tetanic potentiation (PTP). 
Synaptic facilitation is a transient increase in synaptic transmission 
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observed when two or more action potentials arrive at the presynaptic 
terminal in close succession. PTP is also a similar but more 
pronounced increase in the synaptic transmission lasting a few minutes 
in response to a high frequency burst of action potentials (tetanic 
stimulation). PTP is thought to be due to enhanced neurotransmitter 
release and activation of presynaptic kinases, both resulting from 
prolonged elevation of Ca2+. A synaptic depression can also be 
observed following repeated synaptic activity in succession because of 
the depletion of neurotransmitter vesicles. Both PTP and PPF 
phenomena are NMDA receptor independent. 
 
LTP is usually distinguished into two temporally distinct types based on 
the differences in the type of stimulation involved in the induction and 
on the requirement for new protein synthesis - an early-LTP (E-LTP) 
and a late-LTP (L-LTP) (Frey et al., 1993; Frey et al., 1988); reviewed 
in (Kelleher et al., 2004). E-LTP is a transient form usually induced with 
a weak, high frequency stimulation (HFS) (single train of 100 pulses at 
100 Hz) and it only lasts for about 1-3 hours. E-LTP mostly involves 
post-translational modifications of the existing proteins brought about 
by the activation of different protein kinases and the synaptic trafficking 
of these proteins, but no de novo protein synthesis is involved (Bliss 
and Collingridge, 1993; Frey et al., 1993; Malenka and Bear, 2004). 
Late-LTP, on the other hand, is the persistent form which is induced 
with a strong high frequency stimulation protocol involving multiple 
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trains of tetanizing stimulus (100 pulses at 100 Hz). It can last > 4 
hours in vitro and few weeks to months in vivo (Abraham et al., 2002; 
Neves et al., 2008). L-LTP requires, along with the activation of 
kinases, synthesis of new proteins (translation) and/or synthesis of new 
mRNA (transcription) (Frey et al., 1993; Huang and Kandel, 1994; 
Nguyen et al., 1994). A representative comparison between E-LTP and 
L-LTP is shown in Figure 1.6. 
 
 
Figure 1.6: Characteristics of E-LTP and L-LTP. A schematic 
drawing showing the properties of different phases of LTP. (A) E-LTP, 
induced with a single train of high frequency stimulation (HFS) (arrow) 
lasts only for short duration (control). E-LTP is not affected by inhibitors 
of translation (anisomycin) or transcription (actinomycin-D). (B) L-LTP, 
induced with repeated HFS trains (four arrows), lasts for many hours 
(control) and is sensitive to inhibitors of translation and transcription. 
Black bar in both (A) and (B) represents the time of application of 
inhibitors. (Reprinted from Kelleher et al. Copyright (2004), with permission from Elsevier; 
(Kelleher et al., 2004)). 
 
 
Some researchers use the terms E-LTP and L-LTP to refer to different 
temporal phases of LTP each subserved by different maintenance 
mechanisms of different time courses and durations. Here, these two 
phases are not mutually exclusive but rather, depending on the LTP 
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induction protocol, they can overlap i.e., L-LTP can develop over the 
ongoing E-LTP (Roberson et al., 1999; Sweatt, 2003). Further, another 
classification describes different phases of LTP as LTP1, LTP2 and 
LTP3 (Abraham and Otani, 1991; Raymond, 2007). Here, LTP1 is 
similar to E-LTP; LTP2 and LTP3 are both components of L-LTP where 
LTP2 is an intermediate phase between E-LTP and L-LTP. 
 
1.3.5 Mechanisms of NMDAR-dependent LTP 
 
 
Molecular mechanisms of LTP can be differentiated into three types: 
Induction, maintenance and expression, each of which can be 
selectively blocked (Malinow et al., 1988; Sweatt, 1999). Induction 
refers to the transient events that act as triggers for the formation of 
LTP. Events during induction can lead to a persisting biochemical 
signal that constitutes a ‘maintenance’ mechanism. This persisting 
maintenance mechanism then acts upon one or more effectors, for 
example a glutamate receptor or cytoskeletal protein, resulting in the 
‘expression’ of LTP (Sweatt, 1999; Sweatt, 2003). 
 
1.3.5.1 LTP induction: NMDARs as synaptic ‘Coincidence Detectors’  
 
Basal or the so called ‘general purpose’ synaptic transmission mostly 
involves AMPAR-mediated currents (Osten et al. 2007). NMDAR-
dependent LTP induction requires the activation of NMDARs 
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(Reviewed by (Malenka and Bear, 2004). At resting membrane 
potentials (more negative than -50 mV) the ion channel of the NMDARs 
is blocked by Mg2+ ions, which is released upon depolarization (Figure 
1.7) (Mayer et al., 1984; Nowak et al., 1984).  
 
An interesting property of NMDARs is that they can mediate an EPSC 
only when there is a conjunction of presynaptic glutamate release and 
postsynaptic membrane depolarization. In other words, even if 
glutamate and glycine are bound to the receptor, the channel becomes 
permeable to Ca2+ only after the Mg2+ block of the ion channel is 
removed by depolarisation of postsynaptic membrane. This confers on 
the NMDAR a ‘coincidence detector’ function (Figure 1.7) wherein it 
only becomes functional when pre- and postsynaptic activity occur 
together (Wigstrom and Gustafsson, 1986). This property has 
important implications in the induction of activity-dependent changes in 
synaptic strength. The NR2B type receptors stay open longer than the 
NR2A receptor type thus providing a larger time window for 
coincidence detection. 
 
When an LTP-inducing stimulus arrives at the presynaptic 
compartment it causes the release of glutamate into the synaptic cleft. 
Glutamate binds to both AMPARs and NMDARs on the postsynaptic 
membrane. However, AMPARs open rapidly due to their fast binding 
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kinetics and greater open probability allowing the rapid influx of Na+ 
and Ca2+ ions and causing membrane depolarisation. 
 
Figure 1.7: Role of NMDAR in LTP induction: NMDAR mediates an 
EPSC only when there is a conjunction of presynaptic (golden color) 
glutamate release and postsynaptic (green color) membrane 
depolarization. The channel becomes permeable to Ca2+ only after the 
Mg2+ block of the ion channel is removed by the depolarization of 
postsynaptic membrane. This leads to Ca2+ entry which then triggers 
LTP. (Reprinted by permission from Macmillan Publishers Ltd: Neuropsychopharmacology. 
Citri and Malenka. copyright 2007; (Citri and Malenka, 2008)). 
 
 
NMDARs are highly permeable to Ca2+ and other monovalent cations 
(Ascher and Nowak, 1988) and show a very slow kinetics and thus the 
ion flux through the channel continues for few hundred milliseconds 
after the termination of glutamate signal. The single-channel 
conductance of NMDARs is greater than that of AMPARs (Jahr and 
Stevens, 1987). Once the membrane becomes sufficiently depolarized 
(more positive than -50 mV) the Mg2+ ions are expelled out of the 
NMDAR channels resulting in a huge influx of Ca2+. The influx of Ca2+ 
causes a transient elevation of Ca2+ levels in the dendritic 
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compartments which then leads to activation of signal transduction 
cascades and trafficking events necessary for LTP induction. 
 
1.3.5.2 LTP induction 
 
The influx of Ca2+ through NMDARs and the transient rise in dendritic 
Ca2+ is an absolutely necessary trigger for the NMDAR-dependent LTP 
(or LTD) induction (Bliss and Collingridge, 1993). The dynamics of the 
calcium transients i.e., their duration and magnitude determines 
whether LTP- or LTD-like mechanisms are activated. Current 
evidences suggest that a rapid and huge influx in Ca2+ resulting in 
intracellular Ca2+ concentration beyond 5 µM, predominantly activate 
kinases thus leading to LTP whereas a slow and small rise in Ca2+ 
leads to activation of phosphatases and sets in LTD mechanisms 
(Malenka and Bear, 2004; Mulkey and Malenka, 1992). 
 
1.3.5.3 Mechanisms of E-LTP 
 
 
Rise in the intracellular Ca2+ sets in motion a host of signal transduction 
mechanisms. Ca2+ binds to calmodulin, which in turn can interact with 
and activate Ca2+/calmodulin (CaM)-dependent protein kinase-II 
(CaMKII). Strong lines of evidence support that CaMKII is a key 
component of LTP induction machinery. CaMKII undergoes 
autophosphorylation following LTP induction (Barria et al., 1997; 
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Fukunaga et al., 1995). Many other kinases can also be activated and 
these include protein kinase C (PKC) (Bliss and Collingridge, 1993; Hu 
et al., 1987; Linden and Routtenberg, 1989; Malenka and Bear, 2004; 
Malinow et al., 1989), and in particular the atypical PKC isozyme, 
protein kinase M zeta (Hrabetova and Sacktor, 1996; Ling et al., 2002), 
mitogen-activated protein kinase (MAPK) cascade that activates 
extracellular-signal regulated kinases (ERKs) (Sweatt, 2004; Thomas 
and Huganir, 2004), phosphatidylinositol 3-kinase (PI3 kinase) and the 
tyrosine kinase Src. Activation of these kinases can bring about the 
potentiation in many possible ways as shown in Table 1.1 below: 
 
Mechanism Possible molecular basis 
 
Increasing single-channel 
conductance of AMPARs 
Direct phosphorylation of AMPA 
receptor alpha subunits  by CaMKII 
or PKC — Ser831 of GluR1 
Increasing steady-state 
levels of AMPARs: Increased 
trafficking to synapses and 
stabilization 
Phosphorylation of AMPAR-
associated trafficking and scaffolding 
proteins; Inhibiting AMPAR 
endocytosis-phosphorylation of 
GluR1 Ser818 
Insertion of AMPARs into 
silent synapses 
CaMKII phosphorylation of GluR1-
associated trafficking proteins 
Increased presynaptic 
release and other 
presynaptic mechanisms 
A retrograde messenger such as 
nitric oxide or arachidonic acid 
(Williams et al. 1993) or cell adhesion 
molecules (Sudhof, 2001) 
Enhanced NMDAR function Phosphorylation of NMDAR subunits 
by Src kinase 
 
Table 1.1: Mechanisms of early-LTP expression (Adapted and 
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1.3.5.4 Mechanisms of L-LTP: 
 
 
Long-term forms of LTP (L-LTP) critically depend on the synthesis of 
new proteins and/or transcription (Abraham and Williams, 2003; Lynch, 
2004; Pittenger and Kandel, 2003). Induction of such persistent forms 
of LTP depends, along with the glutamatergic activation of NMDARs as 
discussed above, critically on heterosynaptic co-activation of 
modulatory inputs such as dopaminergic inputs (Reymann and Frey, 
2007). The heterosynaptic activation triggers the mechanisms that 
signal the local translational machinery, as well as send a retrograde 
‘synapse-to-nucleus’ signal activating the somatic protein synthesis 
and translation of plasticity-related genes. L-LTP can be blocked both 
in vitro and in vivo, with translational and transcriptional inhibitors when 
applied during or immediately after LTP induction and are ineffective 
once LTP has become established (Frey and Morris, 1998a; Nguyen et 
al., 1994; Otani et al., 1989) suggesting a time-window for such events. 
The downstream mechanisms and resultant plasticity products are then 
utilized for the strengthening of synapses, maintenance of synaptic 
efficacy, remodeling of the dendritic structure and possibly, growth of 
new synaptic connections. 
 
1.3.5.4.1 Local protein synthesis 
 
 
The initial phase of L-LTP is dependent on protein synthesis from 
preexisting mRNA in the dendrites of potentiated synapses. This is 
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suggested by the rapid effect of translational inhibitors (Frey and 
Schroeder, 1990), reduction in L-LTP following local dendritic 
application of protein synthesis inhibitors (Bradshaw et al., 2003), 
presence of translational machinery in dendrites (Steward and 
Schuman, 2001) and L-LTP observed in isolated dendrites (Vickers et 
al., 2005). Messenger RNAs of several proteins with a known role in 
the induction or expression of LTP are localized in the dendrites, such 
as CaMKII, brain-derived neurotropic factor (BDNF) and its receptor 
tropomyosin receptor kinase-B (TrkB), and AMPA receptor subunits 
GluR1 and GluR2, PKM-zeta, arc/arg3.1, (Martin, 2004; Martin and 
Kosik, 2002). The translational repression of these mRNAs can be 
relieved following activity.  
1.3.5.4.2 De novo Transcription and Translation 
  
 
Blocking transcription with actinomycin-D blocks CA1 L-LTP in vitro 
(Frey et al., 1996; Kelleher et al., 2004; Nguyen et al., 1994) and DG L-
LTP in vivo (Frey et al., 1996) showing a need for new mRNA 
synthesis. This is achieved by a synapse-to-nucleus signaling 
mechanism to activate specific transcription factors (Figure 1.9) and 
thus leading to the synthesis of Immediate Early Genes (IEGs). Such 
signals include active kinases such as Ca2+/CaM-dependent protein 
kinase IV (CaMKIV) activated by CaM kinase kinase (CaMKK), 
Ras/MAP kinase and protein kinase-A (PKA) pathways (for reviews 
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see (Jay, 2003; Lonze and Ginty, 2002; Roberson et al., 1999; Sweatt, 
2004).  
 
Figure 1.9: Key signaling mechanisms in L-LTP: Glutamatergic 
and modulatory transmitter receptor coactivation synergistically 
activates many downstream kinases such as CaMKII, PKA, ERK, 
PKC and CaMKIV. Active ERK1/2 serve as major signal integrators 
and upregulate both translation and transcription machinery. These 
activate transcription of IEGs and plasticity genes, the products of 
which could be captured by the active synapses for consolidation 
mechanisms. PLC, phospholipase-C; DAG, diacylglycerol; PDE, 
phosphodiesterase; IP3, inositol triphosphate; MEK, mitogen-activated 
protein kinase/ERK kinase; MSK, mitogen and stress-activated 
kinase; RSK, ribosomal S6-kinase; ELK1, ETS-like domain-containing 
protein; eIF4E, eukaryotic initiation factor 4E. 
 
Activation of heterosynaptic G-protein-coupled receptors, such as 
D1/D5 dopamine receptors leads to activation of adenylyl cyclases and 
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a rise in cyclic-adenosine monophosphate (cAMP) levels, which in turn 
activates PKA, which phosphorylates and activates transcription factors 
cAMP-response-element-binding protein (CREB), ETS-like domain-
containing protein (ELK1) and other co-activators (Figure 1.9) 
(Reviewed by (Jay, 2003)). Recently, evidence also suggests a crucial 
role for activity-dependent degradation of selective proteins by 
ubiquitin-proteasome system (Hegde, 2004; Jarome and Helmstetter, 
2014). Further, some mechanisms have been suggested to persistently 
maintain LTP. An interesting candidate is PKM-V , a constitutively 
active catalytic fragment of the atypical PKC-V  that has been shown to 
be necessary and sufficient to maintain L-LTP (Serrano et al., 2005) 
and LTM (Reviewed by (Sacktor, 2011)). Another mechanism is based 
on the activity-dependent self-perpetuating property of a prion-like 
protein, cytoplasmic polyadenylation element-binding protein (CPEB) 
(Bailey et al., 2004; Fioriti et al., 2015).  
 
1.3.6 Hippocampal LTP and memory 
 
A number of approaches over the years have provided evidence that 
LTP and related mechanisms are important for hippocampal 
information processing, hippocampus-dependent learning and 
consolidation of memories. A multitude of molecules and molecular 
events shown to be necessary for memory consolidation also are 
necessary for LTP induction and expression, implicating the 
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involvement of LTP in the process (Sweatt, 2003). Delivery of LTP-
inducing stimulation to the DG after training leads to disruption of 
memory consolidation (Brun et al., 2001. Disruption of LTP leads to 
decreased stability and spatial specificity of hippocampal place fields 
{Kentros et al., 1998; McHugh et al., 1996). Thus hippocampus-
dependent spatial learning involves LTP-like mechanisms. Multimodal 
associative learning and relational memories require NMDAR-
dependent LTP in CA1 region (Rondi-Reig et al., 2001). A form of SOP 
in CA1 region has been shown to underlie a despair-associated 
memory (Jing et al., 2015). Hippocampal LTP is involved in the 
reconstitution of visual representations from partial stimuli and thus 
forming a complete representation of complex visual stimuli 
(Bannerman et al., 1995; Nakazawa et al., 2002).  
 
Another suggested role for LTP in area CA1 is the temporary storage 
of information as brief episodes thus allowing association of events in 
temporal order (Huerta et al., 2000). Learning leads to hippocampal 
LTP; in behaving animals with implanted electrodes, LTP in 
hippocampal synapses has been observed following a hippocampal-
dependent learning task (Andersen et al., 1996; Moser et al., 1993; 
Whitlock et al., 2006). Saturating LTP at hippocampal synapses leads 
to learning deficits and poor performance of animals in hippocampus-
dependent tasks (Castro et al., 1989; McNaughton et al., 1986; Moser 
et al., 1998). Taken together, these evidences suggest that, even if 
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LTP does not necessarily equate to memory, it is a critical contributor 
to many aspects of hippocampal memory formation and function. 
 
1.4 Synaptic tagging and Capture (STC) 
 
 
A sensory experience might involve co-activation of neurons in distinct 
brain regions and association of information from these regions might 
be required for learning. Such associations at the single neuron level 
could be brought about by the integrated processing of the multitude of 
inputs coinciding in space and time; and by the cell-wide or synaptic 
changes resulting in selective strengthening or weakening of 
connections between neurons.   
 
1.4.1 Synaptic tagging and capture model 
 
Cellular memory consolidation includes synaptic and cell-wide 
mechanisms operating on different timescales. These triggered events 
lead to a diverse intracellular signal transduction events and 
upregulation of new protein synthesis and/or transcription thus altering 
the synapses biophysically and structurally and eventually result in 
stabilisation of synaptic strength in the face of cellular protein turnover. 
This temporal persistence of synaptic potentiation is critical to maintain 
the memory traces before the systems consolidation mechanisms set 
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in. However, the potentiation (or depression) triggered by a pattern of 
neural activity is synapse-specific and the neuron needs to employ 
mechanisms to achieve this synapse-specific strengthening (or 
weakening) to avoid inadvertent plasticity leading to saturation. How 
does the neuron manage this daunting task given the vast number of 
synapses without burdening the cellular economy? Besides, 
stabilization of potentiation at one set of synapses is bound to come 
under the influence of activity at other synapses happening shortly 
before or after the event triggering potentiation. How do cellular 
mechanisms set in motion by the activity at different synaptic inputs 
interact and on what time scale?   
 
Considering the many possibilities, Frey and Morris proposed a 
conceptually simple and feasible model of ‘Synaptic tagging’ (Frey and 
Morris, 1997; Frey and Morris, 1998a), which is now widely referred to 
as Synaptic Tagging and Capture (STC) hypothesis (Barco et al., 2002; 
Barco et al., 2008; Morris, 2006; Redondo and Morris, 2011). STC 
theory proposes that glutamatergic activation during LTP/LTD-induction 
or memory encoding results in instantaneous local ‘tagging’ of 
activated synapses. These ‘synaptic tags’ later ‘capture’ the diffusely 
transported plasticity-related products (PRPs; mRNA or proteins) 
synthesized in soma or local dendritic domains. They demonstrated, 
using their elegant experiments in rat hippocampal slices, that the tag-
setting process in itself is protein synthesis-independent and thus the 
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tag is set by both weak and strong forms of activity and the tags have a 
decay life-time (Frey and Morris, 1997).  
 
 
Figure 1.10: Synaptic tagging and capture. (a) Schematic diagram 
of the two-pathway experiment. Two stimulating electrodes are 
positioned to stimulate two independent pathways (S1 and S2) 
converging onto the same CA1 neurons. (b) A strong stimulation 
activates local tags and induces PRP production. The capture of PRPs 
by the activated tags allows L-LTP expression in the S1 pathway. (c) A 
weak stimulation only activates local tags and induces E-LTP in the S2 
pathway. (d) Pairing of S1 and S2 pathways results in capture of PRPs 
from the S1 pathway by activated tags in the S2 pathway which 
transforms E-LTP to L-LTP in the S2 pathway. Left lower insets are 
representative traces (black: baseline, red: hours after stimulation), and 
right lower insets are representative slope recordings of field excitatory 
postsynaptic potentials (fEPSP) over hours. (Reproduced from “Synaptic 
Tagging and Capture” (Ed. Sajikumar Sreedharan), ‘PKA anchoring in synaptic tagging and 
capture’, 2015, 61-78, Park and Abel. © Springer Science+Business Media New York, with 
permission of Springer). 
 
  36 
 
They further showed that even though only strong forms of activity lead 
to the synthesis of PRPs, the weakly potentiated synapses will also be 
able to capture the PRPs, if the PRPs arrive before their tags have 
decayed. Thus, E-LTP induced in one synaptic input can be 
transformed into L-LTP by a preceding or subsequent strong 
tetanization of another independent but overlapping synaptic input 
within a specific time window (Figure 1.10) (Frey and Morris, 1998a). 
 
Similar synapse-specific tagging mechanism was also demonstrated in 
Aplysia cultured neuronal network (Martin et al., 1997) wherein a single 
bifurcated Aplysia sensory neuron forms synaptic contacts with two 
spatially separated motor neurons. Martin et al. demonstrated a STC-
like phenomenon by showing that even a single puff of 5-HT, that 
usually leads to short-term facilitation (STF), delivered to one axonal 
branch can be facilitated into a long-term facilitation (LTF) if five puffs 
of 5-HT (which usually results in LTF) are applied to the other axonal 
branch within a discrete time window. 
 
The STC mechanisms have been shown to be operating in a 
compartment-specific manner as well (Alarcon et al., 2006; Sajikumar 
et al., 2007) which function as units for temporal and spatial integration 
of information. Also, a revised STC model suggests that induction of 
LTP leads to structural and functional plasticity both of which are 
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independent but convergent processes and both of them rely on the 
supply of PRPs to be sustainable (Redondo and Morris, 2011).   
 
1.4.2 Cross-tagging and inverse tagging 
 
Even though the original STC theory was proposed to show the 
interaction and consolidation of E-LTP and L-LTP, Sajikumar and Frey 
further expanded on the concept to include the interactions between 
LTP and LTD (Sajikumar and Frey, 2004a). Building on a study that 
reported tag-setting by late-LTD (Kauderer and Kandel, 2000) they 
presented evidence to show that the tags can be process-specific i.e., 
a LTP-inducing stimulus sets a LTP-specific tag and a LTD-inducing 
stimulus generates LTD-specific tag in the respective synapses. Using 
the two-pathway experimental setup in hippocampal slices, they 
showed that E-LTP induced in one input can be transformed to L-LTP 
by utilizing the plasticity factors generated by the L-LTD in the second 
input or conversely, E-LTD induced in one pathway can be transformed 
to L-LTD by utilizing the plasticity factors generated by the L-LTP 
induction in the second pathway. They termed this interaction between 
opposing forms of plasticity as “Cross-tagging” or “Cross-capture” 
(Sajikumar and Frey, 2004a). This suggested that L-LTP or L-LTD lead 
to upregulation of a common pool of PRPs which could include both 
LTP-supporting and LTD-supporting factors. As long as a process-
specific tag is available to capture these PRPs synapses can be 
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strengthened irrespective of the direction of the plastic change. It also 
indicated a basis for how bidirectional changes in synaptic efficacy can 
be simultaneously stabilized (Reymann and Frey, 2007). However, a 
later study has implicated PKM-zeta as a LTP-specific PRP (Sajikumar 
et al., 2005). Like STC, cross-capture processes could also be specific 
within particular dendritic compartments (Pavlowsky and Alarcon, 
2012).  
 
Recently, another mechanism called “Inverse synaptic tagging” has 
also been proposed (Okuno et al., 2012) which acts to mark the 
inactive synapses in the vicinity of potentiated synapses for weakening. 
It was shown that following the induction of L-LTP at a set of synapses, 
an immediate early gene product ‘Arc’ is synthesized rapidly and 
transported to the synapses. In the synapses that received the activity, 
an active form of CaMKIIβ limits the interaction with Arc protein and 
leads to strengthening whereas in the neighboring synapses that were 
not actually the ones to receive the activity, Arc binds with an inactive 
CaMKIIβ thus leading to weakening of synapses. Here inactive 
CaMKIIβ acts as an ‘inverse synaptic tag’ interacting with a negative 
PRP Arc. Such mechanisms are proposed as a basis for regulating 
generalization of plasticity processes and thus contributing to synapse-
specificity. 
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1.4.3 Synaptic tag: Properties and identity 
 
The tags are set by glutamatergic activity, mostly in a NMDAR-
dependent mechanism. Several criteria have been proposed for a 
candidate synaptic tag (Barco et al., 2002; Kelleher et al., 2004). 
Considering these criteria, especially rapid and reversible setting and 
re-setting, proteins that can undergo reversible covalent modifications 
seem to be potential candidates. Indeed, PKA has been proposed as a 
LTP-specific tag (Barco et al., 2002) and protein phosphatases as LTD-
specific tags (Frey and Morris, 1998a; Kelleher et al., 2004; Martin and 
Kosik, 2002; Redondo and Morris, 2011; Reymann and Frey, 2007). 
CaMKII, which upon LTP induction gets autophosphorylated and 
becomes persistently active, has been shown to specifically translocate 
to the potentiated synapses thus tagging the active synapses (Lisman 
et al., 2011; Redondo and Morris, 2011; Redondo et al., 2010; 
Sajikumar et al., 2007). The crucial role of CaMKII in LTP-specific tag-
setting was further substantiated by experiments reported in several 
publications. They include pharmacological inhibition of CaMKII 
(Redondo et al., 2010; Reymann and Frey, 2007; Sajikumar et al., 
2007), optical tracking of the dynamics of CaMKII activation in spines 
following LTP induction (Lee et al., 2009), CaMKII’s role in actin 
dynamics (Okamoto et al., 2007), and LTP and LTM deficits observed 
in mice with mutated CaMKII (Giese et al., 1998; Silva et al., 1992). 
Tropomyosin-related kinase-B (TrkB), the receptor for brain-derived 
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neurotrophic factor (BDNF) has also been suggested as a synaptic tag 
for L-LTP (Lu et al., 2011). Extracellular signal-regulated kinases 1/2 
(ERK1/2) are implicated as LTD-specific tags (Sajikumar et al., 2007).  
However, any molecule that is preferentially located near the synapse 
and whose activity, configuration or concentration changes in response 
to activity, can act as a tag. On another note, it is increasingly being 
appreciated that tag may not be a single molecule but rather a ‘state’ 
(Martin and Kosik, 2002; Redondo and Morris, 2011). Activity-driven 
dynamic changes in the whole microenvironment of the synapse may 
act as a tag. This might include changes in the actin network structure 
(Bosch et al., 2014; Ramachandran and Frey, 2009), combined with a 
local gradient of a synaptically localized molecule, such as the small 
GTPase Ras (Harvey et al., 2008), compartmentalized mRNA 
translation (Wang et al., 2010) and even proteasome-mediated protein 
degradation (Cai et al., 2010).  
 
1.4.4 Synaptic tag decay and resetting 
 
 
Synaptic tags have a certain life-time, around 1-2 hours (Frey and 
Morris, 1998a; Redondo and Morris, 2011), after which they will 
dissociate or decay from the synapses. It can depend on experimental 
conditions and other regulatory mechanisms (Barco et al., 2008). Tags 
can also be actively reset or even erased by a pattern of activity (low-
frequency stimulation) that induces ‘depotentiation’ (DP) within a time 
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window. They also found that the effective time-window (Sajikumar and 
Frey, 2004b; Young and Nguyen, 2005). Depending on the nature of 
the tag, the mechanism involved in its decay, either passive or active, 
may differ. It might be a process of complete degradation or 
dismantling, or may be a reversible activation-inactivation switch 
mechanism. SOP is an intriguing case compared to conventional LTP 
and STC, which assume that tag-setting occurs instantaneously with 
LTP-induction, as it suggests a possibility of alternative, slower tag-
setting mechanisms, as shown for instance by (Li et al., 2014) in a 
metaplastic context. 
 
1.4.5 Plasticity-related products (PRPs) 
 
 
Initially plasticity factors mostly were thought to be the proteins that are 
synthesized in the soma in response to activity and transported 
diffusely to be captured by the tags at active synapses (Frey and 
Morris, 1997; Frey and Morris, 1998a; Frey and Morris, 1998b). Now 
there is good evidence that such protein synthesis can also occur in 
local dendritic domains (Pfeiffer and Huber, 2006). Further, evidences 
also show that even mRNAs can also be transported to dendritic 
branches or domains or their translational repression can be relieved in 
an activity-dependent manner and hence they have to be considered 
as plasticity factors. Thus, the acronym PRPs now stands for ‘plasticity-
related products’ rather than ‘plasticity-related proteins’ (Rudy, 2008).  
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Some PRPs that have been implicated to be involved in synaptic 
plasticity and memory include AMPARs (specifically subunit GluR1) 
(Lanahan and Worley, 1998; Miyashita et al., 2008), PKM-zeta 
(Sajikumar et al., 2005), Homer1a (Okada et al., 2009) BDNF (Lu et al., 
2011; Sajikumar and Korte, 2011) and activity-regulated cytoskeleton-
associated protein (Arc) (Steward et al., 1998). There have also been 
reports suggesting that the PRPs can also be process-specific (i.e., 
LTP- or LTD-specific) and even compartment-specific (Govindarajan et 
al., 2006). PKM-zeta, in particular, has been a fascinating PRP 
molecule shown to be critical for the consolidation of E-LTP (Sajikumar 
and Korte, 2011; Sajikumar et al., 2009; Sajikumar et al., 2005) and 
also necessary and sufficient to maintain long-lasting LTP and many 
forms of memories (Sacktor, 2011; Serrano et al., 2005). A continued 
supply of PRPs to maintain the synaptic strength persistently can be 
achieved by many positive feedback loops operating at the level of 
synapse and at the sites of transcription and translation as has been 
shown for PKM-zeta (Reviewed by (Sacktor, 2011)). 
 
1.4.6 Synaptic associativity: cooperation and competition 
 
 
STC and cross-capture mechanisms reveal a complex pattern of 
synaptic associativity. Given the strong-activity-induced PRPs are 
diffusely transported and they are in a common pool, it can lead to 
different scenarios. First, if the PRPs up-regulated are in plenty and are 
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to be shared between a small number of synapses, then it can lead to 
the strengthening of all synapses as long as the tag-PRP interactions 
occur. This can be seen as a ‘cooperative’ process. Otherwise, there 
could be a ‘winner-takes-all’ scenario where only some inputs 
benefitted preferentially whereas others fail to (Kano and Hashimoto, 
2009; Sajikumar et al., 2014). A third scenario would be there being a 
large number of active synapses sharing PRPs from a limited pool. In 
such case, a competition sets in between these synapses which has 
two outcomes: one, some inputs can be strengthened at the expense 
of others, a scenario termed ‘competitive maintenance’ (Fonseca et al., 
2004); second, all the inputs may fail to capture enough PRPs for 
strengthening and thus none of them would be stabilized. 
 
1.4.7 STC-like mechanisms underlying behavior 
 
Associative processing and reinforcement of multiple synaptic inputs, 
selective stabilization or removal of resultant synaptic changes at the 
level of neuron could possibly be facilitated by late-associative 
interactions such as synaptic tagging, cross-tagging and capture (Frey 
and Frey, 2008). 
 
STC theory, in a way, indicates that induction of LTP only creates a 
potential for lasting change in synaptic strength without any 
commitment for such a change because persistence can be influenced 
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by neural activity before or after induction. It also reveals a complex 
pattern of temporal and spatial associativity in synaptic plasticity. Thus, 
the fate of memory traces can be dynamically regulated by 
heterosynaptic events that occur before or after encoding. Behaviorally, 
STC-like phenomena might help to add richness of contextual details 
as moderately significant events occurring around a highly significant 
event can all acquire the same mnemonic potential.  
 
STC-like phenomenon have been demonstrated in anaesthetized and 
behaving animals (Ballarini et al., 2009; Redondo and Morris, 2011; 
Shires et al., 2012). Identical phenomenon in behavioral settings, 
called ‘behavioral tagging’, showed the reinforcement of a weak 
inhibitory avoidance memory into a persistent form by the open field 
exploration paradigm (Moncada et al., 2011; Moncada and Viola, 2007) 
and also in a spatial memory task (Wang et al., 2010). Recently, similar 
mechanism is also reported in humans, involved in the retroactive 
strengthening of emotional memories (Dunsmoor et al., 2015). 
 
1.5 Dopamine in hippocampal synaptic plasticity 
 
 
Dopamine (DA) is one of the most studied neurotransmitters. It is 
involved in a variety of brain functions and processes such as control of 
movement, emotional response, learning and memory, reward and 
goal-directed behaviors (Jay, 2003; Laviolette, 2007). DA belongs to 
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the class of monoamines or catecholamines, which also consists of 
epinephrine (adrenaline) and norepinephrine (noradrenaline). It is 
synthesized from the amino acid tyrosine (which can be synthesized 
from phenylalanine). In noradrenergic neurons, DA can further be used 
to synthesize noradrenaline (NA) by the action of the enzyme 
dopamine beta hydroxylase. 
 
1.5.1 Dopamine receptors: Expression in the hippocampus 
 
 
DA exerts its effects by binding to a family of seven transmembrane, G 
protein-coupled, metabotropic receptors. Currently, five DA receptors 
have been cloned and they are classified into two main types- D1-like 
and D2-like (Missale et al., 1998) D1-like class consists of D1 and D5 
receptors, and are mostly exclusively expressed post-synaptically. The 
D2-like class consists of D2, D3 and D4 receptors and are expressed 
both on pre- and post-synaptic membranes. The D1 receptors couple 
to the Gɑs or Gɑolf proteins and thus lead to the activation of adenylyl 
cyclase. The D5 receptors couple to the Gɑq protein and subsequently 
lead to the activation of Phospholipase-C (PLC) resulting in 
diacylglycerol (DAG) and inositol triphosphate (IP3)-mediated 
pathways (Reviewed by (Beaulieu and Gainetdinov, 2011)). There are 
no introns in the coding regions of the D1 and D5 receptor genes. D2-
like receptors, on the other hand, are coupled to Gɑi or Gɑo proteins 
and thus they inhibit adenylyl cyclase (Reviewed by   (Beaulieu and 
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Gainetdinov, 2011)). The coding regions of the D2-class receptor 
genes are interrupted by many introns and thus many receptor variants 
can be generated. The D1 and D5 receptors share a 80% homology in 
their transmembrane domains (Missale et al., 1998). Although there 
are ligands specific for activating D1-class receptors, but currently 
there are no ligands that can differentiate between D1 and D5 
receptors selectively.   
 
All dopamine receptors subtypes are expressed in different subregions 
of the hippocampus, some albeit in low levels. D1-class receptors 
highly expressed but due to a high level of similarity in their amino acid 
sequence, the use of antibodies to identify region-specific D1R and 
D5R expression has been ineffective (Missale et al., 1998). In situ 
hybridization studies using subtype-specific probes suggested that the 
D1R mRNA is distributed throughout hippocampus with highest 
expression in DG and D5R mRNA is expressed strongly in the DG, 
CA3, and CA1 (Sarinana et al., 2014). D2-receptors are expressed in 
low levels hippocampal CA1 region (Levey et al., 1993)  and are more 
concentrated in the septal portions of lacunosum moleculare layer 
(Goldsmith and Joyce, 1994). D4 receptors are the most abundant D2-
class receptors in the hippocampus (Missale et al., 1998).  
 
As mentioned above, hippocampus receives dopaminergic inputs from 
the VTA and SNPc (Gasbarri et al., 1997; Gasbarri et al., 1994; 
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Scatton et al., 1980; Storm-Mathisen, 1977a) and dopamine receptors 
are also widely expressed in all regions of hippocampus. Recent 
evidences also suggest that the major source of DA released in 
hippocampus is from noradrenergic fibers of Locus coeruleus rather 
than VTA (Smith and Greene, 2012); Takeuchi et al. 2015; Dusckewicz 
et al. 2015).  
 
1.5.2 Dopamine in hippocampal plasticity 
 
1.5.2.1 Hippocampal dopamine in LTP and memory 
 
A variety of neuropharmacological and genetic approaches has 
established the involvement of D1/D5 receptors in LTP in CA1 region 
both in vitro and in vivo. D1 antagonists block protein synthesis-
dependent late-phase LTP in vitro (Frey et al., 1991; Frey and 
Schroeder, 1990),  in vivo (Swanson-Park et al., 1999) and LTM in vivo 
(Rossato et al., 2009). Slices from D1R knockout mice have no late 
phase LTP (Matthies et al., 1997). D1/D5R-mediated mechanisms are 
crucial for the protein-synthesis dependent late phase of LTP and LTM 
and thus their temporal persistence (Frey et al., 1991; Lemon and 
Manahan-Vaughan, 2006; Matthies et al., 1997; O’Carroll et al., 2006; 
Swanson-Park et al., 1999). Indeed, strong LTP induction protocols in 
slices co-stimulate dopaminergic fibers (Lisman et al., 2011; Reymann 
and Frey, 2007). D1/D5R agonists also lead to enhanced early-LTP 
(Otmakhova and Lisman, 1996). Lisman and colleagues (Lisman et al., 
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2011) suggested that the protein synthesis-dependent late phase of 
NMDAR-dependent LTP is ‘neo-Hebbian’ as it critically requires, along 
with the two Hebbian factors (presynaptic glutamate release and 
postsynaptic depolarization), dopamine release as a third factor.  
 
Activity of midbrain dopaminergic neuron activity promotes 
hippocampal network dynamics associated with memory persistence 
(McNamara et al., 2014) and bidirectionally regulate CA3-CA1 synaptic 
drive (Rosen et al., 2015). Facilitation of CA1 LTP by spatial novelty is 
dopamine-dependent (Li et al., 2003). D1R-null mice exhibit impaired 
associative learning and CA3-CA1 synaptic plasticity (Ortiz et al., 
2010). Pharmacological approaches targeting DA receptors have also 
pointed to the requirement of DA in the persistence of hippocampus-
dependent memories (Bethus et al., 2010; O’Carroll et al., 2006; 
Rossato et al., 2009). Although initial findings suggested that dopamine 
modulates long-term memory (LTM) encoding and consolidation during 
or a short period after training (Jay, 2003; O’Carroll et al., 2006; 
Rossato et al., 2009) showed that dopamine acting through D1 
receptors also controls the maintenance of LTM storage by a late post-
acquisition mechanism involving BDNF and interestingly, NMDAR 
activity in the VTA. Encoding only leads to a short-lasting strengthening 
of synaptic connections.  
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Dopamine antagonists at encoding cause an impairment of 
hippocampus-dependent memories tested after long delays but not 
after short delays (Bethus et al., 2010). Dopamine-dependent protein 
synthesis is necessary to stabilize and maintain the short-lasting 
strengthening of synaptic connections resulting from encoding (Lisman 
et al., 2011). In behavioral tagging experiments dopaminergic 
activation, along with beta adrenergic activation, is shown to be 
involved in the synthesis of PRPs required to consolidate inhibitory 
avoidance LTM (Moncada et al., 2011). Hippocampal dopamine 
deficiency also underlies learning and memory deficits observed in 
Neurofibromatosis-1 preclinical mouse model (Diggs-Andrews et al., 
2013). 
 
1.5.2.2 D1/D5 receptor-mediated signaling 
 
An essential component of STC framework is the upregulation of PRP 
synthesis and is triggered by heterosynaptic co-activation of 
glutamatergic and neuromodulatory inputs. DA action in hippocampus 
involves a strong synergistic interaction between D1/D5 receptors and 
NMDARs (Navakkode et al., 2007). DA acting through D1/D5 receptors 
leads to the upregulation of somatic and dendritic protein synthesis 
(Granado et al., 2008; Smith et al., 2005) and also activates 
transcription of plasticity-related genes (Moncada et al., 2011; 
Redondo and Morris, 2011). These effects of DA have been shown to 
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involve PKA (Abel et al., 1997), MAPKs ERK1 and ERK2 (Kelleher et 
al., 2004), CaMKII and CaMKIV (Redondo et al., 2010) and CREB 
(Abel et al., 1997; Barco et al., 2002). Dopamine receptor activation 
leads to upregulation of cAMP and presumptive translocation of 
activated PKA to the soma, where it can directly phosphorylate the 
transcription factor CREB on ser133 (Lonze and Ginty, 2002) which 
then leads to expression of plasticity-related genes. DA induces LTP 
via different mechanisms in the apical and basal dendritic region of 
CA1 (Navakkode et al., 2012). Interestingly, bath application of DA or 
D1/D5R agonists itself induces a SOP in CA1 SC synapses (Huang 
and Kandel, 1995); however, this crucially requires test stimulation-
induced NMDAR synergism (Navakkode et al., 2007; Navakkode et al., 
2012). 
 
Stimulation of dopamine receptors can lead to a complex network of 
signaling pathways downstream. However, the predominant pathway 
that gets involved and the functional response might depend on the cell 
type and the context. One determinant may be the coactivation of other 
types of receptors, which then impinges on some ‘coincidence detector’ 
molecules. MAPKs are one such coincident detectors that integrate a 
variety of signals and lead to differential activation of downstream 
pathways. Interestingly, D1/D5 receptor activation in CA1 region leads 
to robust activation of MAPKs (Pfeiffer and Huber, 2006; Roberson et 
al., 1999; Sarantis et al., 2009).  
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Small differences in the concentration of the modulatory transmitter can 
result in different degrees of activation of the receptors, or differentially 
involve subtypes of receptors based on their affinity. Dose-dependent 
effects of dopaminergic signalling have been reported in brain regions 
such as striatum (Williams and Millar, 1990), prefrontal cortex (Zheng 
et al., 1999) and nucleus accumbens (Chao et al., 2002) with linear or 
non-linear profiles. 
 
Hippocampus is not an ‘island’ structure; it forms complex networks 
with prefrontal cortex, nucleus accumbens and indirectly back to VTA. 
The ‘hippocampus and VTA loop’ is involved in the encoding and 
integration of motivationally relevant, novel, contextual and reward-
related information (Lisman and Grace, 2005). Activation of 
hippocampal D1/D5 receptors modulates the dopamine efflux and 
locomotor activity in nucleus accumbens (Zornoza et al., 2005). 
Blockade of D1Rs in hippocampus prevents reinforcement and state-
dependent learning in addiction (Ricoy and Martinez, 2009; Zarrindast 
et al., 2011). 
 




Aging affects hippocampal morphology, function and dynamics (Burke 
and Barnes, 2010). Regionally specific patterns in the loss of 
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hippocampal neurons and their connectivity have been observed in 
rodents, monkeys and humans (Keuker et al., 2003; Rapp and 
Gallagher, 1996; Small et al., 2004; West, 1993; West et al., 1994). 
Loss of neurons and interneurons or a reduction in the neurogenesis 
does not appear to explain these cognitive deficits (Burke and Barnes, 
2010).  In contrast to DG and CA3, aging is not associated with a loss 
of synaptic contacts in any of the CA1 synapses (Burke and Barnes, 
2006); however, some proportion of the SC synapses might become 
nonfunctional or silent (Nicholson et al., 2004). An increase in AMPAR-
mediated currents and a decrease in NMDAR-mediated currents in DG 
is also reported (Gazzaley et al., 1996; Yang et al., 2008). A reduction 
in the amplitude of the field-EPSP in CA1 SC synapses is seen in aged 
rats compared to that of young rats (Barnes et al., 1992; Landfield et 
al., 1986; Rosenzweig et al., 1997). 
 
Age-related deficits in functional plasticity, such as LTP/LTD, correlate 
with memory impairments in old animals (Barnes, 1979). Deficits in 
LTP induction are observed, especially in response to weaker 
stimulation protocols; maintenance deficits, however, are common 
irrespective of the protocol (Burke and Barnes, 2006; Deupree et al., 
1993; Rosenzweig and Barnes, 2003). Further, the threshold for LTD 
and depotentiation appears to be low in aged rats (Kumar and Foster, 
2007; Norris et al., 1996) accompanied by an increase in LTP 
threshold. Aged rats also show a disruption of behaviorally-induced 
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place-field expansion plasticity (Shen et al., 1997). A dysregulation in 
the homeostatic control of intracellular Ca2+ has been proposed to 
contribute to age-related plasticity deficits (Burke and Barnes, 2010). 
Increased Ca2+ entry through L-type voltage-dependent calcium 
channels (L-VDCC) has been strongly implicated (Foster and Norris, 
1997). In support of this, regulating the Ca2+ entry using L-VDCC 
inhibitors (Norris et al., 1998; Rose et al., 2007; Veng et al., 2003) or 
NMDAR blocker Memantine (Pieta Dias et al., 2007) or inhibiting 
intracellular Ca2+ release (Kumar and Foster, 2005) have been shown 
to improve synaptic plasticity deficits and memory in aged animals. 
 
1.6.1 Dopaminergic deficit in age-related memory impairment  
 
 
In humans, a decline in episodic memory in old age is well recognized 
(Buckner, 2004; Hedden and Gabrieli, 2004; Light, 1991). Episodic 
memory consolidation requires hippocampal dopamine and aging is 
associated with degeneration of substantia nigra/ventral tegmental 
area (SN/VTA) dopamine neurons (Backman et al., 2006; Fearnley and 
Lees, 1991). The dopamine system is affected by the aging process 
which could involve decreased DA release from the terminals, reduced 
expression of dopamine receptors and transporters (Backman et al., 
2006; Backman et al., 2010; Volkow et al., 1994). Exogenous 
administration of a DA precursor was shown to improve episodic 
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memory persistence in elderly within a narrow dose range (Chowdhury 
et al., 2012). 
 
Brief exposure to novelty facilitates LTP in DG of aged rats (Sierra-
Mercado et al., 2008) and novelty is known to stimulate DA release in 
hippocampus. Systemic administration of a D1/D5 receptor agonist 
improves spatial memory deficits in aged mice (Bach et al., 1999). 
Further, associative memory components are commonly affected in 
aging which, in the context of cellular consolidation, refers to deficits in 
synaptic associative processes, such as STC. Altered functioning of 
the dopaminergic system is implicated in the associative memory 
deficits seen in biological aging (Li et al., 2005). Given that dopamine 
plays critical role in the STC processes because of its involvement in 
the upregulation of PRPs (See above), a deficiency in dopamine levels, 
loss of dopamine transporters or even reduced receptor levels can all 
underlie associative memory deficits in aging. 
 
1.6.2 Impaired dopaminergic mechanisms in Alzheimer’s disease-
related cognitive deficits 
 
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder 
that leads to memory loss and other associated cognitive impairments 
(Selkoe, 2001a; Selkoe, 2001b). Age is the greatest risk factor for AD 
and thus it is the most common form of dementia in older adults. It is 
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characterized by pathological hallmarks such as extracellular senile 
plaques (SPs) and intracellular neurofibrillary tangles (NFTs). Amyloid 
plaques arise from an altered cleavage of the amyloid precursor protein 
(APP) and the aggregation of resultant toxic peptide oligomers. NFTs, 
on the other hand, are the result of hyper-phosphorylated cytoskeletal 
protein Tau. Even though extensive evidences support both the 
amyloid and tau hypothesis of AD, whether these are the causes or 
effects of the disease process remains unclear.  
 
Recent evidences suggest altered functioning of the dopaminergic 
system, along with other modulatory transmitter systems, as a factor 
contributing to the pathogenesis of the AD (Simic et al., 2009); Trillo et 
al., 2013); Martorana   and   Koch,   2014). In support, decreased DA 
levels have been observed in post-mortem brain tissues of AD patients 
(Nazarali   and   Reynolds,   1992;;   Storga   et   al.,   1996;;   Winblad   et   al.,  
1985). A marked reduction in the expression and changes in the 
distribution pattern of dopamine receptors (both D1-like and D2-like) 
have been reported in the temporal lobe and other brain regions AD 
patients (Joyce et al., 1998; Kemppainen et al., 2003; Kumar and 
Patel, 2007). Restoration of DA neurotransmission was shown to 
improve learning and memory impairments in transgenic AD mouse 
models (Ambree et al., 2009; Guzman-Ramos et al., 2012; Himeno et 
al., 2011). Further, amyloid beta oligomer-induced LTP impairment in 
hippocampal slices of adult mice could be rescued with dopamine 
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D1/D5 receptor agonists (Jurgensen et al., 2011; Yuan Xiang et al., 
2016). Several pharmacological therapies currently used to treat AD, 
such as acetylcholinesterase inhibitors and muscarinic agonists, are 
also suggested to increase extracellular DA levels (Preda et al., 2008; 
Shearman et al., 2006), which in turn could be involved in the 
therapeutic effect of these treatments. Given that aging is an important 
risk factor for AD, understanding altered dopaminergic mechanisms in 
aging-related synaptic plasticity would also provide insights into AD 
pathogenesis.   
 




An important factor affecting the brain function in aging is the 
dysregulation in the homeostasis of brain metal ions, in particular, 
divalent metal ions such as Fe2+, Zn2+, Cu2+ and Mn2+. Especially, Zn2+, 
in addition to its plethora of physiological functions, is critical for the 
precise functioning of the brain including the formation and 
maintenance of long-term memories. 
Zinc is abundant in the brain where most of it (~90%) is found in 
complexes with proteins, acting as a structural or catalytic cofactor 
(Huang, 1997; Takeda, 2000). This complexed zinc pool is 
histochemically invisible. In different regions of the brain, such as the 
cerebral cortex and limbic regions, zinc is present in its free, ionic form 
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(Zn2+) within the synaptic vesicles (Frederickson and Danscher, 1990; 
Takeda and Tamano, 2014). This constitutes the chelatable or 
histochemically reactive zinc pool. These neurons that release Zn2+ are 
mostly glutamatergic and are thus sometimes referred to as 
‘Glucinergic’ or ‘Zincergic’ neurons.  
 
The hippocampus and amygdala are enriched with histochemically 
reactive zinc (Frederickson and Danscher, 1990). Vesicular zinc can be 
detected in the trisynaptic circuits of the hippocampus with highest 
levels in the Mossy fiber synapses of CA3 region. Zinc is co-released 
with glutamate in an activity-dependent manner from these neuronal 
terminals (Takeda and Tamano, 2014; Ueno et al., 2002). Once 
released, it is quickly taken up into pre-synaptic and post- synaptic 
neurons and astrocytes (Takeda and Tamano, 2014). In addition, zinc 
modulates the activities of several important receptors, including the 
AMPA/kainate receptors, NMDA receptors, and γ-amino butyric acid 
(GABAA) receptors in the extracellular compartment (Smart et al., 
1994). Zinc is not only released as a neurotransmitter, but also 
functions as a secondary messenger in neurons and has a functional 
role in synaptic plasticity and memory (Takeda and Tamano, 2014).  
 
Zinc homeostasis is critical for brain function and is tightly regulated by 
the blood- brain barrier and a host of transporters and zinc-binding 
  58 
proteins (Takeda, 2000; Takeda et al., 2001). Alterations in zinc 
homeostasis may lead to adverse complex implications and 
neurological diseases (Barnham and Bush, 2008; Takeda and 
Tamano, 2014).  
 
Aging is associated with structural and functional changes in the brain 
that could be related to zinc homeostasis (Brown and Dyck, 2003; 
Sensi et al., 2011). It has been predicted that brain zinc levels may rise 
with age possibly leading to age-related memory loss and neuro-
degenerative diseases (Sensi et al., 2011). The hippocampus primarily 
appears to be the most responsive region to either a deficiency or an 
excess of zinc (Suh et al., 2009; Takeda and Tamano, 2014). 
Perturbation of zinc homeostasis in hippocampal neurons is also linked 
to cognitive decline under stress or in pathological conditions. For 
instance, it has been reported that excess intracellular zinc signaling 
induced by corticosterone and/or stress results in the impairment of 
hippocampal long-term potentiation (LTP), an important cellular 
correlate of learning and memory (Takeda and Tamano, 2014). A 
compromised blood-brain barrier, reduced levels or activity of 
transporters, amyloid deposition and oxidative stress may all contribute 
to dyshomeostasis. In support, increased zinc levels are seen in the 
hippocampus and amygdala of AD patients (Danscher et al., 1997; 
Thompson et al., 1988). Furthermore, extracellular Zn2+ can be 
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sequestered by amyloid oligomers; thus can precipitate plaque 
formation (Bush et al., 1994; Deshpande et al., 2009).  
Zinc supplementation causes spatial memory deficits in a model of 
late-onset AD, which correlates with levels of amyloid-beta (Flinn et al., 
2014). Interestingly, rats raised on elevated levels of dietary zinc show 
high levels of zinc in the brain, and display cognitive and memory 
deficits (Flinn et al., 2005). The widely studied mouse models of 
accelerated aging, Senescence-Accelerated Mouse Prone-8 and 10 
(SAMP8 and SAMP10), display different aspects of brain aging and 
zinc homeostasis (Onozuka et al., 2002; Saito et al., 2000). A zinc- 
enriched diet leads to spatial memory deficits in wild-type mice and 
worsens the deficits in transgenic AD models (Linkous et al., 2009). 
Excess intracellular Zn2+ signaling also leads to a negative cross-talk 
that suppresses Ca2+ signaling, which then impairs synaptic plasticity 
(Takeda and Tamano, 2014). Thus, it appears that the alterations in 
synaptic plasticity and related mechanisms in advanced aging and 
other neurodegenerative conditions, which may underlie the learning 
and memory deficits, could be associated with the effects of increased 
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Though significant progress has been made over the years, our 
understanding of the mechanisms of cellular memory consolidation is 
not complete. Many broad questions, such as how is information from 
multiple inputs integrated, how does activity at a given set of synapses 
affect response of other synapses to subsequent stimuli and how is the 
selective stabilization or erasure of memories achieved in the face of 
ongoing activity, demand further investigations. The influence of 
neuromodulators on plasticity is particularly important as it brings about 
behavioral state-dependent consolidation of memories.     
 
Dopaminergic D1/D5 receptor signalling in the hippocampus is critical 
for the induction of protein synthesis-dependent forms of synaptic 
plasticity and long-term memory. Interestingly, bath application of 
dopamine or D1/D5 receptor agonists itself leads to a slow-onset 
potentiation of fEPSPs at CA1 SC synapses. Such a potentiation 
occludes electrically induced LTP and it too takes part in synaptic 
associativity processes (Huang and Kandel, 1994; Navakkode et al., 
2007; Navakkode et al., 2012; Sajikumar and Frey, 2004a). However, it 
is known that dopaminergic signalling exhibits dose-dependent 
responses in other brain regions such as striatum, prefrontal cortex and 
nucleus accumbens, with linear or nonlinear profiles (Chao et al., 2002; 
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Goldman-Rakic et al., 2000; Knecht et al., 2004; Williams and Millar, 
1990; Zheng et al., 1999). Whether the functional response of the 
D1/D5 receptor signalling in hippocampal CA1 region differs over a 
range of dopamine (or agonist) concentrations is not known. Further, 
coincidental synaptic activity in the vicinity of potentiated synapses can 
lead to either cooperation or competition (Sajikumar et al., 2014). 
Altered dopaminergic signaling and modulation are implicated in the 
pathophysiology of many neuropsychiatric disorders. Consequently, 
systemic administration of dopamine receptor agonists or dopamine 
precursors in some studies indicated this approach could be a 
beneficial strategy (Cai and Arnsten, 1997; Castner and Goldman-
Rakic, 2004).  
 
Acute and chronic dopaminergic therapies used in the treatment of 
Parkinson’s disease can have different cognitive effects and some of 
them could involve the hippocampus (Poletti et al., 2013). On the other 
hand, many addictive and psychoactive compounds also modulate 
dopamine levels in the brain (Summers and Giacobini, 1995); 
Reviewed by (Pierce and Kumaresan, 2006). This raises important 
concerns on how changes in the extracellular dopamine concentrations 
influence ongoing information processing in the hippocampus and 
affect the encoding and maintenance of memories. 
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With this background, the main objectives of the first part of the study 
are: 
1)   To investigate the dose-dependency of dopamine D1/D5 receptor-
mediated potentiation in hippocampal CA1 SC synapses. 
2)   To investigate the mechanisms of D1/D5 receptor signalling-
mediated potentiation and synaptic associativity processes — 
specifically the role of CaM kinases and MAP kinases (ERK1/2) in 
the induction and maintenance phases 
 
The second part of the study aims to investigate age-associated 
alterations in the synaptic plasticity and associativity, in particular, the 
D1/D5 receptor-mediated potentiation in the hippocampal CA1 region. 
Though LTP at hippocampal synapses have been studied in aged 
animals, the associative properties have not been investigated. 
Further, considering the predictions that aging is associated with 
increased zinc levels, the effects of zinc chelation on hippocampal 
synaptic plasticity will be examined. The specific objectives for the 
second part of the study are: 
1)   To investigate the age-associated alterations in the synaptic 
plasticity and associativity, including the D1/D5 receptor-mediated 
potentiation. 
2)   To study the effects of zinc chelation on hippocampal synaptic 
plasticity alterations in aged hippocampal CA1 pyramidal neurons  
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Mounting evidences demonstrate that activity-dependent, persistent 
synaptic modifications play crucial roles in a variety of adaptive brain 
functions, especially in learning and long-term memory formation. This 
calls for continued efforts towards a detailed understanding of 
molecular basis of the various forms of synaptic plasticity. Such 
knowledge will further our understanding and, alongside pacifying our 
curiosity, impact the treatment of various brain disorders. 
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CHAPTER 3 - MATERIALS AND METHODS 
 
3.1 Technical notes and background: 
 
 
3.1.1 Field potential recordings: 
 
Field potentials are extracellular potentials recorded from groups of 
neurons in response to synaptic or antidromic stimulation. The 
cytoarchitecture of the hippocampal formation makes it highly favorable 
for field potential studies. The striking appearance of hippocampal field 
potentials is because of the densely packed layer of cell bodies, the 
roughly parallel orientation of the apical dendrites with dense excitatory 
synapses and the ease with which they can be synchronously 
activated.  
During synaptic transmission, the neurotransmitter released at the 
synapse acts on the postsynaptic receptors or ion channels to cause 
depolarization in the postsynaptic membrane. This resulting 
depolarization in the postsynaptic membrane leads to the postsynaptic 
potential (PSP). If the synapse is excitatory, then the potential 
developed is an excitatory PSP (EPSP) and if it is an inhibitory 
synapse then the potential is an inhibitory PSP (IPSP). PSPs are not 
all-or-none events like action potentials but are graded. This allows 
EPSPs to be temporally or spatially summated and if the potential 
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difference crosses the threshold then an action potential can be 
generated.  
 
A change in the membrane potential in response to a stimulation can 
be measured from both intracellularly and extracellularly. Synaptic 
currents generated by single neurons are usually too small to be 
detected. However, in hippocampus and certain other structures with 
highly laminated cytoarchitecture, it is possible to record the localized 
synaptic currents because of the synchronous synaptic activation of a 
population of neurons. Such local evoked field potentials due to 
activation of a group of neurons is called a ‘field EPSP (fEPSP)’ or a 
‘Population EPSP’.  
 
Upon stimulation of an excitatory input, a synaptic current is generated 
in the region of stimulation which flows into the dendrites. This creates 
a ‘current sink’ in the synaptically active region (See Figure 3.1). Inside 
the cell, the current then flows proximally towards the cell body (soma) 
and exits to the extracellular space (as the membrane area is greatest 
at the soma). This forms a ‘current source’. This open field 
configuration creates a dipole where the current flows between sink 
and source, completing the loop extracellularly. These synchronous 
current flows can be measured as field potentials between an 
extracellular recording electrode and a ground electrode. In the region 
of active current sinks, the fEPSPs will be negative and they will be 
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positive in the region of strong current sources (Figure 3.1). If the 
synaptic response is below the threshold for generation of action 
potentials in the cells, (with weaker stimulation), a pure fEPSP is 
generated. With stronger stimulation, the cells discharge 
synchronously, giving rise to a ‘Population Spike (PS)’ which is 
superimposed on the rising phase of the fEPSP. The population spike 
is also a graded response. 
 
 
Figure 3.1: Field-potential recording: A schematic drawing of a 
pyramidal neuron showing the generation of current sink and source 
following synaptic stimulation and the signals obtained from 
extracellular field-potential measurements (For details see text). 
 
In fEPSP recordings, typically the initial slope of the EPSP waveform is 
measured as a preferred index than absolute peak amplitude. This is 
because the initial slope is less likely to be contaminated from other 
sources of current flow in the slice, such as those generated by feed-
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forward inhibition due to the activation of GABAergic neurons. Further, 
the later stages of the EPSP can also be contaminated with the action 
potentials fired by the neurons being recorded (Sweatt, 2003). 
 
3.1.2 Hippocampal Slices 
  
In vitro slice preparation techniques were pioneered by Henry Mcllwain 
(1957). These techniques were further refined by Per Andersen, Knut 
Skrede and Rolf Westgaard (1971, 1972) to study single-cell activity 
and short-term plasticity and were later adopted by Tim Bliss and Chris 
Richards (1971) to record field potentials in the transverse 
hippocampal slices. Subsequently, rodent hippocampal slices were 
also shown to be useful for stable long-term intracellular recordings 
(Schwartzkroin, 1975) and long-term potentiation studies. Since then, 
in vitro hippocampal slice preparation has been used extensively 
because of some of the following benefits it offers: 
-   Allows precise location of electrodes 
-   Signals observed are similar to those recorded in vivo 
-   Provides mechanical stability for recordings 
-   No blood-brain barrier; easy and rapid pharmacological 
manipulations 
 




All of the animal procedures used in the study were in accordance with 
the protocols approved by the Institutional Animal Care and Use 
Committee (IACUC) of the National University of Singapore, Singapore 
[Protocol numbers: 072/12, R13-4656(A)13 and R13-5711(A1)14]. All 
necessary measures were followed to reduce the number of animals 
used and their suffering.  
 
Male Wistar rats were used in all the studies. For the first part of the 
study, a total of >300 acute hippocampal slices from 216 young adult 
(5-7 week old) male Wistar rats were used for electrophysiological 
recordings. Young adult animals of 5-7 weeks age with fully expressed 
adult receptor functions were used. The aged rats used in the study 
(Part-II) were 82-84 week old male Wistar rats. The rats were 
purchased from the vendors InVivos Pte Ltd, Singapore and Janvier 
Labs, France and housed in the institutional animal housing facility until 
use. Two young rats were housed in a single standard cage while the 
aged rats were housed singly. They were maintained on a 12-hour 
light/dark cycle with food and water available ad libitum. 
 
For the second part of the study, a total of 144 acute hippocampal 
slices from twenty seven 82-84 week old male Wistar rats and 46 slices 
from twenty two 5-7 week old male Wistar rats were used for 
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electrophysiological recordings. Since the number of aged animals was 
limited, the slices from each rat were utilized maximally by 
simultaneously performing four different experiments in four interphase 
chambers. For the zinc imaging, left hippocampal slices (>50 each) 
from nine adult rats and ten aged rats were used. 
 
3.3 Hippocampal Slice preparation 
 
 
3.3.1 Composition of artificial cerebrospinal fluid (aCSF) 
   
The aCSF used is a modified Krebs-Ringer solution containing the 
following (in mM): 124 sodium chloride (NaCl), 3.7 potassium chloride 
(KCl), 1.2 potassium dihydrogen phosphate (KH2PO4), 1 magnesium 
sulphate heptahydrate (MgSO4.7H2O), 2.5 calcium chloride dihydrate 
(CaCl2.2H2O), 24.6 sodium bicarbonate (NaHCO3) and 10 D-glucose. 
All the chemicals were purchased from Sigma-Aldrich. A 10x stock 
solution containing NaCl, KCl, KH2PO4, MgSO4 and CaCl2 was 
prepared and stored at 4oC. 1x working solution was prepared freshly 
by diluting the stock and adding NaHCO3 and D-glucose. This working 
solution was used for both the dissection and for the perfusion during 
recordings. The pH of the solution ranged between 7.3-7.4 when 
bubbled with 95% oxygen and 5% carbon dioxide (Carbogen) and the 
osmolality of the solution was ~390 mOsm. 
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3.3.2 Preparation of acute hippocampal slices 
 
Just prior to the sacrifice, the rats were brought to the procedure room 
and anaesthetized in an induction chamber using 100% carbon dioxide 
(CO2) for about 1-2 minutes. Usage of any standard anesthetic drugs 
was avoided as they might affect synaptic and neuronal properties 
(MacIver et al., 1989; Simon et al., 2001) which in turn might affect the 
synaptic plasticity experiments. CO2 at high concentrations acts initially 
as a rapid depressant and anaesthetic but this will soon be followed by 
death through asphyxiation. Hence, once the animal is sufficiently 
anaesthetized (as confirmed by unresponsiveness to a toe pinch), the 
brain isolation was performed rapidly. 
 
Figure 3.2: Tools used for dissection, hippocampus isolation and 
slice preparation. (a) Bandage Scissors (b) Iris scissors (c) Bone 
rongeur (d) Thin spatula, (e) Scalpel number 11 (f) Sickle scaler (g) 
Soft-bristle paint brush (h) Plastic Pasteur pipette (i) filter paper 
(85mm) (j) filter paper (30mm) (k) Glass beakers (l) Aluminum cooling 
blocks to fit petri dish and beakers (m) Petri dish. 
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The tools and materials used for the dissection procedure are shown in 
Figure 3.2. Following the anaesthetization with CO2, the rats were 
quickly decapitated and the fur and skin over the skull was removed. 
The brain stem was removed with a cut to the posterior side followed 
by two small incisions laterally to remove the skull plates with the help 
of a bone rongeur. Any dura was carefully removed and the brain was 
rapidly removed into cold (2-4oC) aCSF in a petri dish (placed on a pre-
cooled aluminum block) that was continuously being bubbled with 
carbogen. To isolate the hippocampus, first, cerebellum and anterior 
one quarter of the brain was cut away followed by a shallow cut along 
the inter-hemispheric fissure. The cortex covering the hippocampus 
was carefully removed with a sickle scaler starting from midline. A 
small cut was given to the hippocampal commissure and the right 
hippocampus was gently separated out. Hippocampus was then placed 
on the stage of a manual tissue slicer (Stoelting) and sliced 
transversely, at an angle of about 70o to the fimbria, into 400 μm-thick 
slices. The slices were then picked up gently with a wet soft-bristled 
paint brush and collected in a small beaker containing ice-cold, 
oxygenated aCSF. Quickly following the slicing, the slices were 
transferred on to a nylon net in an interface chamber (Figure 3.3 and 
Figure 3.4).  
 
 





Figure 3.3: Interface Brain slice chamber. (Model BSC1; Scientific 
Systems Design Inc. Canada) (a) Cross sectional view of the BSC1 
chamber showing the build and components: (1) Bubble trap (2) Heat 
exchanger for perfusion fluid (3) Control temperature sensor (4) 
Heating element (5) Carbogen bubbler (6) Exit for perfusion fluid via 
suction line. (b) Interface chamber mounted on a vibration-resistant 
table and electrodes positioned. 
 
 
We have recently published a video article demonstrating this 




The interface chamber provides a controlled environment for 
maintaining the slices for long-term recordings. Slices were 
continuously perfused with oxygenated aCSF at a flow rate of 1 ml/min 
and the temperature was maintained (using a proportional temperature 
controller) at 32oC both during incubation and for the entire recording 
period. The slice environment was also kept saturated with humidified 
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carbogen bubbled through the lower compartment of the chamber (16 








Figure 3.4: Acute hippocampal slices of rat. (a) Rat hippocampal 
slices inside the interface chamber resting on a nylon net. They are 
surrounded by a thin meniscus of aCSF without being submerged. (b) 
A slice illuminated to show the characteristic shape and sub-regions. 
 
 
In all the experiments, the slices were incubated for at least 3 hours 
before starting the experiments. Such long incubation hours have been 
suggested to be crucial for more physiological long-term plasticity 
studies (Sajikumar et al., 2005; Shetty et al., 2015). Long incubation 
hours are necessary for achieving metabolic stability and basal 
phosphorylation status of many proteins involved in synaptic plasticity 
(Ho et al., 2004; Sajikumar et al., 2005). 
 




3.4.1 Location of electrodes 
 
In this study, the fEPSPs were recorded from the Schaffer collateral 
synapses on CA1 apical dendrites (stratum radiatum). In all 
experiments, monopolar, lacquer-coated, stainless steel electrodes (5 
MΩ resistance; A-M Systems) were used for both stimulating and 
recording purposes. Guided under the microscope, the stimulating 
electrode(s) were positioned in the stratum radiatum of the CA1 region 
to stimulate the Schaffer collateral fibers and the recording electrode 
was positioned in the apical dendritic region of CA1 to record field-
EPSP (fEPSP, measured as its slope function) (See Figure 3.5).  
 
 
Figure 3.5: Schematic representation of electrode location in a 
slice and a typical fEPSP signal. (Left panel) schematic drawing of a 
hippocampal slice with a stimulating electrode (Stim S1) in CA1 
stratum radiatum (s.rad) to stimulate Schaffer collaterals (SC) and a 
recording electrode (Rec) to record fEPSP from the same region. 
(Right panel) A representative fEPSP signal showing stimulus artefact 
(a), fiber volley (b) and initial slope of fEPSP (c). 
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In synaptic tagging and capture experiments, according to the need of 
the experiment, two (for two pathway experiments) or three stimulating 
electrodes (for two pathway experiments) were positioned on either 
side of the recording electrode to stimulate two or more independent 
but overlapping inputs.  
 
When both the electrodes have touched the slice, using the acquisition 
software, a test stimulation (biphasic, constant-current pulses, impulse 
duration 0.1 ms/half-wave) was delivered to ensure a proper fEPSP 
signal, upon which the electrodes were carefully lowered about 200-
250 μm deep using fine movement knobs of the manipulators.  
 
3.4.2 Input-output relation 
 
 
The input-output relation (afferent stimulation vs fEPSP slope) for each 
input was determined by measuring the slope value at a range of 
stimulation intensities. The stimulation intensity for each input was set 
to obtain 40% of the maximal fEPSP slope. This intensity was kept 
unchanged throughout each recording session. In STC experiments, 
pathway independence was tested using a paired-pulse facilitation 
protocol with 30 ms interpulse interval (Li et al., 2014; Sajikumar et al., 
2014; Young and Nguyen, 2005). In all experiments, a stable baseline 
of at least 30 minutes was recorded before any LTP induction or 
pharmacological manipulation. 
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Figure 3.6: Electrophysiology set-up for in vitro field-potential 
recordings.  It consists of stimulators, a differential amplifier, an 
analog-to-digital converter, oscilloscope, computer with acquisition 
software, vibration-resistant table-top, microscope with >4x 
magnification, interface brain-slice chamber, a perfusion system for 
aCSF and carbogen supply, a temperature controller, an illumination 
source and manipulators with electrode holders.  
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3.4.3 Stimulation protocols: 
 
 
The stimulation was generated and delivered using an isolated pulse 
stimulator (Model 2100, AM Systems). Signals were filtered and 
amplified by a differential amplifier (Model 1700, AM Systems) and 
digitized using a CED 1401 analog-to-digital converter (Cambridge 
Electronic Design) and monitored online with a custom-made software 
(IntraCell, IfN, Magdeburg) (See Figure 3.6 for the complete set-up). 
For the measurement of synaptic strength, the initial slopes of the 
evoked fEPSPs per recording time-point were normalized to baseline 
[calculated as (fEPSP slope per recording time point /mean EPSP 
slope baseline) × 100].  
 
3.4.3.1 Test stimulation: 
 
 
Four 0.2 Hz biphasic, constant current pulses (spaced at 5 s), given 
every five minutes, were used for baseline and post-induction recording 
and the average slope value from the four sweeps was considered as 
one repeat while used for analysis and plotting. A plot of fEPSP slopes 
recorded with this test stimulation frequency over 3 h is shown in 
Figure 3.7, showing the stability of the recordings. This low rate of the 
test stimulation was important to maintain network stability while 
avoiding any metaplastic changes in the slices (Sajikumar et al., 2005; 
Schurr et al., 1986). 
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Figure 3.7: Stable long-term field-EPSP recordings. A plot of mean 
field-EPSP slope (percentage of initial 30 min baseline values) versus 
time showing the stable long-term recordings (n=6). The test 
stimulation was given every 5 min. The slope values did not show 
statistically significant deviation from the baseline values at any time-
point (Wilcoxon matched pairs test, P>0.05). Error bars represent 
±SEM. Representative fEPSP traces shown in the inset are recorded at 
the respective time points as mentioned. Scale bar for the traces, 




3.4.3.2 Early-LTP induction protocol 
 
 
Early-LTP was induced with a weak tetanization protocol (WTET) 
consisting of a single high frequency stimulation (100 Hz, 21 biphasic 
constant current pulses, single burst, 0.2 ms pulse duration). This 
protocol has been shown to induce a protein synthesis-independent E-
LTP that lasts only for 2-3 hours (Frey and Morris, 1998a; Sajikumar 
and Korte, 2011; Sajikumar et al., 2007; Sajikumar et al., 2008).  
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3.4.3.3 Late-LTP induction protocol 
 
 
A strong tetanization protocol (STET) involving repeated high-
frequency stimulation (three trains of 100 Hz, 100 pulses, single burst, 
0.2 ms pulse duration) with an inter-train interval of ten minutes was 
used for L-LTP induction. 





Figure 3.8: Schematic overview of the experimental procedure. A 
schematic outline of the steps involved in the long-term field-EPSP 
recording experiments (For details see text). Lower panel shows the 
experimental timeline of a typical long-term recording experiment.   
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3.5.1 Dopamine D1/D5 receptor agonists 
 
•   SKF-38393: SKF-38393 hydrochloride [(±)-1-Phenyl-2,3,4,5- 
tetrahedro-(1H)-3-benzazapine-7,8-diol hydrochloride] (SKF; #D047, 
Sigma-Aldrich) was stored as a 15-50 mM stock in deionised water 
at -20 ̊C protected from light. 
•   6-Bromo-APB: 6-Bromo-APB hydrobromide [R-(+)6-Bromo- 7,8-
dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine 
hydrobromide] (APB; #B135, Sigma-Aldrich) was stored as 15–50 
mM stock in DMSO at -20 ̊C protected from light. 
The stocks were made fresh whenever possible or otherwise used 
within a week. Just before application, the stocks were diluted to the 
final concentration in aCSF and bubbled with carbogen. The drugs 
were protected from light during storage and bath application was 
carried out under dark conditions.  
Application paradigm: 
The agonists diluted to final concentration were bath applied to the 
slices at 1 ml/min flow rate for three 5-minute durations with a 5-minute 
interval between each application. Such a paradigm has been 
suggested to be identical to spaced HFS-like LTP induction paradigm 
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(Navakkode et al., 2007; Navakkode et al., 2012; Sajikumar et al., 
2005).  
 
3.5.2 CaM kinase inhibitors 
 
•   KN-93: A cell-permeable, competitive inhibitor of Ca2+/calmodulin-
dependent protein kinase II (Ki = 370 nM). Selectively binds to the 
Calmodulin (CaM) binding site of the enzyme and prevents the 
association of CaM with CaM Kinase II. Inhibits both CaM kinase II 
and IV at higher concentrations (~10 µM, (Redondo et al., 2010). 
Purchased as a 5 mM (1 mg/399 µl) solution of KN-93 in DMSO 
(InSolution KN-93, #422712, Calbiochem) or prepared as a 20 mM 
stock in DMSO (from KN-93, #422708, Calbiochem) and stored as 
aliquots at -20oC protected from light. 
•   KN-92: Cell-permeable negative control for KN-93. Purchased from 
Calbiochem (#422709). Reconstituted in DMSO to 5 mM-20 mM 
stock and stored as aliquots at -20 ̊C protected from light. 
  
Just before application, both the stocks were diluted to the final 
concentration in aCSF, bubbled with carbogen, and bath applied. 
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3.5.3 MAP kinase kinase (MEK) inhibitors (ERK1/2 activation 
inhibitors) 
•   U0126:(1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio] 
butadiene) purchased from Promega, Madison (#V1121), and stored 
as aliquots of 20 mM stock in DMSO. 
It specifically inhibits MEK1 and MEK2, upstream kinases of ERK1/2, 
and thus inhibits activation of ERK1 and ERK2. Inhibition is 
noncompetitive with respect to ERK and ATP substrates. IC50 of 0.53 
μM for active MEK. U0126 inhibits MEK directly by inhibiting the 
catalytic activity of the active enzyme. 
•   PD98059: Another MEK inhibitor purchased from Cell Signaling 
Technology, Beverly (#9900L). Stored as aliquots of 50 mM stock in 
DMSO at -20 ̊C. 
PD98059 specifically inhibits MEK1 and MEK2 activation with IC50 
values of 4 μM and 50 μM, respectively (Alessi et al., 1994; Crews et 
al., 1992; Rosen et al., 1994). 
 
3.5.4 Protein synthesis inhibitor 
 
•   Emetine dihydrochloride hydrate: Purchased from Sigma-Aldrich 
(#E2375), concentrated stocks prepared in DMSO were stored as 
aliquots at -20 ̊C; diluted in aCSF to obtain a final concentration of 
20 μM just prior to bath application.  
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Emetine inhibits protein synthesis irreversibly in eukaryotic cells by 
binding to the 40S ribosomal subunit and inhibiting translocation 
(Courchesne et al., 1986). 
 
3.5.5 NMDA receptor antagonist 
 
•   D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5): Competitive 
NMDAR antagonist. Purchased from Tocris Bioscience (#0106); 
concentrated stocks prepared in DMSO are stored as aliquots at -
20 ̊C. Diluted in aCSF to obtain a final concentration of 50 μM just 
prior to bath application (Korte et al., 1995; Navakkode et al., 2005; 
Navakkode et al., 2007).  
 
3.5.6 Zn2+-selective fluorescent indicator 
 
•   FluoZinTM-3, AM 
 
Cell-permeable, Zn2+-selective fluorescent indicator. Exhibits high Zn2+-
binding affinity (Kd ~ 15 nM) that is unperturbed by significantly high 
Ca2+ concentrations, up to 10 mM (Zhao et al., 2008). 
Excitation/emission wavelength: ~494/516 nm. Exhibits >50-fold 
increase in fluorescence in response to saturating levels of Zn2+. 
Purchased from ThermoFisher Scientific (Molecular Probes, #F24195); 
stored at -20 ̊C as aliquots of 2 mM stock in DMSO. Diluted in aCSF to 
working concentration of 2 μM immediately prior to use.   
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Zn2+-imaging with FluoZinTM-3, AM:  
 
Acute hippocampal slices of 400 μm thickness were prepared from the 
left hippocampus of adult and aged rats as described above in Section 
3.3. The slices were then incubated in a submerged holding chamber 
for 2 hours at 32 ̊C in aCSF (composition as in Section 3.3.1). After the 
incubation period, the slices were carefully collected and stored in 4% 
paraformaldehyde (PFA) in phosphate-buffered saline (PBS) (pH 7.4) 
at 4 ̊C. On the day of imaging, the slices were rinsed three times in 
aCSF and treated with 2 μM FluoZinTM-3 AM solution for ten minutes in 
dark. Then the slices were rinsed once with aCSF to wash off the 
unbound FluoZinTM-3, carefully transferred to a glass-bottomed 
imaging dish and imaged using Zeiss LSM 710 confocal microscope (at 
the NUHS Confocal Microscopy Unit).  
 
Image acquisition:  
 
The images were acquired with an inverted Zeiss Axiovert LSM 710 
confocal microscope (Carl Zeiss, Oberkochen, Germany) using Zen 
Black software. The excitation source was 543 nm He-Ne laser.  The 
objective lens used was 10x (numerical aperture 0.4). Images were 
acquired from the middle layer of the slice and each image was 
stitched with Tile Scan mode (4x3 frames). All the settings and 
acquisition parameters were kept constant for all the images. 
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Image analysis: 
 
The acquired raw images were analyzed using the ImageJ 1.50i 
software (NIH). For the quantification of the fluorescence intensity from 
the whole slice, entire field of view containing a single slice was used 
(all the images had the same image properties). The background signal 
was negligible in all the images. Auto-fluorescence from the unstained 
slice was checked and was almost nil (data not shown). The raw 
intensity density of the FluoZin-3 fluorescence from the whole slice was 
measured from the adult and aged rat slices. The raw intensity density 
of the two groups was expressed as mean±SEM. 
 
Further, the raw intensity density of the FluoZin-3 fluorescence from 
the CA1 region was measured. The CA1 region was selected as the 
region of interest (ROI) in each image by drawing a polygon along the 
CA2-CA1 border, the alvear border of CA1, CA1-subicular border and 
along the hippocampal fissure between the DG molecular layer and the 
lacunosum molecular layer of CA1. The raw intensity density from the 
ROI in each slice was normalized to the area of ROI. The raw intensity 
density of the two groups was expressed as mean±SEM. The data was 
subjected to statistical analysis using GraphPad Prism 6.0. In both 
cases, unpaired t-test with Welch’s correction was used for 
comparison.        
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3.5.7 Zn2+ chelator 
 
•   TPEN: [N,N,N’,N'-Tetrakis (2-pyridylmethyl) ethylenediamine].  
Cell-permeable Zn2+ chelator. Very high affinity for Zn2+ compared to 
other heavy metal ions; activity decreases intracellular Zn2+ levels. 
Purchased from Tocris Bioscience (#4309). Stored as aliquots of 25 
mM stock in DMSO at -20 ̊C; diluted in aCSF to obtain a final 
concentration of 5 μM just prior to bath application.  
The drugs were stored and handled according to the instructions from 
the manufacturer. All light-sensitive drugs were protected from light 
during storage and bath application. Prior to application, the drug 
stocks were diluted to the final concentration in ACSF, equilibrated with 
carbogen and bath applied for specified durations. Whenever the 
stocks were prepared in DMSO, the final DMSO concentration was 
kept below 0.1%, a concentration which has been shown to not affect 
basal synaptic responses (Navakkode et al., 2005).  
 
 
3.6 Data presentation and statistical analysis  
 
 
The fEPSP recordings automatically saved by the recording software 
were analyzed offline. The fEPSP slopes per time point were 
expressed as percentage of average baseline values in each 
experiment (and for each input in two or three pathway experiments). 
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The time-matched, normalized data were averaged across replicate 
experiments, plotted against time as ‘mean ± SEM’ and were then 
subjected to statistical analysis with GraphPad Prism 6.0. 
Nonparametric tests were used considering the normality violations at 
small sample numbers. Wilcoxon matched-pairs signed rank test was 
used when comparisons were made within a group (a post-induction 
value compared to its own baseline value). Mann-Whitney-U-test was 
used for comparisons between groups. Multiple, between-group 
comparisons for specified time-points were performed with either one-
way or two-way ANOVA with Tukey’s or Dunnet’s post-hoc tests. 
Statistical significance was assumed at P < 0.05. (*P < 0.05 **P < 0.01 
***P < 0.001, ****P < 0.0001). In all the experiments, the number of 
experiments ‘n’ represents the number of slices used. However, the 
slices in each experimental group were from at least four biological 
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CHAPTER 4- RESULTS 
 
 
In the first part of the results section (Results-I), results concerning the 
dopamine D1/D5 receptor signaling-mediated slow-onset potentiation 
and its associative properties are presented. Evidence is also 
presented for the differential involvement of CaM kinases and MAP 
kinases in the induction and maintenance phases of this form of 
potentiation. 
 
In the second part (Results-II), results from the investigation of 
synaptic plasticity and associativity in the CA1 region of aged rats are 
presented along with the experimental evidence for the increased 
hippocampal zinc levels and the effects of zinc chelation on these 
processes. 
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RESULTS-I: Dopamine D1/D5 receptor 
signaling-mediated synaptic plasticity and 
associativity in CA1 pyramidal neurons of adult 
rats 
 
4.1 D1/D5 receptor-mediated slow-onset potentiation at 
CA1 Schaffer collateral synapses is concentration-
dependent 
 
Dopamine (DA) or D1/D5 receptor agonists, upon bath application to 
hippocampal slices, induce a slow-onset potentiation (SOP) in CA1 SC 
synapses (Gribkoff and Ashe, 1984; Huang and Kandel, 1995). 
Concentration of the DA or agonists used in majority of the studies 
investigating this form of plasticity varies between 50-100 µM (Huang 
and Kandel, 1995; Navakkode et al., 2007; Navakkode et al., 2012; 
Roberson et al., 1999). One study reported a bidirectional effect of 
spaced, repeated DA application on plasticity in CA1 region wherein 10 
µM DA resulted in a slow-onset LTD and 50 µM DA lead to a slow-
onset LTP (Sajikumar and Frey, 2004a). Given that DA signaling is 
known to exhibit dose-dependent responses in other brain regions, we 
started with a series of experiments investigating the dose-dependency 
of the D1/D5 receptor-mediated SOP in CA1 SC synapses. As DA can 
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act on many subclasses of its receptors, to specifically isolate the role 
of D1/D5-type receptor signaling we chose to use specific agonists of 
this class rather than DA itself. After a stable baseline recording, we 
applied the D1/D5 receptor agonist SKF-38393 (from now on, SKF) at 
a range of concentrations from 50 µM to 0.1 µM. 
  
Application of 50 µM SKF lead to a potentiation that developed 
gradually as observed in earlier reports (Huang and Kandel, 1995; 
Navakkode et al., 2007; Navakkode et al., 2012). The fEPSP slope 
value became significantly different from the baseline value 35 minutes 
after the start of the application (118.1±3.06%, Wilcoxon test, P=0.031) 
and remained significant over 4 hours (155±7.28%, Wilcoxon test, 
P=0.031; n=6, Figure 4.1a). Application of 25 µM SKF also resulted in 
a similar SOP that became significantly different from the baseline 
value by 25 minutes (116±2.84%, Wilcoxon test, P=0.002). The mean 
potentiation at the end of 4 hours was 148.77±5.52% (Wilcoxon test, 
P=0.002, n=10, Figure 4.1b). The result was similar with the application 
of 10 µM SKF; the potentiation was significantly different from the 
baseline value 20 minutes post-application (114.2±5.78%, Wilcoxon 
test, P=0.008) and remained significant over 4 hours (132.03±4.71%, 
Wilcoxon test, P=0.008; n=8, Figure 4.1c). Interestingly, a delayed-
onset potentiation was also observed following the application of 5 µM 
SKF. The potentiation developed rather slowly compared to higher 
concentrations, became significant by 90 minutes following first 
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application (115.05±5.63%, Wilcoxon test, P=0.023) and stayed 
significant thereafter until the end of the recording period 
(126.30±8.20%, Wilcoxon test, P=0.03, n=8, Figure 4.1d). Bath 
application of further lower concentrations, 1µM SKF and 0.1 µM SKF, 
did not induce any significant potentiation. The mean fEPSP slope 
values at the end of 4 hours were not significantly different from the 
baseline values for both 1 µM SKF group (107.52±3.78%; Wilcoxon 
test, P=0.148, n=8, Figure 4.1e) and 0.1 µM SKF group (98.71±8.23%; 
Wilcoxon test, P=0.843, n=8, Figure 4.1f).  
 
The mean potentiation observed in each group at the end of 4 hours 
clearly showed a concentration-dependent linear response (Figure 
4.1g). The normalized mean slope values in each group were analyzed 
using a one-way analysis of variance (one-way ANOVA) which showed 
a significant difference between the mean values (F (6,51) = 16.02; 
P<0.0001). Further multiple post-hoc comparisons with Dunnette’s test 
revealed significant differences compared to a control baseline group 
(100%) in 50 µM (P<0.0001), 25 µM (P<0.0001), 10 µM (P<0.001) and 



















                           
                            (g) 
 
 
Figure 4.1: Concentration-dependent slow-onset potentiation 
induced by SKF-38393. (a)-(f) Time course of the fEPSP slope 
responses following bath application of the D1/D5 receptor agonist 
SKF-38393. After 30 minutes of baseline recording, the agonist at the 
respective concentration was applied in three 5-minute durations with 
a 5-minute interval between each application (represented by three 
broken arrows). In (a) 50 µM SKF, n=6, (b) 25 µM SKF, n=10, (c) 10 
µM SKF, n=8  (d) 5 µM SKF, n=8  was applied that resulted in a slow-
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We observed similar response using another structurally different 
D1/D5R analog 6-bromo-APB (APB) (Figure 4.2 a-g).  
onset potentiation lasting over 4 hours. In (g) 1 µM SKF, n=8, and (h) 
0.1 µM SKF, n=8  was applied and both failed to induce any 
significant potentiation or depression. (i) A histogram of the mean 
potentiation (% of baseline) in each SKF groups 4 hours following the 
application (one-way ANOVA, F=16.02 (6,51), P<0.0001). Asterisks 
indicate significant deviations from baseline group (100%); Dunnett’s 
post-hoc test, **P<0.01, ***P<0.001, ****P<0.0001). Error bars in all 
graphs represent ±SEM.  Error bars in all graphs represent ±SEM. 
Representative fEPSP traces shown in each case are recorded at the 
respective time points as mentioned. Scale bars for all the traces, 
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Taken together these first series of experiments revealed that the 
D1/D5 receptor-signaling mediated potentiation at the CA1 SC 
synapses is concentration dependent. 
                           (g) 
 
 
Figure 4.2: Concentration-dependent slow-onset potentiation 
induced by 6-bromo-APB. 
(a)-(f) Concentration-dependent long-lasting potentiation induced by 
bath application of the D1/D5 receptor agonist 6-bromo-APB. Three 
broken arrows in all the figures indicate the application of the agonist 
in three pulses. Following 30 min baseline recording, APB was 
applied for three 5-minute durations with 5-minute interval between 
each application. (a) Application of 50 µM APB resulted in slow-onset 
potentiation that maintained over 3 hours. The potentiation at the end 
of 3 hours (146.91±8.68%) was significantly different from the pre-
induction baseline (P<0.05, n=5). (b) 25 µM APB induced slow-onset 
potentiation that lasted for 4 hours; potentiation at the end of 4 hours 
(137.94±3.93%) was significantly different from the pre-induction 
baseline (P<0.01, n=8). (c) 10 µM APB induced slow-onset 
potentiation; potentiation at the end of 4 hours (131.08±3.76%) was 
significantly different from the baseline (P<0.01, n=7). (d) 5 µM APB 
induced slow-onset potentiation of fEPSP slope; potentiation at the 
end of 4 hours (123.75±3.24%) was significantly different from the 
pre-induction baseline (P<0.05, n=7). (e)-(f) 1 µM APB (n=10) and 
0.1µM APB (n=8) failed to induce significant potentiation. Potentiation 
at the end of 4 hours (1 µM: 103.25±5.31%; 0.1 µM: 98.87±8.63%) 
was not significantly different from baseline values. (g) A histogram 
showing differences in mean potentiation (percentage of baseline) 4 h 
after the application of the different concentrations of APB (one-way 
ANOVA, F=13.24, P<0.0001). Asterisks indicate significant deviations 
from baseline (100%; Dunnet’s post-hoc test, **P<0.01; ***P<0.001; 
****P<0.0001). Error bars in all graphs represent ±SEM. 
Representative fEPSP traces shown in each case were recorded at 
the respective time points as mentioned. Scale bars for all the traces, 
vertical:3 mV, horizontal:5 ms. 
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4.2 D1/D5 receptor-signaling dose-dependently regulates 
synaptic associativity  
 
 
As we observed that the D1/D5 receptor mediated potentiation exhibits 
dose-dependent response, we wondered whether this could lead to 
differential effects on the synaptic associativity processes because 
heterosynaptic D1/D5 receptor signaling is critically involved in the 
induction of protein-synthesis-dependent late phase of LTP. Further, 
the SOP induced by D1/D5 receptor agonists is protein-synthesis 
dependent (Navakkode et al., 2007). 
 
We designed a series of two-pathway experiments under the 
conceptual framework of STC hypothesis. Late-LTP requires the 
synergistic coactivation of glutamatergic inputs and heterosynaptic 
dopaminergic inputs (O’Carroll et al., 2006).  It was reported that the 
SOP induced by bath application of D1/D5 receptor agonist depends 
on low-frequency test stimulation during or around the time of induction 
wherein test stimulation acts to provide the synergistic glutamatergic 
NMDAR activation (Navakkode et al., 2007). It was also shown that if 
the test stimulation is suspended during the agonist application, no 
agonist-induced SOP could be observed (Navakkode et al., 2007). We 
incorporated this observation with the classic two-pathway ‘strong-
before-weak’ STC experimental framework (Frey and Morris, 1997; 
Frey and Morris, 1998b) and reasoned that D1/D5 receptor activation-
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induced SOP could be used as a ‘strong stimulation paradigm’ in one 
pathway wherein input specificity can be achieved by selective 
suspension of test stimulation during agonist application. A transient 
form of LTP could then be induced in a second pathway with a ‘weak 
stimulation’ (WTET) to study the late associative properties. 
 
Two stimulating electrodes (S1 and S2) were located in the CA1 
stratum radiatum of the hippocampal slice to stimulate two independent 
Schaffer collateral inputs converging onto a common population of 
neurons and a recording electrode (rec) was positioned also in the 
stratum radiatum midway between the stimulating electrodes to record 
fEPSP (Figure 4.3a). After recording a stable baseline of 30 minutes in 
both the inputs, test stimulation in S2 was suspended and SKF, at the 
respective concentration, was bath applied to the slice in the same 
manner as in the first series of experiments (Figure 4.1). The test 
stimulation in S2 was kept suspended for the next 1 hour from the start 
of SKF application after which it was resumed and baseline response 
was recorded for 30 minutes. Then E-LTP was induced in input S2 with 
a weak tetanization protocol (WTET). The fEPSP responses were then 















Figure 4.3: Synaptic cooperation and competition mediated by 
D1/D5 receptor-mediated signaling. (a) Schematic representation 
of a hippocampal slice showing the location of electrodes in CA1 
region for the 2-pathway synaptic tagging and capture experiments. 
S1 and S2 are two stimulating electrodes in the stratum radiatum 
that stimulate two independent synaptic inputs to the same neuronal 
population; one recording electrode was positioned in between the 
two stimulating electrodes to record field-EPSP from the apical 
dendrites. S1 and S2 are two independent but convergent inputs. 
The test stimulation in S2 was silenced just before SKF application 
for one hour. After resumption and 30 minutes of baseline recording, 
E-LTP was induced in S2. (b) Application of 25 µM SKF induced a 
slow-onset potentiation in S1 (blue circles) and also transformed the 
transient form of LTP (E-LTP) induced in S2 (orange triangles) into a 
persistent potentiation (n=7). (c) 10 µM SKF induced a slow-onset 
potentiation in S1 (blue circles) but the weak tetanization in S2 
(orange triangles) resulted in E-LTP that was not reinforced (n=7). 
(d) 5 µM SKF-induced slow-onset potentiation in S1 (blue circles) 
failed to maintain after weak tetanization of S2 (orange triangles) and 
both the responses decayed back to baseline within two hours of E-
LTP induction (n=9). Insets show representative fEPSP traces for 
each input (same color as the input) recorded at baseline (solid line, 
-15 min), 120 min (dotted line), and 240 min (hatched line). Single 
arrow represents the application of WTET for the induction of E-LTP. 
Symbols and scale bar for traces as in Figure 4.1. 
 
  98 
These two-pathway experiments were performed using 25 µM SKF, 10 
µM SKF and 5 µM SKF. In all these experiments, SKF-induced SOP 
was only seen in the input with active test stimulation (Figure 4.3; S1 in 
all groups) but not in the input where test stimulation was suspended 
during SKF application (Figure 4.3; S2 in all groups). Also, in any 
group, no significant deviation from the baseline response was seen in 
input S2 upon resuming the test stimulation after 1 hour of silencing. 
 
Application of 25 µM SKF induced a SOP in input S1 which became 
significantly different from the baseline values 20 min onwards and 
maintained over 4 hours (Figure 4.3b; Wilcoxon test, P=0.016; n=7). 
The input S2 showed no potentiation after resuming the recording 
(Wilcoxon test, P=0.687). Upon WTET, S2 showed significant 
potentiation (Wilcoxon test, P=0.016). Interestingly however, the 
potentiation did not decay to baseline as expected of E-LTP induced 
with WTET. Rather, the E-LTP was transformed to L-LTP that 
maintained for the entire recording period (139.98±10.72%; n=7; 
Wilcoxon test, P=0.031).  
 
Application of 10 µM SKF also resulted in a significant potentiation in 
S1 by 20 min (Wilcoxon test, P=0.031) that lasted over 4 hours (Figure 
4.3c; Wilcoxon test, P=0.031; n=7). Input S2, that did not show any 
potentiation even after resuming stimulation, showed significant 
potentiation following WTET (Wilcoxon test, P=0.016). Unlike as seen 
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with 25 µM SKF, the input S2 showed E-LTP; the potentiation decayed 
to baseline values gradually and the mean fEPSP slope value at the 
end of the recording period was not significantly different from the pre-
induction baseline values (108.69±8.89%; Wilcoxon test, P=0.296). 
             
The result with 5 µM SKF application (Figure 4.3d) was quite 
interesting. Here, the input S1 failed to show any significant delayed 
onset potentiation unlike as observed before (Figure 4.1d). The 
potentiation followed the same time course but the mean fEPSP slope 
did not become significantly different (mean potentiation at +100 min, 
109.78±7.26%; Wilcoxon test, P=0.300). Intriguingly rather, following 
the weak tetanization of S2, which resulted in a significant potentiation 
(Wilcoxon test, P=0.004; n=9), both the inputs decayed rapidly to 
baseline values. The potentiation in S2 was not significantly different 
from the baseline values after 160 min (Wilcoxon test, P=0.054). 
  
Together, these series of experiments showed that the D1/D5 receptor-
mediated signaling could differentially influence the ongoing 
information processing in the synapses in the temporal vicinity in a 
dose-dependent manner. 
  100 
4.3 Late-plasticity in vicinity of competing synapses 
rescues them from synaptic competition 
 
The intriguing result observed in the two-pathway experiments with 5 
µM SKF indicated a possibility that the rapid decay of both D1/D5 
receptor-mediated SOP and WTET-induced E-LTP could have resulted 
from the competition between these two set of synapses for PRPs from 
a limited common pool (Fonseca et al., 2004; Sajikumar et al., 2014). 
Hence, we asked whether these synapses could be rescued from the 
competition by providing additional PRPs by means of a strong 
stimulation of another converging input within a certain time-window. 
Additionally, late-LTP-inducing strong stimulation also causes release 
of endogenous dopamine in slices (Frey and Schroeder, 1990) and 
activation of D1/D5 receptors was required for the synthesis of PRPs 
during L-LTP (Frey and Schroeder, 1990; Sajikumar and Frey, 2004a). 
To test this, we designed a three-pathway experiment wherein three 
stimulating electrodes (S1, S2 and S3) were positioned in CA1 stratum 
radiatum to stimulate three independent but convergent synaptic 
pathways onto a common population of neurons and a recording 
electrode was located between them (Figure 4.4a). 
 
The experimental plan was similar to the two-pathway experiments; 
Following a stable baseline recording of 30 min, test stimulation was 
suspended in inputs S2 and S3 just before SKF application for the next 
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one hour after which it was resumed and baseline response was 
recorded in both for 30 min. Then E-LTP was induced in input S2 with 
WTET followed 15 min later by L-LTP induction in S3 with a strong 
tetanization protocol (STET). The fEPSP responses were then 
recorded in both the inputs until 4 hours from the start of agonist 
application. The three forms of activity given to the common population 
of neurons are represented in Figure 4.4b schematically. 
 
As observed in the two-pathway experiments, the potentiation in S1 
followed a slow time course and was not significantly different from the 
baseline values until 90 min (Figure 4.4c; Wilcoxon test, P=0.078; n=7) 
and the inputs S2 and S3 did not show significant deviation from the 
baseline after resuming the test stimulation (Wilcoxon test, P>0.05). 
Significant potentiation was seen in S2 following WTET (Wilcoxon test, 
P=0.016) and in S3 following STET (Wilcoxon test, P=0.016). The L-
LTP in S3 lasted over the entire recording period (149.25±7.76%; 
Wilcoxon test, P=0.016). Interestingly, potentiation in both S1 and S2, 
that otherwise decayed rapidly (see Figure 4.3c), also maintained at 
significantly different levels from the baseline values until the end of 
recording period (S1:119.35±4.13%; Wilcoxon test, P=0.016 and 













Figure 4.4 Late-plasticity in vicinity of competing synapses 
prevents synaptic competition.  
(a) Schematic representation of a hippocampal slice showing the 
location of electrodes in CA1 region for the 3-input, synaptic tagging 
and capture experiments. S1, S2, and S3 are three independent but 
convergent inputs. The test stimulation in S2 and S3 was silenced just 
before SKF application for one hour. After resumption and 30 minutes 
of baseline recording, E-LTP was induced in S2 (WTET) followed, after 
15 min, by L-LTP induction in S3 (STET). (b) A schematic of a 
pyramidal neuron showing three forms of activity induced in three 
independent synaptic inputs S1, S2 and S3; 5 µM SKF stimulation in 
S1, weak tetanization (WTET) in S2, and repeated strong tetanization 
(STET) in S3. (c) The otherwise decaying forms of LTP (see Fig. 4.3d) 
in S1 (blue circles) and S2 (orange triangles) were rescued by the 
STET-induced L-LTP in S3 (green inverted triangles); (n=7). Three 
block arrows represent the point of application of STET for the 
induction of L-LTP. Insets show representative fEPSP traces (shown in 
respective colors) for each input recorded at baseline (solid line, -15 
min), 120 min (dotted line), and 240 min (hatched line). Symbols and 
scale bar for traces as in Figure 4.2. 
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4.4 Role of CaM kinases in induction and maintenance of 
D1/D5 receptor-mediated potentiation 
 
4.4.1 Role of CaMKII in the induction phase 
 
 
To investigate the role of CaMKII in the induction phase of D1/D5 
receptor-mediated potentiation, we made use of the specific inhibitor of 
the CaM kinases, KN-93. KN-93 is a cell-permeable, potent inhibitor 
with an IC50 of 0.37 µM for CaMKII (Sumi et al., 1991). It has been 
reported earlier that at a concentration of 1 µM, KN-93 selectively 
inhibits the activity of CaMKII while sparing other CaM kinases (Ishida 
et al., 1995; Redondo et al., 2010). Hence, we planned to co-apply 1 
µM KN-93 along with the different concentrations of D1/D5 receptor 
agonist SKF. 
 
Following a stable baseline recording for 30 minutes, 1 µM KN-93 was 
bath applied and 15 minutes later SKF, at the respective concentration, 
was co-applied in three pulses as in earlier experiments (Figure 4.1). 
KN-93 application was continued for another 15 minutes after the end 
of SKF application i.e., KN-93 was applied for a total duration of 40 
minutes. All these experiments were also performed with KN-92, the 
control analog of KN-93. 
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Figure 4.5: Role of CaMKII in the induction of D1/D5 receptor-
mediated potentiation. Following a stable baseline recording for 30 
minutes, CaMKII inhibitor KN-93 (1 µM) or its inactive analog KN-92 (1 
µM) was bath applied and 15 minutes later, SKF, at the respective 
concentration, was co-applied in three pulses as in earlier experiments 
(Figure 4.1). The duration of the inhibitor application is represented 
with the green bar (KN-93) or the grey bar (KN-92) in each case. (a)-
(b) Inhibition of CaMKII completely blocked the potentiation induced by 
5 µM SKF (n=7) as compared to that with the control analog (n=6). (c)-
(d) Coapplication of KN-93 with 10 µM SKF (n=7) resulted in a 
transient potentiation compared to the treatment with control drug KN-
92 (n=6). The potentiation decayed to the baseline by the end of the 
recording period. (e)-(f) Inhibition of CaMKII activation did not affect the 
maintenance of the potentiation induced by 25 µM SKF (n=8) but the 
magnitude of potentiation was reduced compared to the treatment with 
KN-92 (n=7). (g) A histogram comparing the mean potentiation values 
at the end of the recording period in the respective SKF concentration 
groups with KN-93 or KN-92 treatment. Asterisks indicate significant 
difference between two groups (Mann-Whitney U test; *P<0.05; 
**P<0.01). For 5 µM SKF group P=0.008; for 10 µM SKF group 
P=0.022 and for 25 µM SKF group P=0.351). Error bars in all graphs 
represent ±SEM. Representative fEPSP traces shown in each case 
were recorded at the respective time points as mentioned. Scale bar 
for all the traces, vertical:3 mV, horizontal:5 ms.    
 
 
Blocking the CaMKII activity with KN-93 (as above) during 5 µM SKF 
application completely blocked the SKF-induced potentiation (Figure 
4.5a). No significant potentiation was observed at any phase over the 
entire recording period (Wilcoxon test, P>0.05; n=7). The mean 
potentiation at the end of recording was 105.45±5.13% (Wilcoxon test, 
P=0.218). The experiments were repeated with the KN-92 treatment, 
which showed no non-specific effects (Figure 4.5b; n=6) and the 
potentiation observed (129.61±3.6%) was significantly different from 
the KN-93 treatment group at the end of the recording period (Mann-
Whitney U test, P>0.05). 
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Interestingly, co-application of KN-93 with 10 µM SKF resulted only in a 
transient potentiation (Figure 4.5c). The induction of the potentiation 
was not affected much and the potentiation became significantly 
different from the baseline by 30 minutes following SKF application 
(113.28±3.11%, Wilcoxon test, P=0.015). However, the potentiation 
started decaying gradually after 165 minutes (111.41±5.87%, Wilcoxon 
test, P=0.078) and was not significantly different from the baseline 
values afterwards. The mean potentiation at the end of the recording 
period was 103.54±7.50% (Wilcoxon test, P=0.468, n=7). The 
experiments conducted with KN-92 showed no effect of the treatment 
on the long-lasting potentiation (Figure 4.5d; n=6). The potentiation at 
the end of the experiment (135.43±5.8%, Wilcoxon test, P=0.015) was 
significantly different between the two groups (Mann-Whitney U test, 
P>0.05). 
 
When KN-93 was applied in the above fashion along with 25 µM SKF, 
a long-lasting potentiation was observed (Figure 4.5e). The potentiation 
followed the usual time course and became significantly different from 
the baseline values 25 minutes after the start of SKF application 
(Figure 4.5e; 112.85±2.45%, Wilcoxon test, P=0.023) and maintained 
over the entire recording period (133.39±4.75%, Wilcoxon test, 
P=0.007, n=8). The potentiation observed was less compared to that 
observed with the KN-92 treatment (Figure 4.5f; n=7; 152.99±12.01%; 
  107 
Wilcoxon test, P=0.015) even though the difference was not statistically 
significant (Mann-Whitney U test, P>0.05). A histogram comparing the 
mean potentiation at the end of recording period between the different 
SKF concentration groups with KN-93 and KN-92 treatment is shown in 
Figure 4.5g. 
 
Together, these results indicate that at weaker D1/D5 receptor 
activation, CaMKII has a crucial role in the induction of long-lasting 
forms of plasticity. However, with stronger D1/D5 receptor activation its 
role appears to be dispensable, possibly due to coincidental activation 
of many other kinases, the concerted action of which can compensate 
for the blockade of CaMKII activity. 
 
4.4.2 Role of CaMKII activity in the maintenance phase 
 
 
Having observed the differential role of CaMKII in the induction phase, 
we further investigated its involvement in the maintenance phase of the 
potentiation induced by different concentrations of SKF. 
Autophosphorylated, constitutively active form of CaMKII is known to 
be involved in the maintenance phases of certain forms of LTP. 
Therefore, we tested whether a similar mechanism is involved in the 
D1/D5 receptor-mediated potentiation. 
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As in the previous series of experiments, we made use of the strategy 
of specific inhibition of CaMKII with 1 µM KN-93. Following a stable 
baseline recording, SKF, at the respective concentration, was applied 
to the slices as explained in the initial experiments (Figure 4.1). KN-93 
(1 µM) was then bath applied from 90 minutes after the start of SKF 
application throughout the rest of the recording period. All these 
experiments were also repeated with KN-92, an inactive analog of KN-
93, to rule out any non-specific treatment effects. 
 
Blocking CaMKII activity with KN-93 during the maintenance phase had 
no effect on 5 µM SKF-induced potentiation (Figure 4.6a). The 
potentiation which became significantly different from the baseline 
rather slowly by 80 minutes (112.92±4.09%, Wilcoxon test, 
P=0.031;n=7) stayed significant thereafter till the end of the recording 
(128.46±3.17%, Wilcoxon test, P=0.015). The experiments were 
repeated with the KN-92 treatment, which showed no non-specific 
effects (Figure 4.6b; n=7) and the potentiation observed was not 
























Figure 4.6: Role of CaMKII in the maintenance of D1/D5 receptor-
mediated potentiation. Following a stable baseline recording for 30 
minutes, SKF, at the respective concentration, was co-applied in three 
pulses as in earlier experiments (Figure 4.1). The CaMKII inhibitor KN-
93 (1 µM) or its inactive analog KN-92 (1 µM) was bath applied from 90 
minutes onwards until the end of the recording. The duration of the 
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inhibitor application is represented with the green bar (KN-93) or the 
grey bar (KN-92) in each case. (a)-(b) Inhibition of CaMKII during 
maintenance phase did not affect the potentiation induced by 5 µM 
SKF (n=7) as compared to that with the control analog (n=7). (c)-(d) 
The maintenance of potentiation induced by 10 µM SKF was 
unaffected by the treatment with either the CaMKII inhibitor (n=7) or the 
control drug KN-92 (n=6). (e)-(f) Treatment with KN-93 did not affect 
the maintenance of potentiation induced by 25 µM SKF (n=7), similar to 
the treatment with KN-92 (n=6). (g) A histogram comparing the mean 
potentiation values at the end of the recording period in the respective 
SKF concentration groups with KN-93 or KN-92 treatment. No 
significant difference was observed between the treatments in any 
group (Mann-Whitney U test; P>0.05). Error bars in all graphs 
represent ±SEM. Representative fEPSP traces shown in each case 
were recorded at the respective time points as mentioned. Scale bar 




Application of 10 µM SKF also induced a slow-onset potentiation 
similar to earlier experiments. The potentiation was statistically  
significant (compared to the baseline values) after 20 minutes (Figure 
4.6c; 112.38 ±3.6%, Wilcoxon test, P=0.031; n=7) and lasted for the 
entire recording period. The mean fEPSP slope at the end of the 
recording was 137.91±3.95%, Wilcoxon test, P=0.015). The 
experiments conducted with KN-92 also showed similar result (Figure 
4.6d; n=6) and the potentiation was not significantly different between 
the two groups (Mann-Whitney U test, P>0.05). 
 
Potentiation induced by 25 µM SKF became significantly different from 
the baseline values 30 minutes onwards (Figure 4.6e; 110.43±4.16%, 
Wilcoxon test, P=0.047; n=7). The late phase of the potentiation was 
not affected by the KN-93 application and it stayed significantly 
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different from the baseline until the end of the recording (141.21±5.6%, 
Wilcoxon test, P=0.015). Similar potentiation profile was also observed 
with the application of 1µM KN-92 (Figure 4.6f; n=6). A comparison of 
the potentiation observed with KN-93 treatment and KN-92 treatment 
showed no significant difference between the two at any time-point 
(Mann-Whitney U test, P>0.05). A histogram comparing the mean 
potentiation at the end of recording period between the different SKF 
concentration groups with KN-93 and KN-92 treatment is shown in 
Figure 4.6g. 
 
Together, these series of experiments showed that a sustained CaMKII 
activity is not involved in the maintenance phase of the D1/D5 receptor-
mediated potentiation irrespective of the strength of stimulation. 
 
4.4.3 Role of CaM kinase IV (CaMKIV) in the maintenance phase 
of D1/D5 receptor-mediated potentiation 
 
 
CaMKIV has been reported to take part in the induction of activity-
dependent gene transcription and thus contribute to certain forms of 
transcription and translation-dependent plasticity (Bito et al., 1996; 
Kang et al., 2001; Redondo et al., 2010). CaMKIV is a nuclear kinase 
and becomes activated after phosphorylation by CaM kinase kinase 
(CaMKK) which, in turn, is activated by nuclear calcium entry in 
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response to strong stimulation. The active CaMKIV then 
phosphorylates and activates CREB, thus leading to transcription of 
plasticity-related genes (Bito et al., 1996; Kang et al., 2001; Lee et al., 
2000). We were interested to know whether CaMKIV activation was 
involved in the maintenance phase of the potentiation induced by SKF. 
To investigate this, we made use of the CaM kinase inhibitor KN-93 but 
now at a higher concentration (10 µM), as it has been reported earlier 
that at this concentration KN-93 effectively inhibits many CaM kinases, 
including CaMKIV (Redondo et al., 2010). 
 
The experimental strategy was similar to that followed in Section 4.4.2. 
KN-93 (10 µM) was applied starting 90 minutes after the SKF 
application and for the rest of the recording period. Here also, we 
repeated these experiments with the same concentration of the inactive 
analog KN-92. 
The slow-onset, long-lasting potentiation observed following 5 µM SKF 
application was not affected by the 10 µM KN-93 treatment (Figure 
4.7a n=7). The potentiation became statistically significant by 75 
minutes after the SKF application (108.94±3.89%; Wilcoxon test, 
P=0.046) and then lasted over 4 hours. The mean potentiation at the 
end of the recording (129.80±6.52% Wilcoxon test, P=0.015; n=7) was 
similar to that in the KN-92 group (Figure 4.7b; 130.94±6.14%, 
Wilcoxon test, P=0.031; n=6) and when compared between two 
groups, there was no significant difference in the magnitude of 
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potentiation (Mann-Whitney U test, P>0.05). 
Treatment with 10 µM KN-93 had no significant effect on the 
potentiation induced by 10 µM SKF (Figure 4.7c; n=7). The potentiation 
followed the usual time course becoming significantly different from the 
baseline by 20 minutes after SKF application (114.14±2.37%, Wilcoxon 
test, P=0.031) and maintained at significant levels throughout the rest 
of the recording period (Wilcoxon test, P>0.05). The mean fEPSP 
slope at the end of the recording (133.59±6.81% Wilcoxon test, 
P=0.015; n=7) was similar to that in the KN-92 treatment group (Figure 
4.7d; 134.68±7.63%, Wilcoxon test, P=0.031; n=6) and there was no 
significant difference in the magnitude of potentiation when compared 
between two groups (Mann-Whitney U test, P>0.05). 
 
Application of 25 µM SKF resulted in a slow-onset long-lasting 
potentiation that became significantly different from the baseline values 
30 minutes onwards (Figure 4.7e; 106.90±2.37%, Wilcoxon test, 
P=0.023; n=8) and lasted for the entire recording period (270 min; 
Wilcoxon test, P=0.007). Though the potentiation in the late phase was 
not completely blocked by the treatment with KN-93, the magnitude of 
fEPSP slope was significantly less compared to that observed in the 
KN-92 treatment group (Figure 4.7f; n=6) or that observed with SKF 
alone (Figure 4.1.1b). 



















Figure 4.7: Role of CaMKIV and other CaM-kinases in the 
maintenance of D1/D5 receptor-mediated potentiation. Following a 
stable baseline recording for 30 minutes, SKF, at the respective 
concentration, was co-applied in three pulses as in earlier experiments 
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(Figure 4.1). The CaM-Kinase inhibitor KN-93 (10 µM) or its inactive 
analog KN-92 (10 µM) was bath applied from 90 minutes onwards until 
the end of the recording. The duration of the inhibitor application is 
represented with the green bar (KN-93) or the grey bar (KN-92) in each 
case. (a)-(b) Inhibition of CaMKIV and other CaMKs during 
maintenance phase did not affect the potentiation induced by 5 µM 
SKF (n=7) as compared to that with the control analog (n=6). (c)-(d) 
The maintenance of potentiation induced by 10 µM SKF was 
unaffected by the treatment with either the CaMK inhibitor (n=7) or the 
control drug KN-92 (n=6). (e)-(f) Treatment with 10 µM KN-93 did not 
affect the maintenance of potentiation induced by 25 µM SKF (n=8), 
similar to the treatment with 10 µM KN-92 (n=6). (g) A histogram 
comparing the mean potentiation values at the end of the recording 
period in the respective SKF concentration groups with KN-93 or KN-
92 treatment. No significant difference was observed between the 
treatments in 5 µM SKF and 10 µM SKF groups (Mann-Whitney U test; 
P>0.05). However, treatment with 10 µM KN-93 significantly reduced 
the magnitude of potentiation in 25 µM SKF group ((Mann-Whitney U 
test; *P=0.030). Error bars in all graphs represent ±SEM. 
Representative fEPSP traces shown in each case were recorded at the 
respective time points as mentioned. Scale bars for all the traces, 
vertical:3 mV, horizontal:5 ms.    
 
When compared to the KN-92 treatment group, the potentiation in KN-
93 treatment group was significantly less 135 minutes onwards (Mann-
Whitney U test, P>0.05). The mean potentiation at the end of the 
recording was 130.69±7.04% in KN-93 group whereas it was 
147.98±6.73% in the KN-92 group. A histogram comparing the mean 
potentiation at 4 hours between the different SKF concentration groups 
with KN-93 and KN-92 treatment is shown in Figure 4.7g. 
 
Taken together, these results show that the active CaMKIV-mediated 
mechanisms contribute synergistically to the maintenance phase of 
potentiation only with stronger D1/D5R activation and were not 
activated by weaker D1/D5R stimulation. 
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4.5 Role of MAP kinases (ERK1/2) in induction and 




The MAPKs ERK1 (p44 MAPK) and ERK2 (p42 MAPK) are one of the 
key signal integrators in various forms of LTP (Reviewed by (Sweatt, 
2001). A robust activation of ERK2 has been reported in CA1 region 
following application of dopamine to acute hippocampal slices 
(Roberson et al., 1999). A synergistic interaction between dopamine 
D1 receptors and NMDARs is known to involve ERK1/2 signaling 
mechanisms in rat hippocampus (Sarantis et al., 2009). MAPKs have 
also been suggested to be differentially involved in the different phases 
memory in Aplysia (Sharma et al., 2003) and are also known to 
contribute to both local and nuclear mechanisms following a plasticity-
inducing event (Reviewed in (Davis and Laroche, 2006)). Given these 
evidences, we investigated the potential involvement of active MAPK-
mediated mechanisms in the induction and maintenance phases of the 
D1/D5 receptor agonist-induced long-lasting potentiation. 
   
4.5.1 Role of MAPKs in the induction phase 
 
 
MAPKs can be activated within minutes following a plasticity-inducing 
stimulus (Davis and Laroche, 2006). Hence, we investigated whether 
MAPK activation during the induction phase is critically involved in the 
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SKF-induced potentiation. We used the inhibitor U0126, which 
specifically targets the upstream kinases of ERK1/2 called ‘MAPK/ERK 
kinases’ (MEKs or MAP2Ks). U0126 potently inhibits both MEK1 and 
MEK2 (IC50 of 0.53 µM) and thus prevents the activation of ERK1/2. 
The plan of the experiment was similar to as followed for CaMKII 
inhibition (Section 4.4.1). Following a stable baseline recording for 30 
minutes, 5 µM U0126 was bath applied and 15 minutes later SKF, at 
the respective concentration, was co-applied in three pulses as in 
earlier experiments (Figure 4.1). Application of U0126 was continued 
for another 15 minutes after the end of SKF application; thus, U0126 
was applied for a total duration of 40 minutes.  
 
Co-application of 5 µM SKF with 5 µM U0126 failed to induce any 
potentiation (4.8a; n=7). The mean fEPSP slope values were not 
significantly different from the baseline values at any time-point during 
the entire period of recording (Wilcoxon test, P>0.05). The mean 
potentiation at the end of the recording was (100.34±5.76%, Wilcoxon 
test, P=0.687). 
   
The potentiation induced by 10 µM SKF was also affected by the 
blockade of MAPK activation (4.8b; n=7). Though the induction was not 
affected and the potentiation became significantly different from the 
baseline by 20 minutes (113.73±1.88% Wilcoxon test, P=0.015), the 
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magnitude of potentiation did not follow the time-course as that 











Figure 4.8: Role of MAP kinases (ERK1/2) in the induction of 
D1/D5 receptor-mediated potentiation. Following a stable baseline 
recording for 30 minutes, MAPK activation inhibitor U0126 (5 µM) was 
bath applied and 15 minutes later, SKF, at the respective 
concentration, was co-applied in three pulses as in earlier experiments 
(Figure 4.1). The duration of U0126 application is represented with the 
yellow-green bar in each case. (a) Inhibition of MAPK activation 
completely blocked the potentiation induced by 5 µM SKF (n=7). (b) 
Coapplication of U0126 with 10 µM SKF blocked the late-phase of the 
potentiation (n=7). The potentiation decayed to the baseline by the end 
of the recording period. (c) Inhibition of MAPK activation also blocked 
the maintenance of the potentiation induced by 25 µM SKF (n=8). (d) A 
histogram comparing the mean potentiation values 4 h after SKF 
application in the different SKF concentration groups with or without 
U0126 coapplication. The ‘Control’ group for each SKF concentration is 
considered from the respective group in Figure 4.1. Asterisks indicate 
significant difference between two groups (Mann-Whitney U test; 
*P<0.05; **P<0.01, ***P<0.001). For 5 µM SKF group P=0.046; for 10 
µM SKF group P=0.006 and for 25 µM SKF group P=0.0002). Error 
bars in all graphs represent ±SEM. Representative fEPSP traces 
shown in each case were recorded at the respective time points as 
mentioned. Scale bars for all the traces, vertical:3 mV, horizontal:5 ms.    
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Further, the late phase of the potentiation was blocked and the 
potentiation was not significantly different by 140 min (119.67±6.91%, 
Wilcoxon test, P=0.078) and decayed gradually to the baseline by the 
end of recording (100.82±5.57%, Wilcoxon test, P=0.468). 
 
Interestingly, co-application of U0126 blocked the late phase of the 
potentiation induced by 25 µM SKF (4.8c; n=8). The induction and 
early phase were not affected; the potentiation became significantly 
different from the baseline value 20 minutes after the start of SKF 
application (116.87±5.59%, Wilcoxon test, P=0.039) and remained 
significant until 160 min (123.58±7.46%, Wilcoxon test, P=0.039). From 
165 min onwards the potentiation gradually decayed to the baseline 
values by the end of the recording period (270 min; 101.01±6.16% 
Wilcoxon test, P=0.843). 
 
Collectively, these experiments indicated that MAPK activation during 
the induction phase was crucial for the long-lasting potentiation 
induced by D1/D5 receptor activation. The late-phase mechanisms in 
this case were gated through MAPK activation. When the stimulation 
was sufficiently stronger, potentiation could still be maintained 
transiently by other active kinases but the persistence over long 
durations would require active MAPK. With weaker D1/D5 receptor 
activation, a concerted action of many kinases was necessary for both 
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the induction and maintenance of potentiation and thus blocking any of 
them would interfere with the induction. 
 
4.5.2 Role of sustained MAPK activation in the maintenance 
phase 
 
In the medial prefrontal cortex of 6-hydroxydopamine-lesioned rats, a 
sustained ERK activation has been observed following repeated 
D1/D5-receptor agonist administration which was suggested to be 
important in permanent adaptive changes (Papadeas et al., 2004). A 
persistent ERK activation was also seen in Aplysia neurons in 
response to repeated serotonin pulses (Sharma et al., 2003) and in 
cultured cortical neurons following repeated, spaced application of 
BDNF (Wu et al., 2001). Having observed a crucial role for MAPK 
activation during the induction, we next asked whether a sustained 
activation of MAPKs is involved in the maintenance phase of the long-
lasting potentiation induced by the D1/D5 receptor activation. 
 
To investigate this, we followed the same strategy as used for the 
earlier series of experiments examining the role of CaMKII in the 
maintenance phase (Section 4.4.2). However, the MAPK activation 
inhibitor was applied 60 minutes rather than 90 minutes after the SKF 
application, as the MAPK activation has been reported in some studies 
to peak around 60 minutes following LTP-inducing stimuli (Ahmed and 
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Frey, 2005). Following a stable baseline recording, SKF was applied at 
the respective concentration similar as before and the MEK inhibitor 
was bath applied continuously from one hour after the start of SKF 
application throughout until the end of the recording (4 h). 
 
Application of 5 µM SKF was shown earlier to result in a delayed-onset 
potentiation that lasted over 4 hours (Figure 4.1d). The maintenance of 
this potentiation was disrupted by inhibiting MAPK activation with 5 µM  
U0126 treatment (Figure 4.9a; n=7). The potentiation was significantly 
different 60 minutes onwards (120.41±3.54%, Wilcoxon test, P=0.015) 
and only up to 140 minutes (121.43±7.94% Wilcoxon test, P=0.047). 
From then onwards the potentiation gradually dropped and was not 
significantly different from the baseline at the end of 4 hours 
(97.03±5.28%, Wilcoxon test, P=0.296). 
 
The potentiation induced by application of 10 µM SKF also followed the 
usual time course initially (Figure 4.9b; n=8) and was significantly 
different from the baseline values by 20 minutes (120.54±4.29%, 
Wilcoxon test, P=0.007). However, the maintenance phase was 
affected by 5 µM U0126 treatment. The potentiation was statistically 
significant, compared to the baseline, only until 130 minutes 
(120.03±7.77%, Wilcoxon test, P=0.023) following which it slowly 
decayed to baseline. The mean fEPSP slope at the end of 4 hours was 
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not significantly different from the baseline values (95.73±6.43%, 














Figure 4.9: Dose-dependent, sustained activation of MAP kinases 
(ERK1/2) during the maintenance of D1/D5 receptor-mediated 
potentiation. Following a stable baseline recording for 30 minutes, 
SKF, at the respective concentration, was co-applied in three pulses as 
in earlier experiments (Figure 4.1). The MAPK activation inhibitor 
U0126 was bath applied from 60 minutes onwards until the end of the 
recording. The duration of the inhibitor application is represented with 
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the yellow-green bar in each case. (a) Potentiation induced by 5 µM 
SKF was disrupted from maintenance upon application of 5 µM U0126 
(n=7). (b) Application of 5 µM U0126 also disrupted the maintenance of 
the potentiation induced by 10 µM SKF (n=7). (c) 5 µM U0126 
application had no significant effects on the potentiation induced by 25 
µM SKF (n=6). (d) Maintenance of 25 µM SKF-induced potentiation 
was disrupted by 10 µM U0126 application causing the potentiation to 
gradually decay back to baseline (n=6). (e) Histogram of mean fEPSP 
slope values recorded for SKF and ‘SKF+U0126’ treatment groups 
after 60 and 240 minutes of SKF application, analyzed with two-way 
ANOVA. Asterisks indicate significant potentiation compared to a 
baseline group (Tukey’s post-test, *P<0.05, **P<0.01; ***P<0.001; 
****P<0.0001). Significant differences between groups is shown with 
hashtags (Tukey’s post-test, #P<0.05, ###P<0.001; ####P<0.0001). 
Error bars in all graphs represent ±SEM. Representative fEPSP traces 
shown in each case were recorded at the respective time points as 
mentioned. Scale bars for all the traces, vertical:3 mV, horizontal:5 ms.     
 
 
Interestingly, the treatment with 5 µM U0126 showed no significant 
effect on the maintenance of the potentiation induced by 25 µM SKF 
application (Figure 4.9c; n=6). The potentiation was significantly 
different from the baseline 20 minutes onwards (128.87.73±6.69%, 
Wilcoxon test, P=0.031) and throughout until the end of 4 hours 
(147.99±11.11%, Wilcoxon test, P=0.031). We then checked whether a 
higher concentration of the inhibitor would have any effect and 
observed that application of 10 µM U0126 significantly disrupted the 
late-phase of the potentiation within the experimental time-frame 
(Figure 4.9d; n=6). The potentiation was significantly different from the 
baseline values 20 minutes onwards (121.39±7.07%, Wilcoxon test, 
P=0.031) and only until 115 minutes (140.89±9.16%, Wilcoxon test, 
P=0.031), after which it dropped to the baseline values gradually. The 
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fEPSP slope at the end of 4 hours was (94.89±13.77%, Wilcoxon test, 
P=0.843). 
 
The potentiation induced by different concentrations of SKF with or 
without U0126 treatment during maintenance was analyzed using two-
way repeated measures ANOVA with matched values (i.e., time points 
60 min and 240 min compared to baseline) stacked into sub-columns. 
This analysis revealed a significant variation between time-points 
(F(2,92) = 37.50; P<0.0001) and also between groups (F(6,46) = 4.51; 
P<0.001). The simple effects between groups were analyzed with 
Tukey’s multiple comparisons test that showed significant differences 
at 240 min time-point between the different SKF concentration groups 
and their respective U0126-treatment groups (Figure 4.9e). MAPK 
inhibition with 5 µM U0126 effectively blocked the 5 µM SKF-induced 
potentiation by 240 min as compared to the 5 µM SKF group without 
this treatment (P<0.05). Similarly, 10 µM SKF-induced potentiation was 
also down to the baseline values at 240 min following 5 µM U0126 
treatment; a comparison with 10 µM SKF group, a statistically 
significant difference was observed (P<0.001). The potentiation at 240 
min showed no significant difference when compared between 25 µM 
SKF groups with or without 5 µM U0126 treatment (P>0.05). However, 
the potentiation was effectively blocked by 10 µM U0126  treatment as 
there was a significant difference when compared to 25 µM SKF group 
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(P<0.0001) and also to 25 µM SKF group treated with 5 µM U0126 
(P<0.001).  
 
These series of MAPK inhibition experiments were repeated using 
another MEK inhibitor PD98059, which is also a selective inhibitor of 
MEK1 and MEK2, but is less potent compared to U0126 (Favata et al., 
1998; Levenson et al., 2004). The results obtained were similar to 
those with U0126.  
 
The maintenance of the potentiation induced by 5 µM SKF was 
disrupted by the application of 15 µM PD98059 (Figure 4.10a; n=6). 
The mean fEPSP slope at the end of 4 h was (97.58±10.46%, 
Wilcoxon test, P>0.999).  A similar blockade of the late phase of 
potentiation induced by 10 µM SKF was observed following treatment 
with 15 µM PD98059 (Figure 4.10b; n=6). The potentiation that 
became significantly different from the baseline values by 20 minutes 
(126.21±9.08%, Wilcoxon test, P=0.031) stayed significant only until 
100 min (127.20±9.73%, Wilcoxon test, P=0.031). At the end of 4 h, 
the potentiation was not significantly different from the baseline 

















Figure 4.10: Dose-dependent blockade of MAP kinase activation 
with PD98059 during the maintenance of D1/D5 receptor-
mediated potentiation. Following a stable baseline recording for 30 
minutes, SKF, at the respective concentration, was co-applied in three 
pulses as in earlier experiments (Figure 4.1). The MAPK-activation 
inhibitor PD98059 (PD) was bath applied from 60 minutes onwards 
until the end of the recording. The duration of the inhibitor application 
is represented with the red bar in each case. (a) Maintenance of 5 µM 
SKF-induced potentiation was blocked upon application of 15 µM PD 
(n=6). (b) 10 µM SKF-induced potentiation was blocked upon 
application of 15 µM PD (n=6). (c) 15 µM PD application did not affect 
the maintenance of potentiation induced by 25 µM SKF (n=6). (d) 
Application of 30 µM PD disrupted the maintenance of the potentiation 
induced by 25 µM SKF (n=7). (e) Histogram of mean fEPSP slope 
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values recorded for SKF and ‘SKF+PD’ treatment groups after 60 and 
240 minutes of SKF application analyzed with two-way ANOVA. 
Asterisks indicate significant potentiation compared to a respective 
baseline group (Tukey’s post-test, *P<0.05, **P<0.01; ***P<0.001; 
****P<0.0001). Significant differences between groups is shown with 
hashtags (Tukey’s post-test, #P<0.05, ###P<0.001; ####P<0.0001). 
Error bars in all graphs represent ±SEM. Representative fEPSP traces 
shown in each case were recorded at the respective time points as 
mentioned. Scale bars for all the traces, vertical:3 mV, horizontal:5 
ms.    
 
Quite similar to the observation with U0126, the application of 15 µM 
PD98059 did not affect the maintenance of the potentiation induced by 
25 µM SKF (Figure 4.10c; n=6). The mean fEPSP slope became 
significantly different by 35 min (119.16±7.42%, Wilcoxon test, 
P=0.031) and maintained over 4 h (135.98±10.61%, Wilcoxon test, 
P=0.031). As with U0126, we checked whether a higher concentration 
of PD98059 would be effective and used 30 µM PD98059. 
Interestingly, the 25 µM SKF-induced potentiation was disrupted by the 
application of 30 µM PD98059 (Figure 4.10d; n=7). The potentiation 
was significantly different from the baseline only until 125 min 
(125.98±7.92%, Wilcoxon test, P=0.031) and was gradually back to 
baseline values by the end of 4 h (110.40±9.37%, Wilcoxon test, 
P=0.218). Analysis of this data with two-way repeated measures 
ANOVA also revealed a similar trend as observed for U0126 (Figure 
4.10e; for more details, see legend). 
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RESULTS-II: Alterations in synaptic plasticity 
and associativity in aged hippocampal neurons 
and effects of zinc chelation  
4.6 Alterations in synaptic plasticity and associativity in 
aged hippocampal CA1 pyramidal neurons 
 
4.6.1 High-frequency stimulation (HFS)-induced LTP and D1/D5 
receptor agonist-induced SOP in aged rats 
 
In the first series of experiments, we investigated the HFS-induced LTP 
(both E-LTP and L-LTP) and the SOP induced by the bath application 
of D1/D5 receptor agonist in the CA1-SC synapses of the 82-84 week 
old (aged) rats and compared it to that observed in the 5-7 weeks old 
young adult (henceforth, adult) rats. As a control experiment, long-term 
baseline recording was performed in the slices of aged rats and the 
recordings were stable for the entire recording period (Figure 4.11a; 
n=10; Wilcoxon test, P>0.05). In adult rats, three repeated trains of 
HFS (STET) resulted in significant potentiation (Figure 4.11b; n=6). 
The mean fEPSP slope value immediately after first tetanization was 
164.75±5.46% (Wilcoxon test, P=0.018) and it maintained at 
significantly different levels compared to the baseline, over 4 h 
(168.83±4.82%, Wilcoxon test, P=0.018). The same paradigm of 
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stimulation (STET) also resulted in L-LTP in the slices of aged rats 













   
Figure 4.11: Late-LTP and E-LTP deficits in the CA1 Schaffer 
collateral synapses of aged rats compared to adults. (a) Stable 
long-term baseline recordings from the slices of aged rats (n=10). The 
test stimulation was given every 5 min. The slope values did not show 
statistically significant deviation from the baseline values at any time-
point (Wilcoxon test, P>0.05). (b) Long-term potentiation induced by a 
strong tetanization protocol (STET) in slices from 5-7 week old rats. 
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The potentiation at the end of 4 hours (168.83±4.8%) was significantly 
different from the pre-induction baseline (Wilcoxon test, P=0.018, n=6). 
(c) STET-induced late-LTP in slices from 82-84 week old rats. The 
potentiation at the end of 4 hours (133.02±8.1%) was significantly 
different from the pre-induction baseline (Wilcoxon test, P=0.004, n=9). 
(d) Weak tetanization (WTET)-induced E-LTP recorded in slices from 
adult rats. The potentiation decayed to baseline gradually by around 2-
3 hours (P>0.05, n=6). (e) E-LTP recorded in slices from aged rats. 
The post-tetanic potentiation was less compared to young slices and 
the potentials decayed to baseline by 95 minutes (P>0.05, n=7). The 
representative fEPSP traces shown in each case were recorded at the 
time-points specified in the insets. Scale bar for all analog traces: 3 
mV/5 ms. Error bars indicate ±SEM.  
 
The mean potentiation immediately after the first tetanization was 
120.38±3.6% (Wilcoxon test, P=0.004) and the potentiation maintained 
at significant levels, compared to the baseline values, for the entire 
recording period (4 h; 133.02±8.1%, Wilcoxon test, P=0.004). 
However, the magnitude of potentiation was comparatively less in the 
aged rat slices than that observed in the slices from adult rats (Mann-
Whitney U test; P<0.05). 
 
Next, we induced E-LTP in the slices of aged and adult rats. In the 
slices of adult rats, weak HFS (WTET) resulted in significant 
potentiation immediately (Figure 4.11d; 143.96±9.74%, Wilcoxon test, 
P=0.027; n=5) but the potentiation was significant only up to 145 min 
after which it decayed to the baseline gradually. The potentiation at the 
end of 4 h was not significantly different from the baseline 
(107.23±1.91%, Wilcoxon test, P=0.138). The magnitude of WTET-
induced LTP in aged slices was comparatively lesser (Figure 4.11e; +1 
min, 133.56±18.1%, Wilcoxon test, P=0.031, n=7) and it maintained at 
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significant levels only until 95 min (114.7±3.7%, Wilcoxon test, 
P=0.031) following which it was not significantly different from the 
baseline values (Wilcoxon test, P>0.05). At the end of 3 h the mean 
fEPSP slope values maintained at the baseline values (102.74±8.3%; 
Wilcoxon test, P=0.375). 
 
Further, we tested the duration and maintenance of dopamine D1/D5 
receptor agonist-induced SOP in the CA1 SC synapses in the slices of 
aged rats and compared it to the potentiation observed in the adults. 
We used the D1/D5 receptor agonist SKF-38393 (SKF) at a 
concentration of 50 µM and followed the same spaced, repeated 
application paradigm as used in the earlier part of this study (Results-I, 
Section 4.1). In the adult slices, bath application of SKF lead to a slow-
onset potentiation the time course of which was similar to as observed 
in our study before (Figure 4.1a). The potentiation became statistically 
significantly by 25 min (Figure 4.12a; 111.59±2.39%, Wilcoxon test, 
P=0.049, n=8) and maintained thereafter throughout the entire 
recording. The mean potentiation at the end of the 4 h was 
153.20±4.49% (Wilcoxon test, P=0.011). In the aged slices however, 
the potentiation induced was significantly different from the baseline 
values rather slowly by 65 min (Figure 4.12b; 115.75±5.71%, Wilcoxon 
test, P=0.035, n=8) and only up to 100 min (115.54±6.05%, Wilcoxon 
test, P=0.035). Thus, the potentiation was only transient and the mean 
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fEPSP slope value was not significantly different from the baseline by 







Figure 4.12. Deficits in the dopamine D1/D5 receptor agonist-
induced potentiation in aged rats compared to adults. After 30 
minutes of baseline recording, D1/D5 receptor agonist SKF-38393 (50 
µM) was bath applied in three 5-minute durations with a 5-minute 
interval between each application (represented by three broken arrows) 
(a) Long-lasting potentiation induced by bath application SKF in the 
slices from adult rats (n=8). The potentiation became statistically 
significant from 25 min onwards; potentiation at the end of 4 h is 
153.21±4.49%; P=0.011). (b) In slices of aged rats, bath application of 
SKF induced a transient potentiation (n=8). The potentiation rapidly 
decayed to the baseline values within 2 h (P>0.05 after 105 min). The 
representative fEPSP traces shown in each case were recorded at the 
time-points specified in the insets. Scale bar for all analog traces: 3 
mV/5 ms. Error bars indicate ±SEM.     
 
4.6.2 Associative properties of HFS-induced and D1/D5 receptor-
mediated SOP in CA1 region 
 
Given that the magnitude of the HFS-induced potentiation was less in 
the aged slices and importantly, the late phase of the SKF-induced 
potentiation was lacking, we investigated whether the associative 
properties of these forms of plasticity show any alterations.  
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We performed STC experiments to study the associative properties. 
STC can be studied in the hippocampal networks using weak-before-
strong (WBS) or strong-before-weak (SBW) experimental designs 
(Frey and Morris, 1998b). For studying STC using WBS or SBW, a two 
pathway experimental design was used. In this design two stimulating 
electrodes were used to stimulate two independent synaptic inputs (S1 
and S2) that converge onto the same neuronal population (Figure 
4.3a). These experimental designs enable us to deliver appropriate 
stimulations to induce E-LTP and L-LTP in S1 and S2 at different time 
intervals to study STC. In this study, we used a SBW paradigm to 
investigate STC interactions.  
 
First, we studied STC in hippocampal slices from adult rats (Figure 
4.13a; n=6). After a stable baseline recording of 30 min in S1 and S2, 
L-LTP was induced in S1 by STET (grey circles) and 60 min later, a 
single weak tetanus (WTET) was applied to S2 for inducing E-LTP in 
this pathway (orange circles). The post-tetanization potential in S1 was 
statistically significant from immediately after tetanization 
(162.84±4.51%, Wilcoxon test, P=0.015) throughout until the end of 
recording (153.70±9.14%, Wilcoxon test, P=0.015). In S2 also WTET 
lead to statistically significant potentiation immediately (155.08±4.82%, 
Wilcoxon test, P=0.015) and it maintained up to the end of the 
recording period (159.42±6.82%, Wilcoxon test; P=0.015). Thus, the 
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procedure resulted in the reinforcement of the E-LTP in S2 











Figure 4.13: Synaptic tagging and capture of HFS-induced and 
D1/D5 receptor-mediated potentiation in aged rats compared to 
adults. The location of electrodes for these experiments is similar to 
the two-input STC experiments as in Figure 4.3a. In (a) and (b) After a 
stable baseline recording of 30 min in S1 and S2, L-LTP was induced 
in S1 by STET and 60 min later, WTET was applied to S2 for inducing 
E-LTP in this pathway. The experimental plan in (c) and (d) is identical 
to that in Figure 4.3b. (a) “Strong-before-weak (SBW)” stimulation 
paradigm demonstrating STC in the adult rats (n=6). STET in S1 (black 
circles) resulted in a significant potentiation that maintained till the end 
of recording (4 h, Wilcoxon test, P=0.027) and also lead to the 
reinforcement of the WTET-induced E-LTP in S2 (orange circles; 4 h, 
P=0.027). (b) SBW paradigm in aged slices shows impaired STC 
(n=8). The STET in S1 (black diamonds) resulted in L-LTP that 
maintained over 4 h (Wilcoxon test, P=0.016) but did not lead to the 
reinforcement of the WTET-induced E-LTP in S2 (orange triangles). 
The potentiation in S2 was significant only until 145 min (Wilcoxon test, 
P=0.039) after which it gradually decayed to baseline (Wilcoxon test, 
P>0.05). (c) In the adult rat slices (n=6), SKF induced a slow-onset, 
persistent potentiation in S1 lasting 4 h (blue circles; P=0.043) and also 
transformed the E-LTP induced in S2 (orange circles) into a persistent 
one (P=0.043). (d) In the aged rat slices (n=12), SKF induced a 
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transient potentiation in S1 that decayed to baseline by 4 h (blue 
diamonds; Wilcoxon test, P=0.381) and failed to reinforce the E-LTP 
induced in S2 (orange triangles, 4 h, Wilcoxon test, P=0.851). Insets 
show representative fEPSP traces for each input (same color as the 
input). In (a) and (b), the traces were recorded at baseline (solid line, -
30 min), 30 minutes after the respective tetanization/stimulation in each 
input (dotted line), and at 240 min (hatched line). Scale bar for the 
traces 3 mV/5 ms. 
 
However, the same experimental procedure did not result in STC in the 
neuronal population of aged rats (Figure 4.13b; n=8). The STET-
induced L-LTP in S1 (grey diamonds) was intact and was significantly 
potentiated following tetanization (+1 min; 125.1±6.1%, Wilcoxon test, 
P=0.008) and maintained over 4 h (133.5±8.99%, Wilcoxon test, 
P=0.016). The post-tetanization potentials in S2 (orange triangles) 
were significantly potentiated after the WTET (121.91±3.25%, Wilcoxon 
test; P=0.008) but only until 145 min (111.7±5.2%, Wilcoxon test, 
P=0.039) following which the potentiation decayed rapidly and was at 
the baseline values at the end of recording (104.83±4.52%, Wilcoxon 
test; P=0.312). Thus, the aged neurons failed to express STC.  
 
We then investigated the STC processes initiated by D1/D5 receptor 
agonist-induced SOP. The experimental plan and rationale was the 
same as in the earlier part of this study (Results-I, Section 4.1). After 
recording a stable baseline of 30 min, 50 µM SKF was applied in three 
pulses (similar to as in Figure 4.1a).  
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While input S1 potentials were recorded normally, test stimulation was 
suspended in input S2 for 1 h from the beginning of SKF application. 
Test stimulations were resumed in S2 from 60 min onwards and a 
baseline was recorded again for 30 min. At the 90th min, WTET was 
applied to S2 and the potentials were recorded in both the inputs until 
the end of 4 hours. 
 
Control experiments performed on adult rat slices showed normal STC 
(Figure 4.13c; n=6), wherein the slow-onset potentiation induced by 
SKF in S1 (blue circles) became significant after 30 minutes and lasted 
for 4 h (144.44±6.40%, Wilcoxon test; P=0.043) and the WTET-
induced E-LTP in S2 (orange circles) was reinforced to L-LTP (4 h, 
146.73±10.64%, Wilcoxon test; P=0.043).  
 
In the slices of aged rats (Figure 4.13d; n=12), the input S1 (blue 
diamonds) displayed slow-onset potentiation that was statistically 
significant after 15 min (108.2±2.7%, Wilcoxon test; P=0.034) but was 
not significant after 55 min (110.7±5.4%, Wilcoxon test; P=0.064). 
WTET applied to S2 (orange triangles) resulted in significant 
potentiation immediately (130.2±9.2%, Wilcoxon test; P=0.002) but it 
maintained only transiently and decayed to baseline levels 140 min 
(111.97±4.9%, Wilcoxon test; P=0.091) onwards.  
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Together, these results showed that the associative properties such as 
synaptic tagging and capture are impaired in the aged hippocampal 
CA1 pyramidal neurons. 
 
4.7 Effect of hippocampal zinc chelation on synaptic 
plasticity and associativity in aged CA1 pyramidal 
neurons 
 
Evidences from mouse models of accelerated aging have suggested 
that brain zinc homeostasis is dysregulated in aging (Onozuka et al., 
2002; Saito et al., 2000). Brain zinc levels have also been predicted to 
rise with age (Sensi et al., 2011). Particularly, Zn2+ affects NMDAR 
function and the subunit composition of NMDARs changes with aging 
to a predominantly GluN2A/GluN2B composition. GluN2A containing 
NMDARs are much more sensitive to modulation by Zn2+. Further, zinc 
overdose was shown to result in a decline in the binding affinity of 
dopamine D1 receptors and an accompanied spatial reference memory 
deficit (Turner and Soliman, 2000). Having observed the deficits in 
NMDAR-dependent forms of plasticity (including HFS-induced and 
D1/D5 receptor agonist-induced) and their associative properties, we 
asked whether excess Zn2+ could be contributing to the plasticity 
deficits observed in aged slices. As such, we investigated the effects of 
Zn2+ chelation on these observed impairments in plasticity and 
associativity.  
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4.7.1 Imaging hippocampal Zn2+ with a cell-permeable fluorescent 
indicator, FluoZin-3 AM 
 
To investigate whether the hippocampal Zn2+ levels are increased in 
aging, we used a cell-permeable fluorescent indicator, FluoZin-3 (AM) 
to visualize Zn2+ in hippocampal slices. To maintain consistency in the 
imaging conditions (due to technical limitations) we chose to store the 
slices, following incubation, in 4% PFA/PBS solution at 4oC until 
imaging. For imaging, following three washes in aCSF, slices were 
treated with 2 µM FluoZin-3 (AM) solution for ten minutes in dark, 
rinsed once with aCSF and imaged with a confocal microscope (for 
details see Section 3.5.6). Representative images showing the FluoZin-
3 fluorescence intensities from the slices of adult and aged rats are 
shown in Figure 4.14a,b. The images showed a striking difference in 
the FluoZin-3 signal between the slices of adult and aged rats 
indicating increased Zn2+ levels in the hippocampus of aged rats. We 
performed the imaging on 48 slices from nine adult rats and 49 slices 
from ten adult rats and compared the mean fluorescence intensities 
(raw intensity density) between the two groups. The analysis showed a 
significant increase in the mean fluorescence intensity in the aged rat 
group compared to the adult rat group (Figure 4.14c, Unpaired t-test 
with Welch’s correction, t=9.60; ****P<0.0001). 
 









Figure 4.14: Increased Zn2+ levels in the hippocampus of aged rats 
compared to adult rats. A cell-permeable fluorescent Zn2+ indicator 
FluoZin-3 (AM) was used. The acute hippocampal slices (400 µm-
thick) were incubated in aCSF at 32oC for 2 h and then stored in 
4%PFA/PBS at 4oC. Following three washes in aCSF, slices were 
treated with 2 µM FluoZin-3 solution for ten minutes in dark, rinsed 
once with aCSF and imaged with a confocal microscope. (a) FluoZin-3 
fluorescence from a representative hippocampal slice of 5-7 week-old 
adult rat. (b) FluoZin-3 fluorescence from a representative hippocampal 
slice of aged rat (82-84 week-old). The images are shown as pseudo-
colored intensity maps. The pixel-intensity calibration bar is shown in 
the inset with violet representing the lowest intensity and yellow 
representing the highest. (c) A plot of mean fluorescence intensities 
(raw intensity density) from slices of adult and aged rats. The analysis 
showed a significant increase in the mean fluorescence intensity in the 
aged rat group compared to the adult rat group (Unpaired t-test with 
Welch’s correction, t=9.60; ****P<0.0001). (d) A plot of mean 
fluorescence intensities from the CA1 region (raw intensity density 
normalized to area) from slices of adult and aged rats. A significant 
increase was observed in the mean fluorescence intensity in the aged 
rat group compared to the adult rat group (Unpaired t-test with Welch’s 
correction, t=6.44; ****P<0.0001).  
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As our particular interest was in the plasticity impairments in the CA1 
region, we compared the mean fluorescence intensities from the CA1 
region (raw intensity density normalized to area) between the two 
groups. The analysis also showed a significant increase in the mean 
fluorescence intensity in the aged rat group compared to the adult rat 
group (Figure 4.14d, Unpaired t-test with Welch’s correction, t=6.44; 
****P<0.0001).  
 
These experiments demonstrated increased Zn2+ levels in the 
hippocampus of aged rats, supporting our hypothesis that excess zinc 
could underlie the plasticity impairments in aging. 
 
4.7.2 Effects of Zn2+ chelation on HFS-induced L-LTP  
 
We used a cell-permeable, high affinity Zn2+ chelator TPEN. This 
chelator at a concentration of 5 µM was used in an earlier study to 
chelate Zn2+ in hippocampal mossy fiber synapses (Matias et al., 
2006). We chose this concentration and, in the initial series of 
experiments, checked whether treatment with 5 µM TPEN before and 
during the STET has any effect on the induced L-LTP in hippocampal 
slices of adult rats.  
 
 







                         
                        (d) 
 
 
Figure 4.15: Hippocampal Zn2+ chelation restores the deficits in 
HFS-induced L-LTP in aged rats. Following 30 minutes of stable 
baseline recording, a cell-permeable zinc chelator TPEN (5 µM) was 
bath applied to the slices for a total duration of 1 h. The time of TPEN 
application is shown with a red bar in each graph. (a) STET-induced L-
LTP in adult slices in the presence TPEN was not significantly different 
from the control L-LTP (n=7). The potentiation lasted over 4 h 
(P=0.018). (b) Induction of L-LTP in aged slices combined with TPEN-
treatment resulted in substantial augmentation of potentiation that 
lasted for 4 h (n=10); potentiation at the end of 4 h was significantly 
different from the baseline (Wilcoxon test, P=0.002). (c) A histogram 
comparing the mean potentiation at various time points (-30 min, +1 
min, +120 min and +240 min) between STET-induced L-LTP in adult 
and aged slices with or without TPEN treatment. Asterisks indicate 
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significant difference between two groups (Mann-Whitney U test; 
*P<0.05; **P<0.01; ***P<0.001). (d) Bath application of TPEN for 1 
hour following a stable baseline did not significantly alter the baseline 
responses in the slices of aged rats (n=8). The mean potentiation at 
any time-point was not significantly different from the baseline 
(P>0.05). Error bars in all graphs represent ±SEM. Representative 
fEPSP traces shown in each case were recorded at the respective time 
points as mentioned. Scale bars for all the traces, vertical:3 mV, 
horizontal:5 ms.    
 
 
Following a stable baseline recording of 30 min, bath application of 
TPEN (5 µM) was started. After 30 min of TPEN treatment, L-LTP was 
induced with STET (three HFS trains spaced at 10 min) and the TPEN 
application was continued until the total duration of the treatment was 1 
hour (Figure 4.15a; n=7). This treatment with the Zn2+ chelator did not 
show any significant effect on the induction and maintenance of the L-
LTP induced; the potentials immediately after first tetanization 
(151.85±6.45%, Wilcoxon test; P=0.018) and at the end of 4 h 
(151.64±10.76%, Wilcoxon test; P=0.018) were similar to that of non-
treated control LTP (Figure 4.11a.). There was no statistically 
significant difference in the induction and maintenance of Zn2+-chelated 
L-LTP compared to control L-LTP (Mann-Whitney U test, +1 min 
P=0.174; +240 min P=0.094). We also, did not observe any significant 
changes in the baseline fEPSP slopes during the initial 30 min 
treatment with the chelator, before the induction of LTP. 
 
In the next critical series of experiments, we tested the effect of Zn2+-
chelation on the STET-induced LTP in the slices from aged rats. The 
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experimental plan was the same as explained above. Interestingly, the 
magnitude of STET-induced LTP in the Zn2+ chelator-treated slices of 
aged rats (Figure 4.15b; n=10) was similar to that of control L-LTP in 
adult rat slices (Figure 4.11a). The potentiation was statistically 
significant after first tetanization (154.26±5.6%, Wilcoxon test; 
P=0.002) and maintained over 4 h (166.89±10.5%, Wilcoxon test; 
P=0.002). A histogram comparing the potentiation at various time 
points (30 min before, 1 min, 2 h and 4 h after LTP induction) between 
L-LTP in adult and aged slices with or without TPEN treatment is 
shown in Figure 4.15c). 
 
We did not observe any significant changes in the baseline recordings 
of aged slices during the initial 30 min treatment with the chelator. We 
also reconfirmed this in a separate set of experiments where, following 
a 30 min stable baseline recording, TPEN (5 µM) was applied to the 
slices of slices of aged rats for the same duration of 1 hour and then 
baseline responses were recorded for 3 hours (Figure 4.15d; n=8). In 
these experiments also, no significant change was observed in the 
baseline responses; the mean potentiation was not significantly 
different from the pre-treatment baseline values at any time-point 
(Wilcoxon test; P>0.05). 
 
Next, we addressed the question of whether the augmented L-LTP 
observed in Zn2+ chelator-treated aged slices required NMDAR activity 
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for its induction and new protein synthesis for its persistence. As shown 
in Figure 4.16a, bath application of a protein synthesis inhibitor emetine 
(20 µM) 30 min before and after the induction of LTP along with TPEN 
(5 µM) and then emetine alone for the entire recording period similar to 
that of the earlier report (Serrano et al., 2005) resulted in a transient 
form of LTP. Statistically significant potentiation was observed up to 
145 min after STET (119.95±7.2%, Wilcoxon test, P=0.042; n=12) after 
which the potentials gradually decayed to baseline values (Wilcoxon 







Figure 4.16: Protein-synthesis- and NMDAR-dependence of L-LTP 
in Zn2+-chelated slices of aged rats. (a) STET coupled with 
coapplication of TPEN (5 µM; red bar) and emetine (EME, 20 µM; 
black bar) resulted in a potentiation that remained significant for 145 
minutes (n=12; P=0.042) and decayed to baseline afterwards. The 
mean potentiation at the end of 4 hours was not significantly different 
from the baseline (P=0.850). (b) STET failed to induce potentiation in 
the presence of NMDAR antagonist AP5 (50 µM; pink bar) and TPEN 
(5 µM; red bar). The fEPSP response throughout the recording period 
was not significantly different from that of baseline (P>0.05, n=8). Error 
bars in all graphs represent ±SEM. Representative fEPSP traces 
shown in each case were recorded at the respective time-points as 
mentioned. Scale bar for all the traces, vertical:3 mV, horizontal:5 ms.     
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STET in presence of TPEN and the NMDA receptor antagonist AP5 
(50 µM) completely abolished the induction of LTP (Figure 4.16b; n=8). 
The fEPSP slope values were not statistically significant at any point 
compared to the baseline values (Wilcoxon test, P>0.05). Thus, the 
augmented L-LTP observed in the aged hippocampal neurons after 
Zn2+ chelation was protein synthesis- and NMDA receptor-dependent.  
 
4.7.3 Effects of Zn2+ chelation on D1/D5 receptor agonist-induced 
slow-onset potentiation 
 
Similar to the experiments with HFS-induced LTP, we first checked 
whether chelation of Zn2+ with TPEN (5 µM) before and during the 
induction of potentiation by SKF has any effect on the long-lasting 
potentiation induced in the slices of adult rats. The experimental plan 
was also similar; following a stable baseline recording of 30 min, bath 
application of TPEN (5 µM) was initiated. After 30 min of TPEN 
treatment, 50 µM SKF was co-applied (three 5-min pulses spaced at 5 
min) and the TPEN application was continued until the total duration of 
the treatment was 1 hour (Figure 4.17a; n=8). The potentiation followed 
the usual time course becoming statistically significant by 30 min 
(116.90±5.47%, Wilcoxon test, P=0.046) and maintained over the 4 h 
recorded (147.88±6.67%, Wilcoxon test, P=0.011).  The treatment with 
Zn2+ chelator did not affect the SOP induced by SKF application in 
adult slices as there was no significant difference between the 
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potentiation observed with or without Zn2+ chelator application (Figure 













Figure 4.17: Hippocampal Zn2+ chelation re-establishes the 
deficits in D1/D5 receptor agonist-induced potentiation in aged 
rats. Following 30 minutes of stable baseline recording, a cell 
permeable zinc chelator TPEN (5 µM) was bath applied to the slices for 
a total duration of 1 h. The time of TPEN application is shown with a 
red bar in each graph. (a) Application of TPEN along with SKF (50 µM) 
to slices from adult rats did not significantly affect the potentiation 
induced (n=8; 4  h, P=0.011). (b) Application of SKF to aged slices 
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coupled with TPEN-treatment resulted in re-establishment of delayed 
onset, persistent potentiation that lasted for 4 hours (n=11); 
potentiation at the end of 4 h was significantly different from the 
baseline values (P=0.001). (c) A histogram comparing the mean 
potentiation at various time points (-30 min, +30 min, +120 min and 
+180 min) between SKF-induced potentiation in adult and aged slices 
with or without TPEN treatment. Asterisks indicate significant difference 
between two groups (Mann-Whitney U test; **P<0.01, ***P<0.001). (d) 
SKF application coupled with application of TPEN (5 µM) and emetine 
(20 µM) completely abolished the SKF-induced potentiation (Wilcoxon 
test, n=6; P>0.05). (e) SKF application failed to induce potentiation in 
the presence of NMDAR antagonist AP5 (50 µM) and TPEN (5 µM). 
The fEPSP response at the end of 4 h (99.25±9.6%) was not 
significantly different from that of baseline values (Wilcoxon test, 
P>0.05, n=9). Error bars in all graphs represent ±SEM. Representative 
fEPSP traces shown in each case are recorded at the respective time 
points as mentioned. Scale bar for all the traces, vertical:3 mV, 
horizontal:5 ms.    
 
 
Using the same experimental plan, we then investigated the effect of 
Zn2+-chelation on the SKF-induced SOP in the slices from aged rats. 
Interestingly, SKF application under Zn2+-chelated conditions resulted 
in a SOP that lasted over 4 h (Figure 4.17b; n=11). Statistically 
significant potentiation was observed from 80 min (120.84±7.5%, 
Wilcoxon test; P=0.042) until the end of the recording period 
(139.40±6.1%, Wilcoxon test, P=0.001). When compared between the 
SKF-potentiation in aged rat slices with or without TPEN treatment 
(Figure 4.17b and 4.12b), the potentiation became significantly different 
105 min onwards (Mann-Whitney U test; P=0.041). A comparison of 
potentiation at various time points (30 min before, 30 min, 2 h and 3 h 
after SKF application) between adult and aged slices with or without 
TPEN treatment is presented in Figure 4.17c.  
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Again in this case, we tested whether the induction and maintenance of 
long-lasting SOP observed in Zn2+-chelated slices of aged rats required 
NMDAR activity and new protein synthesis for its persistence. As 
shown in Figure 4.17d (n=6), co-application of the protein synthesis 
inhibitor emetine (20 µM) with TPEN (5 µM) blocked the induction of 
SKF-induced potentiation. Similarly, co-application of NMDAR 
antagonist AP5 (50 µM) and TPEN could completely abolish the SKF-
induced SOP (Figure 4.17e; n=9). The potentiation in both the cases 
was not significantly different from the baseline values throughout the 
recording period (Wilcoxon test, P>0.05). 
 
4.7.4 Effects of Zn2+ chelation on late-associative properties in 
aged hippocampal neurons 
  
Since Zn2+ chelation in aged hippocampal slices led to augmentation of 
L-LTP magnitude and re-established the late-phase of D1/D5 receptor 
agonist-induced potentiation in a protein synthesis- and NMDA 
receptor-dependent manner, we asked whether the deficits in late-
associative properties such as STC could also have been restored? To 
test this hypothesis, we performed the two-pathway STC experiments 
in hippocampal slices of aged rats (same as in Figure 4.13b and 4.13d) 
but now, including the TPEN treatment.  
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After a 30 min stable baseline recording in S1 and S2, TPEN (5 µM) 
was bath applied for the next 60 min (Figure 4.18a; n=9). Once 30 min 
elapsed from the start of TPEN application, STET was delivered to S1 
(Figure 4.18a; grey diamonds) for inducing L-LTP and at the 60th min 
WTET was delivered to S2 (Figure 4.18a; orange triangles) for inducing 
E-LTP. STET-induced potentiation in S1 was statistically significant 
immediately after tetanization (+1 min; 148.4±11.2%, Wilcoxon test  
P=0.004) and maintained over 4 h (151.7±10.8%, Wilcoxon test  
P=0.004). The potentiation in S2, that otherwise decayed rapidly (see 
Figure 4.13b), was transformed to a long-lasting form demonstrating 
restored STC. The post-tetanization potentials in S2 were significantly 
potentiated immediately after WTET (129.4±6.0%, Wilcoxon test  
P=0.008) up to the end of the recording period (128.1±3.2%, Wilcoxon 
test  P=0.008). 
 
We also tested the same possibility of restored late-associative 
properties for SKF-induced SOP observed upon Zn2+ chelation (Figure 
4.18b; n=8). Here, not only did input S1 (blue diamonds) showed 
statistically significant potentiation from 10 min onwards (109.13±2.2%; 
Wilcoxon test; P=0.023) and maintained over 4 h (132.1±7.7%; 
Wilcoxon test; P=0.008) but also the transient LTP in S2 (orange 
triangles) was transformed to L-LTP thus showing STC. The mean 
potentiation in S2 was statistically significant following WTET 
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(141.8±4.9%; Wilcoxon test; P=0.008) and maintained over 4 h 






                           (c)  
 
 
Figure 4.18: Hippocampal Zn2+ chelation re-establishes synaptic 
tagging and capture of HFS-induced and D1/D5 receptor-mediated 
potentiation in aged rats. The location of electrodes for these 
experiments is similar to the two-input STC experiments as in Figure 
4.3a. (a) The experimental plan is similar as in Figure 4.13b, but the 
slices were also treated with the Zn2+ chelator TPEN (5 µM) for 1 h 
after the baseline recording (red bar). STET in the presence of TPEN 
resulted in a significant potentiation in S1(black diamonds) lasting 4 h, 
(Wilcoxon test, P=0.004) and also transformed the E-LTP induced in 
S2 (orange triangles) into a long-lasting one (Wilcoxon test, P=0.008; 
n=9). (b) The experimental plan is similar as in Figure 4.13d, but the 
slices were also treated with TPEN (5 µM) for 1 h after the baseline 
recording (red bar). Application of SKF to aged rat hippocampal slices 
in the presence of TPEN resulted in restoration of potentiation in S1 
(blue diamonds) that lasted for 4 h (Wilcoxon test, P=0.008) and re-
established STC leading to reinforcement of the E-LTP in S2 (orange 
triangles, Wilcoxon test, P=0.008, n=8) (c) Bath application of TPEN (5 
µM) for 1 h itself did not reinforce the WTET-induced E-LTP. The post-
tetanization potentiation was significantly different from baseline values 
only for 90 minutes (Wilcoxon test, P<0.05; n=8). The mean 
potentiation at the end of 3 h was not significantly different from the 
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baseline (Wilcoxon test, P>0.05). In (a) and (b) Insets show 
representative fEPSP traces for each input (same color as the input). In 
(a) and (b), the traces are recorded at baseline (solid line, -30 min), 30 
minutes after the respective tetanization/stimulation in each input 
(dotted line), and at 240 min (hatched line). In (c), representative 
fEPSP traces shown were recorded at the time points as mentioned. 
Scale bars for all the traces, vertical:3 mV, horizontal:5 ms.    
 
 
A control series of experiments was conducted wherein prior TPEN 
application itself did not reinforce the WTET-induced E-LTP (Figure 
4.18c). The post-tetanization potentiation was significantly different 
from the baseline values only until 90 min (112.8±3.9%; Wilcoxon test, 
P=0.039; n=8). The mean potentiation was at the baseline values at 
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CHAPTER 5 – DISCUSSION 
 
 
5.1: Dopamine D1/D5 receptor signaling-
mediated synaptic plasticity and associativity 
in CA1 pyramidal neurons of adult rats 
 
Extensive evidence, over the years, has shown that dopamine release 
in the hippocampus is important for the consolidation of at least certain 
forms of hippocampus-dependent memories (Jay, 2003; Rossato et al., 
2009). Lisman and colleagues proposed that dopamine-mediated late-
phase LTP is an additional requirement, along with Hebbian factors, for 
the consolidation of novel and motivational events and thus such 
episodic memories are to be referred to as ‘neo-Hebbian’ (Lisman et 
al., 2011). Dopaminergic signaling and modulation of synaptic plasticity 
in the hippocampal CA1 region is well documented. The dynamics of 
dopamine release and the timing could result in bidirectional plasticity 
modulation in the CA1 region (Edelmann and Lessmann, 2013; Rosen 
et al., 2015). Given that the effects of dopaminergic signaling and 
response significantly vary across a range of concentrations and 
between different brain regions, the present study was aimed at 
understanding the nuances of dopamine D1/D5 receptor-mediated 
synaptic plasticity in the hippocampal CA1 region, specifically at the 
Schaffer collateral synapses.  
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5.1.1 Dose-dependency of dopamine D1/D5 receptor-
mediated SOP at CA1 SC synapses: Significance 
 
A significant body of research has established that dopamine release 
and the subsequent activation of dopaminergic D1/D5 receptor-
mediated mechanisms has a key role in the late-phase LTP in CA1 
region. D1/D5 receptor antagonists applied during the HFS-induced 
LTP block the late-phase (Frey and Schroeder, 1990; O’Carroll et al., 
2006), so does the depletion of dopamine during the induction (Yang et 
al., 2002). LTP induced in D1 receptor knockout mice lacks late-phase 
(Matthies et al., 1997). Experiments in vivo also have supported these 
findings (Granado et al., 2008; Swanson-Park et al., 1999). Dopamine 
receptor antagonism can also affect early-phase of LTP when the 
stimulation protocols are comparatively less strong (Otmakhova and 
Lisman, 1996).  
 
In slices, strong tetanizations cause the release of endogenous 
dopamine (Frey and Schroeder, 1990). In 1995, Huang and Kandel 
reported that dopamine agonists alone could lead to a long-lasting 
potentiation of fEPSP responses upon bath application on acute 
hippocampal slices (Huang and Kandel, 1995). This demanded further 
insights as to how this would fit into the role of dopamine in information 
processing. Later, it was shown that such agonist-induced potentiation 
critically required NMDAR activation, provided by test stimulation, 
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during induction (Navakkode et al., 2007). Together with earlier 
observations (O’Carroll et al., 2006), these results showed that the role 
of dopaminergic mechanisms in induction of persistent potentiation 
depends on the synergistic activation of NMDARs.  
 
The mechanisms involved in LTP induction could act either as a 
‘trigger’ or a ‘permissive’ or an ‘instructive’ signal (Malenka and 
Siegelbaum, 2001). The NMDAR activation is a necessary requirement 
for the induction of persistent LTP by dopamine or it’s agonists; in other 
words, dopamine or agonists themselves cannot induce potentiation 
without co-activation of NMDARs. Thus, NMDARs act as triggers and 
dopaminergic signals are permissive (Lisman et al., 2011). Similar 
trigger and permissive roles for NMDAR and dopamine D1 receptors 
have been reported for the production of Fos in the hippocampus in 
vivo (Radulovic et al., 2000). Our results showed that the permissive 
role of dopamine D1/D5 receptor activation at CA1-SC synapses was 
dose-dependent.  
 
The onset of D1/D5 agonist-induced potentiation in the study by Huang 
and Kandel (1995) was fairly delayed compared to that shown in our 
study in which potentiation peaked by 3-4 hours. However, the 
comparison between these two results is warranted due to 
methodological differences. First, in our study we allowed extended 
slice recovery periods (pre-incubation) which have been reported to 
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greatly influence the metabolic stability and kinase activation levels in 
the slices (Sajikumar et al., 2005). Second, the agonist was applied in 
a repeated, spaced paradigm in our study whereas it was applied in a 
continuous massed paradigm in theirs. Spaced and massed 
stimulations could involve substantially different mechanisms (Kim et 
al., 2010; Mauelshagen et al., 1998; Scharf et al., 2002; Wu et al., 
2001). 
 
Dose-dependent effects of dopaminergic activation have been 
documented in certain other brain regions such as striatum and 
prefrontal cortex (PFC) (Williams and Millar, 1990; Zheng et al., 1999) 
and in nucleus accumbens cultures (Chao et al., 2002). Several studies 
have shown that in medial PFC, D1 receptor activation follows an 
inverted U-shaped dose-response curve (Arnsten et al., 1994; 
Goldman-Rakic et al., 2000; Sawaguchi and Goldman-Rakic, 1994; 
Vijayraghavan et al., 2007), wherein too much or too little activation of 
D1 receptors impaired mPFC function. However, low levels of D1 
receptor stimulation was suggested to play an adaptive role by 
enhancing spatial tuning during a spatial memory task, increasing 
signal-to-noise ratio and thus help in sculpting neural selectivity 
whereas high levels led to impaired performance (Puig and Miller, 
2012; Vijayraghavan et al., 2007). Concentration of dopamine applied 
also differentially modulated NMDAR-mediated responses in mPFC 
slices; at lower concentrations (<50 µM), it enhanced NMDAR currents 
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preferentially acting through D1-like receptors whereas at higher 
concentrations it suppressed NMDAR currents acting through D2-like 
receptors (Zheng et al., 1999). In nucleus accumbens cultures, D1-
receptor agonist concentration-dependently enhanced GluR1-Serine-
845 phosphorylation that was suggested to augment AMPAR 
transmission (Chao et al., 2002). Then, what is the significance of 
concentration-dependent potentiation observed at CA1 SC synapses in 
our study following D1/D5 receptor agonist application?    
 
5.1.2 Dose-dependent regulation of synaptic 
associativity 
 
The results from the two-pathway experiments provide evidence for the 
significance of observed concentration-dependent potentiation 
responses during associative information processing from multiple 
synaptic inputs, under the conceptual framework of STC. When the 
D1/D5 receptor activation is sufficiently strong, as in the case of 25 µM 
SKF, it leads to the upregulation of many plasticity-related products in 
sufficiently large amounts which could be shared by the synapses with 
an active synaptic tag during that time-window. Thus, even weakly 
active synapses could be strengthened. This could be seen as synaptic 
cooperation; if learning tags and plasticity-products are available to 
interact, this will lead to cooperation between synapses and thus 
formation of stable memory traces (Sajikumar and Frey, 2004b).  
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However, at moderate levels of D1/D5 receptor activation, as with 10 
µM SKF, the synapses that lead to the upregulation of the plasticity-
products, turn out to be less sharing and preferentially get the PRP 
benefit.  Thus, other synapses which become active comparatively at a 
later time, would get less or no benefit even with an active learning tag 
set. This is identical to the recently reported scenario of ‘winner-takes-
all’ (Kano and Hashimoto, 2009; Sajikumar et al., 2014). It could also 
be possible that at stronger stimulation the PRP upregulation might last 
longer than at moderate levels of stimulation. Hence, the input weakly 
tetanized ~90 minutes after the strongly activated input, gets second 
preference and loses the competition for PRPs. As such, only the 
synapses that initially lead to the production of PRPs get strengthened 
while those that are active subsequently, failed to do so. 
 
With weak D1/D5 receptor activation (such as with 5 µM SKF), the 
mechanisms led to the synthesis of PRPs but at very limited levels. 
Thus, the input by itself maintained late form of potentiation but when in 
the presence of a competing input, the PRPs were not sufficient for 
either of the inputs and both the set of synapses failed to get stabilized. 
This scenario is similar to the ‘competitive maintenance’ reported 
earlier (Fonseca et al., 2004) where many synapses active during a 
certain time window competed for PRPs from a limited pool and 
attempted to get stabilized at the expense of others. The result from 
the three-pathway experiments further lend support to this wherein 
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providing additional PRPs to the pool by means of a strong tetanization 
in a third, convergent input rescued the synapses from competition. 
 
These results revealed a modulatory role of dopamine D1/D5 receptor-
mediated mechanisms in allowing the synapses to dynamically switch 
between cooperative and competitive states. Events with strong 
content of novelty, saliency and significance got preferentially 
strengthened and would also lead to cooperative strengthening of 
weaker events in the temporal penumbra. On the other hand, events 
with lesser significance would have to win out the competition with 
other weak events and they would be stabilized only if there occurred a 
strong event in the temporal vicinity. 
   
5.1.3 Differential involvement of kinase activation in the 
induction of D1/D5 receptor-mediated potentiation 
 
The experiments investigating the role of CaM kinases and MAP 
kinases in the induction phase of D1/D5 receptor-mediated SOP 
revealed that at weaker levels of dopaminergic stimulation (5 µM SKF), 
inhibiting either of the kinases, CaMKII or MAPKs, completely blocked 
the induction of potentiation. At moderate levels of stimulation (10 µM 
SKF), inhibition of either of the kinases selectively led to the blockade 
of late phase but not the early phase of potentiation. However, when 
the dopaminergic stimulation was sufficiently strong (25 µM SKF), 
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inhibiting CaMKII during induction had no effect on the induced 
potentiation whereas inhibiting MAPKs blocked the late phase. 
 
These results indicate that at substantially weak levels of dopaminergic 
stimulation, both CaMKII and MAPK activation were necessary for the 
induction of the slow-onset potentiation. At moderate levels of 
stimulation, however, either one of these kinases alone could maintain 
the potentiation transiently but a concerted action of both appeared to 
be necessary for the maintenance of late phase. Interestingly, when 
the dopaminergic stimulation was sufficiently stronger CaMKII 
mediated mechanisms became dispensable while MAPK activation 
remained necessary. Differential involvement of kinases in different 
forms of plasticity has been well appreciated. Though CaMKII is known 
to be involved in many form of LTP in hippocampus, its role is not 
ubiquitous to all forms of NMDAR-dependent LTP. CaMKII inhibitors 
have no effect on the LTP induction in CA1 during early development 
(Yasuda et al., 2003) and its involvement is minimal in medial perforant 
path synapses of DG (Cooke et al., 2006). Inhibitors of MEK block 
theta-induced LTP while sparing tetanus-induced or pairing-induced 
LTP (Opazo et al., 2003). Further, in some cases, CaMKII might play a 
role as a part of a parallel cascade involving MAPK and PKA (Cooke et 
al., 2006). Such parallel kinase cascades are known to operate in mice 
at an early age (Wikstrom et al., 2003), in the DG of adult mice (Cooke 
et al., 2006) and in rats (Wu et al., 2006). From these studies, two main 
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limbs of such parallel cascades have been identified one involving 
CaMKII and the other involving PKA/PKC/MAPK. 
 
5.1.4 No significant role for CaM kinase activation during 
the maintenance of D1/D5 receptor-mediated 
potentiation 
 
In our study, we found no significant role for CaMKII activation or for 
CaMKIV activation in the maintenance phase of the D1/D5 receptor-
mediated SOP. Application of CaMKII inhibitors following LTP induction 
had no effect (Chen et al., 2001; Ito et al., 1991). Whether the CaMKII 
enzyme activity was transient or persistent has been met with 
confounding results (Fukunaga et al., 1995; Lee et al., 2009; Lengyel et 
al., 2004). The inhibitor KN-93 acted by allosterically binding to CaMKII 
holoenzyme (in complex with Ca2+/CaM) and blocking CaMKII 
activation. Hence, it only prevented the Ca2+/calmodulin-dependent 
activation but not the autophosphorylated form of the enzyme (Sumi et 
al., 1991; Vest et al., 2010); but no direct inhibitors of the 
autophosphorylated form are available currently. Therefore, from these 
results we can only conclude that no persistent reactivation of the 
enzyme was involved during the maintenance phase. However, on 
another note, autophosphorylated CaMKII is suggested to act as a 
molecular switch (Lisman, 1994) at the transition of early and late 
phases of LTP and in itself, this mechanism could not sustain the 
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potentiation for long durations (Reviewed by (Giese and Mizuno, 
2013)). A mutant deficient in threonine-286 autophosphorylation 
(T286A) (Giese et al., 1998) can still form memory upon massed 
training, indicating that CaMKII is not absolutely essential for memory 
storage (Irvine et al., 2006). Additionally, no impairment in the storage 
of contextual fear long-term memory was seen following a post-training 
blockade of CaMKII activity (Buard et al., 2010).  
 
We also observed that only at stronger dopaminergic stimulation, 
inhibition of both CaMKII and CaMKIV during the maintenance phase 
resulted in a reduction in the magnitude of potentiation though not 
completely blocking it. This suggests that CaMKIV-mediated 
mechanisms might be involved only with sufficiently stronger 
stimulation. Here, CaMKIV pathway might act synergistically with 
MAPK pathways to induce CREB activation (Wu et al., 2001). Besides, 
studies using mutant mice lines have suggested that CaMKIV may be 
necessary for fear memory but not for spatial learning and memory 
(Kang et al., 2001; Lee et al., 2000; Wei et al., 2002). The CaMKK-
CaMKIV cascade is more sensitive to nuclear calcium entry 
(Hardingham et al., 2001) which might efficiently happen at stronger 
stimulations.  
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5.1.5 Dose-dependent, sustained activation of MAPKs 
(ERK1/2) mediates differential effects D1/D5 receptor-
mediated plasticity 
 
Having observed no significant role for CaM kinases, we then 
investigated the involvement of MAPKs, ERK1/2. Quite interestingly, 
our results showed that a sustained activation of ERK1/2 was involved 
during the maintenance phase of the D1/D5 receptor-mediated 
potentiation.  
 
A similar sustained ERK activation has been observed in many of the 
earlier reports. Following L-LTP induction with a HFS protocol, ERK1/2 
activation was seen immediately within a minute and gradually it 
increased to peak at around 6 hours (Ahmed and Frey, 2005). The 
immediate increase in phosphorylation was more robust for ERK2 than 
ERK1, whereas at later stages both were active at identical levels. One 
reason for this could be that ERK2 is found significantly associated with 
NMDAR complex (Husi et al., 2000). Sustained ERK activation has 
also been seen in response to repeated, spaced serotonin pulses and 
repeated tail shocks in Aplysia sensory neurons and was required for 
both intermediate-term facilitation (ITF), long-term facilitation (LTF) and 
LTM for sensitization (Martin et al., 1997).  
 
  163 
Active ERK levels are reported to sustain for long durations following 
BDNF application in DG (Ying et al., 2002) and in cultured hippocampal 
pyramidal neurons (Wu et al., 2001). In the case of cultured 
hippocampal neurons, sustained MAPK activation was robustly seen 
only in response to repeated, spaced BDNF application whereas 
massed stimulation failed to generate this response. This persistent 
activation was sensitive to delayed treatment with a MEK inhibitor 
suggesting that phosphorylation was maintained by persistent kinase 
activity but not by activity-dependent inhibition of a phosphatase acting 
on MEK or MAPK (Wu et al., 2001). In the same study, it was also 
observed that the peak phosphorylation of MAPKs during the early 
phase was sensitive to inhibition of calmodulin and CaM kinases but 
the sustained MAPK activation was not affected by post-stimulus 
inhibition of PKA, PKC, Ras or CaM kinases.  
 
Persistent MAPK activation was also observed following repeated 
membrane depolarization induced by KCl application to cultured 
pyramidal neurons (Maharana et al., 2013; Wu et al., 2001), in 
response to carbachol application on cortical neurons (Rosenblum et 
al., 2000) and in a behavioral setting, after a memory training in a novel 
taste-learning task (Swank and Sweatt, 2001). In this taste-memory 
study, the authors found that both MAPK and MEK activation followed 
identical biphasic profile; an initial activation phase lasted for 1-2 hours 
after training which declined and then showed another activation phase 
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between 24-48 hours. These were observed both after novel learning 
and repeated learning tasks. 
 
5.1.6 Mechanisms to achieve sustained MAPK activation 
 
The observation of sustained MAPK activation leads to the next 
question: how is this achieved and maintained for prolonged durations? 
There have been evidences and suggestions of a variety of 
mechanisms by which this could be achieved. First possibility is that a 
sustained elevation in Ca2+ influx; but this cannot sustain the activation 
for longer durations as it could have other implications for cell 
physiology. Second, signaling mediated by cAMP and PKA, though not 
necessary for the initial induction of the MAPK activation, was shown to 
be specifically involved in the sustained MAPK activation levels, thus 
acting as a gate controlling persistence (Bhalla and Iyengar, 1999; Wu 
et al., 2001). Another possibility is that MEK itself might get activated in 
a constitutive manner (Wu et al., 2001). Such constitutive MEK 
activation upstream of MAPK was reported in insular cortex following a 
taste-memory related task (Swank and Sweatt, 2001). Another way is 
the release of neurotrophins such as BDNF upon membrane 
depolarization which subsequently act on their membrane receptors 
leading to a feedback loop that maintains sustained activation of 
downstream components and finally MAPK (Maharana et al., 2013; Wu 
et al., 2001). The small GTP-binding proteins, such as Ras, Rap1, and 
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MEK kinases such as Raf, which are upstream of MEK kinases may be 
involved. However, their involvement differs within different brain 
regions and on the stimulation paradigms (Swank and Sweatt, 2001; 
Wu et al., 2001). Ras, but not Rap1 signaling was involved in the 
BDNF-induced MAPK activation in hippocampal neurons (Wu et al., 
2001). In the taste-memory task-associated biphasic MAPK activation 
in insular cortex, the first phase was dependent on persistent Raf 
activation whereas the second phase was independent of Raf (Swank 
and Sweatt, 2001). It was suggested that this second phase of 
activation might depend on another upstream molecule that was 
upregulated by transcriptional activation in the first wave. A similar 
positive feedback activation loop scenario was reported earlier in 
oocytes; here a first wave of MAPK activation led to the transcriptional 
activation of c-Mos (a kinase) which then activated MAPKs by 
phosphorylating MEK (Fisher et al., 2000).  
 
Another proposal suggests that a propagating ERK activation switch 
could form plasticity-facilitating dendritic zones and these can be 
maintained by feedback events (Ajay and Bhalla, 2007). The bistability 
of the MAPKs as explained above could be a plausible mechanism 
contributing to the maintenance of long-lasting forms of LTP and 
memory, where persistently active kinase leads to the upregulation of 
translation and transcription, the products of which keep the signal 
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‘ON’. Several other feedback-loops may also act to connect MAPK 
activation to activation of its upstream molecules (Smolen et al., 2008).  
 
5.1.7 Dose-dependency of sustained MAPK activation 
 
In our results, it was observed that the level of ERK activation following 
D1/D5 receptor agonist application was also concentration-dependent. 
Potentiation resulting from stimulation with lower concentrations of the 
agonist could be blocked with a lower concentration of the MEK 
inhibitor whereas higher concentrations of the inhibitors were needed 
to effectively block the maintenance of the potentiation induced by 
stronger dopaminergic stimulation. This was suggestive of a dose-
dependent level of ERK activation. This is consistent with some earlier 
findings: similar dose-dependent activation ERK1/2 was observed in 
the mouse prefrontal cortex and in cultured cortical neurons in 
response to stimulation with a D1/D5 receptor agonist (Nagai et al., 
2007). Additionally, in amygdala, a Pavlovian fear conditioning study, 
where ERK1/2 activation peaked by 1 hour after conditioning, showed 
that application of a MEK inhibitor dose-dependently disrupted LTP in 
the slices and also similarly impaired fear memory consolidation 
(Schafe et al., 2000). Thus, MAPK activation is capable of acting as a 
‘dose-sensor’ and accordingly activating the downstream mechanisms. 
Following synaptic activity, ERK activation is proposed to occur in the 
proximity of NMDARs, in the calcium microdomains, which takes part in 
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synapse-to-nucleus communication (Hardingham et al., 2001). So, it is 
possible that weaker dopaminergic stimulation might involve only fewer 
of such microdomains whereas stronger stimulation might involve 
many.  
 
5.1.8 Integration of signaling mechanisms during the 
D1/D5 receptor-mediated synaptic plasticity 
 
Synergistic activation of glutamatergic and dopaminergic mechanisms 
is crucial for the persistent forms of synaptic plasticity in the 
hippocampal CA1 Schaffer collateral synapses (Navakkode et al., 
2007; O’Carroll et al., 2006). Glutamate and dopamine, upon binding to 
their cognate receptors, activate different signaling mechanisms that 
converge and exhibit cross-talk at multiple levels. Influx of Ca2+ through 
NMDAR leads to activation of Ca2+/Calmodulin-dependent protein 
kinase CaMKII and Ca2+-dependent PKC. Once active, CaMKII 
phosphorylates and activates many targets resulting in trafficking of 
AMPARs to the synaptic sites. Active CaMKII can activate ERK1/2 and 
CREB (Reviewed by (Lisman et al., 2012)). CaMKII can also get 
autophosphorylated and become constitutively active (Giese et al., 
1998). NMDAR-mediated Ca2+ influx, either directly or indirectly via 
PKC, leads to activation of small GTPase Ras which then activates the 
kinase Raf, finally leading to ERK1/2 activation through MEK1/2 
(Sweatt, 2003).  
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Dopamine binding to the D1 receptor activates the Gas/Olf subunit 
which is positively coupled to the adenylyl cyclase and leads to 
increase in cAMP levels and subsequent activation of PKA. Active PKA 
can feed on to the MAPK pathway via Rap-1/B-Raf/MEK/ERK route. 
PKA also activates phosphodiesterases PDE4/PDE10 as a negative 
feedback loop to keep the cAMP levels in check (Reviewed by (Sweatt, 
2003)). Further, PKA phosphorylates and activates dopamine- and 
cAMP-regulated neuronal phosphoprotein (DARPP-32), also known as 
Protein phosphatase 1 regulatory subunit 1B (PPP1R1B), which then 
inhibits Protein phosphatase-1 (PP1) thus removing the PP1-mediated 
inhibitory constraint on MEK, ERK and CaMKII in cytosol and on 
histone H3 in nucleus (Reviewed by (Fernandez et al., 2006)). 
Phospho-DARPP-32 activity is regulated by the phosphatase 
Calcineurin (PP2B) that is activated by the Ca2+/Calmodulin complex 
(Nishi et al., 1999). Active PKA can also phosphorylate CaMKII, 
MEK1/2 and CREB (Reviewed by (Sweatt, 2003)). D1-receptor 
activation can potentiate NMDAR-mediated mechanisms by Src-family 
kinase (SFK)-mediated phosphorylation of NR2B subunits. 
 
On the other hand, activation of Gaq-coupled D5 receptors leads to 
activation of PLC resulting in DAG and IP3 production. Inositol 
triphosphate (IP3) then leads to Ca2+ release from the intracellular 
stores, contributing to the Ca2+-mediated signaling mechanisms. DAG 
activates PKC which, in turn, can feed onto the MAPK pathway 
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(Reviewed by (Beaulieu and Gainetdinov, 2011)). In addition to these 
mechanisms, somatic and nuclear Ca2+-entry through voltage-
dependent calcium channels (especially L-type) can activate 
CaMKK/CaMKIV pathway contributing to the activation of 
transcriptional events (Cohen and Greenberg, 2008).  
 
As evident, an array of signaling pathways are involved during the 
synergistic activation of dopaminergic and glutamatergic systems. A 
complex crosstalk of kinase and phosphatase-mediated mechanisms, 
negative and positive feedback loops exist to bring about the 
differential outcome. Our results indicate that ERK1/2 act as central 
signal integrators of these mechanisms.    
 
5.1.9 Downstream mechanisms of MAPK activation 
 
Activation of MAPKs is involved in gating the late-phase mechanisms 
of LTP and LTM in many brain regions including hippocampus (Blum et 
al., 1999; English and Sweatt, 1996; Roberson et al., 1999) and in 
mammalian associative learning (Atkins et al., 1998). MAPKs act as 
integrators of a wide variety of signals (Davis and Laroche, 2006; 
Roberson et al., 1999; Selcher et al., 2003; Sweatt, 2001) and once 
activated, can phosphorylate a huge number of effectors, estimated in 
one study to be more than 70 (Lewis et al., 1998). These effectors 
span a variety of proteins including signaling proteins, cytoskeletal 
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proteins, proteins of the synaptosome and nuclear proteins (Lynch, 
2004).  
 
Activation of ERK and phosphatidylinositide-3-kinase (PI3 kinase) 
following co-activation of NMDARs and D1/D5 receptors, results in the 
dendritic translation of many proteins and also triggers the insertion of 
glutamate receptors to the postsynaptic membrane (Pfeiffer and Huber, 
2006). Active ERK brings about local translational upregulation by 
acting through the mTOR pathway (Schicknick et al., 2008; Tsokas et 
al., 2007), via MAP-kinase-interacting kinase-1 (MNK1) and eukaryotic 
initiation factor-4E (eIF4E) (Banko et al., 2004; Kelleher et al., 2004) 
and also by phosphorylating Ribosomal-S6-kinase-2 (RSK2) (Davis et 
al., 2000). By phosphorylating cytoskeletal proteins such as 
Microtubule-Associated Protein-2 (MAP-2), Tau and Activity-regulated 
cytoskeleton-associated protein (Arc or Arg3.1), MAPKs can lead to 
activity-dependent changes in spine structure and dendritic morphology 
(Reviewed by (Davis and Laroche, 2006)). Along with this multitude of 
‘local’ effects, active MAPKs play important roles in synapse-to-nucleus 
communication leading to transcription of plasticity genes. ERKs can 
result in the phosphorylation and activation of the transcription factor 
cyclic-AMP response element-binding protein (CREB) either by directly 
translocating to the nucleus and phosphorylating CREB or indirectly 
through RSK2 (Davis et al., 2000; Impey et al., 1998) or through 
mitogen- and stress-activated kinase-1 (MSK1) (Sindreu et al., 2007; 
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Xia et al., 1996). Acting through RSK2, ERKs can also activate ETS-
domain-containing protein ELK-1 (Davis et al., 2000; Sweatt, 2001). 
ELK-1, another transcription factor, leads to the transcription of serum-
response-element (SRE)-dependent genes such as c-fos, and arc 
(Janknecht et al., 1993; Waltereit et al., 2001; Xia et al., 1996).  
   
CREB activation is an important event for the establishment and 
maintenance of many forms of persistent LTP, associative plasticity 
and LTM (Barco et al., 2002; Chwang et al., 2007; Chwang et al., 2006; 
Dash et al., 1990; Silva et al., 1998). MAPK activation also leads to 
activation of CREB-binding protein (CBP), which is a histone 
acetyltransferase (HAT), thus leading to histone modifications (Swank 
and Sweatt, 2001).  
 
Persistent activation of MAPKs by repeated stimulation with BDNF was 
important for inducing and maintaining activity-dependent changes in 
dendritic shape (Wu et al., 2001). An interesting possibility is that active 
ERKs promote translation of PKMV transcript (Kelly et al., 2007). PKMV, 
an atypical PKC isoform that is constitutively active is necessary for the 
maintenance of L-LTP and some forms of LTM (Pastalkova et al., 
2006; Sacktor, 2012; Serrano et al., 2005). Given that PKM-zeta was 
shown to be essential for the induction and maintenance of D1/D5 
receptor-mediated long-lasting potentiation in CA1 pyramidal neurons 
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(Navakkode et al., 2010),  increased PKMV synthesis by persistently 
active MAPKs could contribute to LTP maintenance.     
 
Blocking MAPK activation following the training period leads to 
impaired LTM (Blum et al., 1999; Walz et al., 1999) indicating that a 
sustained MAPK activation may be required for the consolidation 
process. ERKs are also suggested to play roles in certain forms of LTD 
(Gallagher et al., 2004; Thiels et al., 2002); however, the pattern of 
synaptic activity and the differential involvement of the many GTP-
binding proteins determine the specificity of the response (Gallagher et 
al., 2004). Activation of MAPK cascade and the downstream 
mechanisms appears to be a highly conserved process for the 
establishment of long-lasting forms of LTP and memory (Reviewed by 
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5.2: Age-related alterations in the CA1 plasticity 
and effects of hippocampal zinc chelation 
 
 
5.2.1 Deficits in plasticity and associativity in aged CA1 
pyramidal neurons 
 
Our results with the aged rat hippocampal slices depict that induction 
and persistence of synaptic plasticity such as HFS-induced LTP were 
not completely compromised in aged hippocampal CA1 SC synapses 
but exhibited significant deficit in terms of the magnitude and other 
functional associative properties. These results are in line with earlier 
reports that not all forms of plasticity are impaired in aging (Barnes et 
al., 1996; Diana et al., 1994; Kumar et al., 2007; Norris et al., 1996; 
Watabe and O'Dell, 2003).  
 
It has been suggested earlier that a shift in mechanisms that regulate 
the induction of synaptic plasticity rather than a loss of expression 
mechanisms occurs with aging (Kumar and Foster, 2007). It is 
probable that the shift in the plasticity mechanisms could restrict the 
expression of plasticity leading to reduced magnitude of LTP observed 
in our studies. Indeed, our STC experiments support this since no 
tagging and capture could be observed in the aged slices. This could 
be attributed to the deficits in any of the following factors: (i) Successful 
setting of synaptic tags that can later capture the PRPs; (ii) Production 
  174 
and distribution of PRPs and (iii) requirements of the reinforcing 
neuromodulatory inputs such as dopaminergic inputs (Moncada et al., 
2015; Navakkode et al., 2007; Navakkode et al., 2012; Redondo and 
Morris, 2011). Even though L-LTP maintenance was intact, it has been 
suggested earlier that L-LTP maintenance can be achieved by PRPs 
such as BDNF but certain STC interactions require specific PRPs such 
as PKMV (Sajikumar and Korte, 2011).   
 
A compelling body of evidence suggests that neuromodulatory systems 
such as dopaminergic inputs are critical for the establishment of long-
lasting forms of plasticity and memory (Hansen and Manahan-
Vaughan, 2014; Lisman and Grace, 2005; Redondo and Morris, 2011). 
In our study, we observed a deficit in the late-phase of the D1/D5 
receptor-mediated SOP in the aged slices. Recently, a study reported 
that the lack of dopaminergic modulation with aging leads to 
impairment in associative memory in humans (Chowdhury et al., 2012). 
The lack of late phase of dopaminergic receptor-mediated potentiation 
and its associative properties in our study support this finding by 
providing a possible cellular basis for the impaired associative memory. 
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5.2.2 Increased hippocampal Zn2+ levels in aging 
 
Zinc-containing neuronal terminals have been visualized by 
histochemical tracing methods (Brown and Dyck, 2003; Frederickson, 
1989; Frederickson and Danscher, 1990; Slomianka et al., 1990) and 
the development of fluorescent probes/sensors that are able to detect 
Zn2+ has paved the way for visualizing the levels and dynamics of zinc 
in living systems (Reviewed by (Frederickson, 2003; Maret, 2015); Ollig 
et al. 2016). A wide array of fluorescent and ratiometric probes/sensors 
are available for studying zinc in living systems (Reviewed by 
(Frederickson, 2003; Maret, 2015); Ollig et al. 2016). In our study, we 
have used one of these probes, FluoZin-3, to visualize Zn2+ levels in 
the hippocampal slices. Because the probe we used is cell-permeable, 
the signal is expected to be mostly arising from the intracellular pool. 
Also, because of the technical limitations, we have used the slices after 
fixation with 4% PFA, which might affect the esterase cleavage of the 
AM probe and as a result, may not trap the probe inside the cells. This, 
however, would not affect the probe entry into the intracellular 
compartment. Therefore, we have followed a single brief rinse to 
remove the unbound probe and then imaging immediately. Given that 
the imaging conditions followed were same for both the adult and aged 
rat slices, the observed difference in FluoZin-3 signal seems to indicate 
increased intracellular zinc levels in the hippocampus of aged rats. 
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Zinc imaging with fluorescent probes has limitations in specificity, 
selectivity and sensitivity (detection limit) depending on the property of 
the probes/sensors and on the experimental conditions (Hawkins et al., 
2012; Maret, 2015). Further, more sophisticated and controlled 
methods for estimation of zinc levels in the hippocampus would help in 
confirming these findings.    
 
5.2.3 Restoration of deficits in synaptic plasticity and 
associativity with hippocampal Zn2+ chelation  
 
CA1 pyramidal neurons are suggested to be preferentially vulnerable to 
an increase in cytosolic Zn2+ that might lead to memory deficits 
(Takeda et al., 2011). Excess synaptic Zn2+ signaling in hippocampus 
could contribute to the cognitive decline (Flinn et al., 2005; Takeda and 
Tamano, 2014). Our results lend support to the earlier predictions that 
Zn2+ levels rise with age and possibly contribute to the age-related 
memory deficits and neurodegenerative diseases (Sensi et al., 2011). 
With advanced aging, the function and/or levels of Zn2+ transporters 
may be altered (Adlard et al., 2010; Saito et al., 2000) which could lead 
to the accumulation of chelatable Zn2+ in neurons. Although Zn2+ 
nutritional deficiency is reported in advanced aging, studies in rodents 
have provided mechanistic evidence that systemic Zn2+ deficiency 
increases brain Zn2+ retention by suppressing the zinc transporter 
ZnT1 levels (Chowanadisai et al., 2005; Takeda et al., 2001). Biological 
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stress could be another factor as it was shown that stress induces 
excess intracellular Zn2+ signaling in the hippocampus and leads to 
deficits in hippocampus-dependent memory (Takeda and Tamano, 
2014). 
 
Neurons have relatively large stores of Zn2+ associated with proteins 
such as metallothionein III (MTIII) and this can be readily released 
following excitotoxic and oxidative insults (Vander Jagt et al., 2009). 
Intracellular organelles also have significant stores of Zn2+ (Sensi et al., 
2009). A number of factors could contribute to the increased Zn2+ levels 
in aging: 1) Inhibition of Zn2+ export by products of lipid peroxidation, 
such as 4-hydroxynonenal (Smith et al., 2006). 2) Systemic Zn2+ 
deficiency leading to increased brain Zn2+ retention by suppressing 
ZnT1 levels (Chowanadisai et al., 2005; Takeda et al., 2001). 3) 
Intracellular acidosis leading to enhanced Zn2+ influx through the 
activation of the H+–Zn2+ exchanger (Frazzini et al., 2007; Sensi et al., 
2003). 4) Ischemia-driven [Zn2+]i rises as the result of a combined 
process of Zn2+ influx and Zn2+ release from intracellular stores (Sensi 
et al., 2009). 
 
Accumulation of zinc can have a multitude of effects. Excessive 
intracellular Zn2+ leads to mitochondrial damage resulting in the loss of 
mitochondrial membrane potential. This further releases Zn2+ from 
mitochondrial stores, leads to the formation of reactive oxygen species 
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and depletion of ATP, thus setting up a toxic feedback cycle (Sensi et 
al., 2009; Sensi et al., 2000). Zn2+ inhibits NMDAR (Paoletti et al., 
1997; Rachline et al., 2005) and GABAAR (Smart et al., 1994), 
potentiates the currents through glycine receptor (Hirzel et al., 2006), 
blocks Na+/K+ ATPase activity and impairs glycolysis by inhibition of 
glyceraldehyde 3-phosphate dehydrogenase enzyme (Sheline et al., 
2000). 
     
NMDAR functions are modulated by Zn2+ (Izumi et al., 2006; Zhu et al., 
2012) and the change in the NMDAR composition with age to 
predominantly GluN2A composition renders it more sensitive to 
modulation by Zn2+. Dopaminergic potentiation requires the synergistic 
activation of NMDAR-dependent mechanisms (Navakkode et al., 
2007). Blockade of late-phase of dopaminergic potentiation and 
associativity could partly be attributed to NMDAR function altered by 
excess Zn2+. Chelating Zn2+ might have fine-tuned NMDAR function to 
a degree that facilitates the establishment of long-term plasticity and 
STC. Further, excess Zn2+ could also affect dopamine D1 receptor 
binding affinity and function (Turner and Soliman, 2000). However, it 
cannot be ruled out that there could be additional impairments in 
multiple mechanisms caused by excess Zn2+ and further studies are 
needed in these directions.  
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5.2.4 Hippocampal Zn2+ chelation and dopaminergic 
synaptic plasticity: Implications to cognitive 
impairments in Alzheimer’s disease   
 
Alzheimer’s disease is an exemplar of a condition of age-associated 
cognitive impairment. Though the current study did not directly 
investigate the impairments in AD animal models, the findings have 
implications to the pathogenesis of memory impairments in AD given 
that both zinc accumulation and the dopaminergic system dysfunction 
have been proposed as potential neuropathologic and pathogenic 
factors in AD (Cuajungco and Faget, 2003; Martorana and Koch, 2014; 
Sensi et al., 2009).  
 
Decreased levels of DA, decreased density of hippocampal dopamine 
D1 receptors and dopamine transporters have been reported in AD 
(Joyce et al., 1998; Kemppainen et al., 2003; Kumar and Foster, 2007; 
Nazarali and Reynolds, 1992; Storga et al., 1996; Winblad et al., 1985) 
Treatment with dopamine receptor agonists, restoring dopaminergic 
neurotransmission with DA or dopamine precursors has been shown to 
improve deficits in LTP and learning and memory in both in vitro and in 
vivo studies with AD models (Ambree et al., 2009; Guzman-Ramos et 
al., 2012; Himeno et al., 2011; Jurgensen et al., 2011).  
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On the other hand, disruption in the zinc homeostasis is also heavily 
implicated in the pathogenesis of AD. Increased zinc levels are seen in 
the limbic regions of AD patients (Danscher et al., 1997; Thompson et 
al., 1988). Reports have shown that Zn2+ is a key component of 
amyloid plaques and, in fact, Zn2+ induces rapid aggregation of 
amyloid-b at physiological pH (Bush et al., 1994; Deshpande et al., 
2009; Sensi et al., 2009) thus leading to the toxic amyloid oligomers 
and aggregates. Synaptic Zn2+ favors the attachment of amyloid-b 
oligomers to the NMDAR NR2B subunits, a key mediator of 
excitotoxicity (Deshpande et al., 2009). Additionally, by synaptic 
sequestration of zinc, the amyloid deposits act as ‘zinc sponges’ and 
hamper the physiological actions of zinc on its targets Zinc-sensing 
receptor GPR39 (ZnR), TrkB receptors, glutamate receptors and 
GABAA receptors, ultimately leading to LTP impairments (Sensi et al., 
2009). Intracellular zinc homeostasis is also known to be disrupted in 
AD as a result of many factors such as the reduced levels or activity of 
transporters, amyloid deposition, mitochondrial dysfunction and 
oxidative stress (Lovell, 2009; Sensi et al., 2009; Smith et al., 2006). 
Zinc could induce tau hyperphosphorylation and thus contribute to the 
formation of NFTs (Suh et al., 2009). 
 
Findings from our study support these observations showing that 
dopaminergic mechanisms of synaptic plasticity and associativity in 
hippocampal CA1 region are impaired in aging and a zinc excess could 
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underlie these impairments. In addition, metal chelator- or pro-chelator-
based therapeutic interventions for AD have been suggested and are 
being tested. For instance, oral administration of clioquinol (CQ), an 
antibiotic with metal chelator properties, reduces amyloid load in 
transgenic AD mouse models and improves cognitive performance in 
both mice and humans with AD (Adlard et al., 2008; Cherny et al., 
2001; Ritchie et al., 2003). Another metal chelator DP109, a lipophilic 
BAPTA derivative decreased levels of insoluble amyloid-b in transgenic 
AD mice (Lee et al., 2004).  A second generation derivative of CQ, 
called PBT2, has also showed striking improvement in cognitive 
performance upon oral treatment in AD mouse models (Adlard et al., 
2008). Our results lend support to the idea of using divalent metal 
chelators as a therapeutic strategy to rescue the cognitive impairments 
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CHAPTER 6 - CONCLUSION AND OUTLOOK 
 
 
Neuromodulatory mechanisms help to add the behavioral relevance 
and contextual richness to memories. Dopamine in the hippocampus is 
involved in the consolidation of many forms of declarative memories 
particularly those with novelty, salience and goal-directed contents.  At 
the cellular level, consolidation is supported by long-lasting forms of 
synaptic plasticity and by associative properties such as synaptic 
tagging and capture. Synaptic associative events such as STC have 
been demonstrated in anesthetized and freely behaving animals and it 
has also been shown to operate in humans, strongly underscoring the 
need to understand the mechanisms in detail.  
 
Results from our study present an interesting aspect of dopaminergic 
modulation that in CA1 pyramidal neurons, D1/D5 receptor activation 
leads to dose-dependent, differential intracellular mechanisms which 
significantly influence the ongoing associative information processing. 
We reveal a critical integrator and dose-sensor role for MAPKs in these 
mechanisms. The persistence or elimination of plasticity events 
occurring in specific dendritic compartments could be significantly 
affected by the strength of the dopaminergic activation and also on 
other events occurring within temporal vicinity. Similar mechanisms 
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could contribute to the well-known observations of pro-active and 
retroactive interference in learning and memory. These results also 
provide hints at how concomitant activation of homosynaptic and 
heterosynaptic modulatory mechanisms help to tune the specificity of 
the plasticity events and the duration of the plastic change. The 
concentration-dependent effects of the modulatory transmitter could 
thus provide the neuron with additional computational power and act to 
fine-tune the cellular information processing. As it is known that many 
addictive drugs and drugs used to treat certain neuropsychiatric 
conditions also result in altered extracellular dopamine concentrations, 
our results present an important aspect to consider in understanding 
and treating these conditions.   
 
These results also open up new questions: (i) what are the exact signal 
integration and feedback mechanisms involved in the sustained 
activation of MAPKs? (ii), what are the identities of the specific 
plasticity-related molecules involved in synaptic cooperation and 
competition? (iii) do similar mechanisms operate in behavioral 
settings? and (iv) are there species-specific and strain-specific 
differences in these mechanisms? Further studies are needed to 
address these questions. 
 
The second part of the study provides evidence for altered plasticity 
and dopaminergic mechanisms in aged rat hippocampal neurons, and 
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the consequent deficits in associative information processing. Hints are 
also provided for how an excess Zn2+ signaling process could underlie, 
at least partly, these plasticity deficits, showing that chelating Zn2+ with 
a cell-permeable chelator restores the observed deficits in plasticity 
and associative properties. The strategy of using weak zinc chelators 
and pro-chelators has proven promising in AD animal models and 
human studies with AD patients (Lee et al., 2004; Ritchie et al., 2003). 
Our study provides interesting hints regarding synaptic plasticity 
impairments in aged rat hippocampal neurons resulting from zinc 
accumulation and the possible beneficial effects of its regulation by 
pharmacological chelating agents. These results have important 
implications in understanding the adverse consequences of Zn2+ 
accumulation on synaptic plasticity mechanisms, and both learning and 
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